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SUMMARY 
Introduction: The prevention of mother-to-child transmission of HIV-1 (PMTCT) was 
launched in Uganda in early 2000 and in Mbale Regional Referral Hospital in Eastern Uganda 
in 2002. The initial challenges were the low antenatal HIV testing rates and low male partner 
involvement. The aim of this thesis was to explore determinants of women’s and men’s 
participation in the PMTCT programme in Eastern Uganda and find ways to improve male 
involvement.  

Methods: The thesis contains four studies: (a) a retrospective analysis of routine data 
from hospital records on 54 429 new antenatal attendees and 469 male partners over a 
7-year period; (b) a cross-sectional survey conducted in 2009 among 388 new 
antenatal attendees, who were tested for HIV; (c) a cross-sectional survey conducted in 
2004  among 388 male partners of pregnant women attending antenatal care at Mbale 
hospital, and in addition, 5 key informant interviews and 8 focus group discussions; 
and (d) a double blind, randomized intervention trial to increase male participation 
using an invitation letter to the male partner as the intervention and an information 
leaflet to the partner as the control, conducted in 2009-10 among 1060 new antenatal 
attendees (530 in each arm) in the antenatal clinic at Mbale Hospital, with a follow-up 
period of four weeks. Descriptive statistics and logistic regression analyses were used 
to assess the study outcomes, content-thematic analysis of the qualitative data was 
done and intention to treat analysis was conducted to assess the primary outcome of 
the trial.  
Results: There was a significant increase in HIV testing rates among the new antenatal 
attendees from 22% during the period of voluntary counselling and testing for HIV to 
88% following the change in HIV testing policy to provider-initiated HIV testing and 
counselling (PITC). Our survey showed that PITC was highly acceptable to the 
pregnant women, increasing testing rates considerably and decreasing stigma. 
However, male partners HIV testing rates remained low. Our survey among male 
partners indicated that determinants of male partner participation in the PMTCT 
programme included social, cultural, and health system factors, and that the men had 
never been invited to the antenatal clinic. A simple and cheap intervention, such as a 
letter to the male partner, increased couple antenatal clinic attendance by 10 
percentage points and the large majority of men attending the antenatal clinic accepted 
HIV testing. However, the two study arms had a similar effect. 
Conclusions: PITC remarkably increased the HIV testing rates among the antenatal 
attendees and was highly acceptable to them and can therefore be actively promoted in 
antenatal clinics and possibly other clinical settings. Although cheap and underutilised, 
the use of an invitation letter addressed to the male partners of the ANC attendees 
increased male antenatal attendance and HIV testing. It should be promoted in 
antenatal clinics in Eastern Uganda where it has been shown to work and tried in other 
areas with low male antenatal attendance, both in Uganda and beyond. 
Male involvement in a changing HIV policy context 
9 
1.0 INTRODUCTION 
1.1 Background 
The prevention of mother-to-child transmission (PMTCT) of HIV programme was 
launched in Mbale Regional Referral Hospital in May 2002. I was appointed by the 
hospital administration as the first coordinator of the programme to oversee its 
implementation within in the antenatal clinics at the hospital. One of my duties as a 
coordinator was to write monthly and quarterly reports about the programme, copies of 
which I forwarded to the Programme Manager of the PMTCT programme in the 
Ministry of Health headquarters, Kampala and the District Health Officer (DHO), 
Mbale. Anecdotal evidence showed that one of the challenges to implementation of the 
programme was the low male partner involvement. For example, some of the pregnant 
women who declined to test for HIV in the antenatal clinic reported that they needed 
to first seek for permission from their male partners, yet only few were accompanied 
by their spouses for antenatal care (ANC).  This motivated me to conduct the studies 
on which this thesis is based. In the subsequent sections of the introduction, I present a 
brief history of HIV/AIDS and virological description; describe the HIV/AIDS 
situation (global and local) and the health system in Uganda; review literature on 
PMTCT and male involvement. 
1.2 Brief history of HIV and AIDS  
Acquired immunodeficiency syndrome (AIDS) cases were first reported in specific 
human populations in June 1981 in USA [1, 2] and the term AIDS was coined 
formally by Centers for Disease Control and Prevention (CDC) in 1982 [2, 3]. 
However, the causative agent for AIDS was discovered to be a retrovirus by 
researchers in France (referred to as lymphadenopathy-associated virus, LAV) in 1983 
and in USA (known as human T-lymphotropic virus type III, HTLV-III) in 1984 
respectively [4-6]. The retrovirus was accepted by the scientific community as the 
cause of AIDS in 1984 [7] and later renamed human immunodeficiency virus (HIV) 
by the International Committee on Taxonomy of viruses in 1986 [8, 9]. By 1985, 
AIDS cases had been reported from regions in Europe, Africa, South America, Asia 
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and Australia [10-15]. In addition, it was known  that most of the HIV infections were 
acquired by sexual transmission, use of contaminated sharp instruments (e.g. needles),  
transfusion with infected blood or blood products and as a result mother-to-child 
transmission [10, 12, 15-18]. In Uganda, the first cases of AIDS (locally known as 
‘slim disease’ due to extreme wasting and weight loss) were reported in 1982 in a 
small village on the shores of Lake Victoria in Rakai district, just north of the 
Tanzania border [19]. 
1.3 Brief virological description of HIV – structure, replication cycle and clinical 
progression 
There are two known types of HIV: HIV-1 and HIV-2. HIV is transmitted through 
sexual intercourse, blood contact (transfusion or contaminated sharp objects) and from 
the mother to child (during pregnancy, delivery and breastfeeding period). HIV-1 is 
the predominant virus worldwide. HIV-2 is relatively uncommon, is concentrated in 
West Africa and seems to be less easily transmitted than HIV-1 [20, 21]; for instance it 
is almost never transmitted from the mother to the child [22, 23]. HIV-1 is related to 
simian immunodeficiency viruses (SIV) found in non-human primates (chimpanzees 
and gorillas) and HIV-2 is related to viruses found in monkeys (sooty mangabeys) [24, 
25]. HIV-1 strains are of 4 groups: M (major or main), O (outlier), N (non-M and non-
O) and P [26]. The M group accounts for most (over 90 %) of HIV-1 infections 
worldwide and is divided into at least 9 genetically distinct subtypes (or clades): A, B, 
C, D, G, F, H, J and K [27]. About 48 circulating recombinant forms (CRFs) between 
the subtypes have been described [28]; and subtype C accounts for about half (48%) of 
all HIV infections worldwide. The HIV-I subtypes found in sub-Saharan Africa are 
mainly A, C and D [28]. However in Uganda, the predominant subtypes are A and D 
[29-31], and compared with subtype A, subtype D is associated with more rapid 
disease progression [28, 32-35].  
The HIV particle (virion) is about 0.4 microns in diameter, spherical in shape and its 
structure (figure 1) consists of: 
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(a) an outer viral envelope or membrane from which project some small spikes, 
formed from the proteins gp120 (cap) and gp41 (stem) 
(b) a matrix made from protein p17 
(c) a capsid (bullet-shaped viral core) made up of protein p24. Inside the capsid 
are: (i) two identical RNA strands (each of which has a complete copy of the 
virus’s genes), and (ii) three enzymes (reverse transcriptase, integrase and 
protease) – required for HIV replication. 
HIV has only nine genes; three of them (gag, pol and env) contain information needed 
to make structural proteins for new viral particles; the other six genes (nef, rev, tat, vif, 
vpr and vpu in HIV-1 or vpx in HIV-2) code for proteins which control the ability of 
HIV to infect a cell, replicate or cause disease.  
Figure 1: Structure of HIV virion 
Source: Adapted from: US National Institute of Health: 
http://web.archive.org/web/20041119131214/http://www.niaid.nih.gov/factsheets/grap
hics/howhiv.jpg and http://upload.wikimedia.org/wikipedia/commons/6/63/HIV_Virion-
en.png
The HIV-1 replication process begins when the virus particle gets into contact with a 
host cell that expresses CD4 (a glycoprotein on the surface of CD4+ T-lymphocytes, 
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monocytes and dendritic cells). The spikes (gp120) on the viral envelope stick to CD4 
and a co-receptor (chemokine receptor type 5 - CCR5 or chemokine receptor type 4 - 
CXCR4), and allow the viral envelope to fuse with the host cell membrane, and the 
contents of the HIV particle are released into the cell, leaving the envelope behind. 
Then the reverse transcriptase enzyme converts viral RNA (ribonucleic acid) into 
DNA (deoxyribonucleic acid) and this is transported into the cell’s nucleus where it is 
integrated into human DNA by the integrase enzyme to form a provirus. The HIV 
provirus in the cell can remain dormant for a long time. Once the cell is activated, the 
provirus is converted into messenger RNA using human enzymes, transported outside 
the nucleus and acts as a blueprint for producing new HIV proteins and enzymes to 
form new viral particles. These immature viral particles are released from the cell and 
the protease enzyme chops up long strands of protein to form mature viral cores. The 
mature viral particles are capable of infecting a new cell and begin the process of 
replication all over again. HIV replicates only inside human cells. 
When HIV enters the body, it infects and destroys a large number of CD4+ T-
lymphocytes, and replicates rapidly (figure 2). The CD4+ T-lymphocytes (helper T 
cells) are white blood cells vital for maintaining the function of the immune system in 
humans. The viral load (number of HIV copies) in the blood raises to a high level and 
the virus rapidly spreads throughout the body, seeding many organs, especially 
lymphoid organs (thymus, spleen, and lymph nodes) and gut-associated lymphoid 
tissues [36]. Because of the high viral load, the HIV infected individual is very 
infectious and the risk of HIV transmission is very high [37-39]. These high levels of 
the infectious virus in the blood persist for about 10-12 weeks [40]. During this acute 
phase of HIV infection, there is irreversible destruction of the reservoirs of the T 
helper cells. In addition, the virus may integrate in the resting T cells’ genetic material 
and remain dormant for a long time. In this acute phase of HIV infection, about 50-
70% of HIV infected people manifest flu-like symptoms. The more severe and 
numerous the symptoms are, the higher the likelihood of faster HIV disease 
progression [41, 42]. 
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Consequently, the HIV levels in the blood are significantly reduced to a steady-state 
level (set point) and the CD+ T cell counts, and for some people, the number of CD+ T 
cells rises to the original levels [43].  If untreated, the HIV infection usually leads to a 
progressive decline in the CD4 cell count in the blood over a period of several years, 
leading to generalized failure of the immune system. The patients become more prone 
to life threatening opportunistic infections and are diagnosed with AIDS when the 
CD4+ T cell count drops below 200 cells per cubic millimetre. Treatment of HIV 
infected patients with antiretroviral drugs suppresses HIV replication and often the 
viral load in the blood is reduced to undetectable levels (< 50 viral copies per ml of 
plasma using current assays) [44]. Consequently, the CD4 counts may be restored to 
healthier levels by the patients’ homeostatic mechanisms. HIV infected persons can 
pass on the virus to others in their bodily fluids.
Figure 2: Typical Course of HIV-1 Infection. (Source: Pantaleo et al 1993) [45] 
In the Ugandan population, the normal CD4+ T cell count in adults is about 500-1450
CD4+ T cells per cubic millimetre [46, 47]. Together with the viral load, the CD4+ cell 
count is a surrogate marker of HIV disease progression. It is used to predict the time to 
initiate and monitor the effectiveness of antiretroviral therapy (ART) in HIV positive 
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patients [48-50]. The CD4+ count and the viral load tests are not readily available in 
limited resource settings due to their high costs [51]. 
1.4 The global burden of HIV 
Globally, the size of the HIV epidemic appears to have stabilized and the number of 
new HIV infections has been declining since the late 1990s with the scale up of 
antiretroviral therapy [52]. A recent UNAIDS (Joint United Nations Programme on 
HIV/AIDS) report showed that the HIV incidence has fallen in 33 countries world-
wide, 22 of them in the sub-Saharan region [53]. However, sub-Saharan Africa still 
bears the brunt of the global HIV disease burden. In 2010, sub-Saharan Africa, a 
region with about 12% of the global population, accounted for about 70% of all new 
HIV infections and about 68% of all people living with HIV [53]. In sub-Saharan 
Africa, women of reproductive age (15-49 years) represent about 59% of the people 
living with HIV [53]. While paediatric HIV has been virtually eliminated in high-
income countries through effective prevention of mother to child HIV transmission 
(PMTCT) interventions [54, 55], it remains of public health concern in low-income 
and middle-income countries [52, 56]. For example, an estimated 1000 children (under 
15 years of age) contract HIV infection daily worldwide. Most of these children (over 
90%) acquire it through mother to child transmission (MTCT) and more than 90% of  
this MTCT of HIV occurs in sub-Saharan Africa [52], largely because of the low 
coverage with PMTCT interventions. Worldwide, an estimated 2 million children are 
living with HIV-1 infection [52]. 
WHO/UNAIDS classify HIV epidemics into 4 types based on HIV prevalence and 
major mode of transmission : (1) low-level epidemic where HIV prevalence has not 
exceeded 5% in any defined sub-population, (2) concentrated epidemic where the HIV 
prevalence is above 5% in at least one defined sub-population but is below 1% in 
pregnant women, (3) generalized epidemic where the HIV prevalence is 1-15% in 
pregnant women, and (4) hyper-endemic epidemic where the HIV prevalence exceeds 
15% in the adult population [57].  
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1.5 HIV situation in Uganda 
The HIV epidemic in Uganda is mature and generalized [58], with heterosexual 
contact as the main mode of transmission, and it is still a major public health problem. 
The overall national adult (15-49 years) HIV prevalence rate was 7.3% in 2011 and 
0.6% in children [59, 60]. There are about 1.2 million people living with HIV-1 
(PLWH) in Uganda and about 150,000 of them are children [52]. Annually, 
approximately 120,000 new HIV infections occur countrywide; about 76% are 
acquired through sexual transmission while MTCT contributes about 22% [60, 61]. 
Uganda’s HIV epidemic has evolved over time since the first reports of AIDS cases in 
1982. According to reports from the Ministry of Health, the national HIV prevalence 
rate among antenatal attendees peaked in the early1990s and dropped from 18 % (25-
30% in some urban antenatal care sites) to about 6% (14% in urban sites) in 2002, and 
it has since stabilised between 6.4 and 7.3%, figure 3 [58, 60, 62-64].  
ϲ͘ϰ ϳ͘ϱ ϱ͘Ϭϳ͘ϯ
ϴ͘ϯ ϲ͘ϭ
dŽƚĂůϭϱͲϰϵ tŽŵĞŶϭϱͲϰϵ DĞŶϭϱͲϰϵ
dƌĞŶĚƐŝŶ,/sWƌĞǀĂůĞŶĐĞĂŵŽŶŐtŽŵĞŶ
ĂŶĚDĞŶĂŐĞϭϱͲϰϵ͕hŐĂŶĚĂ
ϮϬϬϰͲϬϱh/^ ϮϬϭϭh/^
Figure 3: HIV prevalence among Ugandan adults aged 15-49 years. 
Source: Uganda Ministry of health press release – key results of the 2011 Uganda 
AIDS indicator survey [65]. 
http://www.tasouganda.org/attachments/292_UAIS%20Press%20Release%20-
%20jUNE%202012-2.doc
The HIV prevalence decline has been debated. One contributing element was the high 
mortality of the AIDS victims. The local history in Uganda also emphasises the early 
public mobilisation by Uganda’s AIDS control programme that led to positive changes 
in sexual behaviour and contributed to the decline in HIV prevalence [66-70]. 
Robert Byamugisha 
16 
However, with the availability of some free antiretroviral drugs (ARVs), there appears 
to have been a shift towards more risky sexual behaviours [71]. 
A recent study of modes of HIV transmission (MoT) revealed that 43% of all the new 
HIV infections in Uganda occurred in discordant sequentially monogamous couples 
and 46% are among people reporting multiple partnerships. In addition, there has been 
a shift in the concentration of HIV epidemic from younger to older people with highest 
HIV prevalence for men being among the 40-44 years age group and for women it is 
highest among the 35-39 age group, figure 4 [58, 59, 61].  
Figure 4: HIV prevalence in Uganda by age groups, 2004-2011 [60].  
A recent report from the Ministry of Health documents that overall, the HIV 
prevalence is generally higher among women (8.3 %) than men (6.1%). In addition, 
for both sexes, the prevalence is lowest among those aged 15-19 years [72, 60]. 
The HIV discordance among couples is high (ranges from 30 to 50%) 
[73-75]. The prevalence of HIV infections also varies by marital status. It is lowest 
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among those who have never married and highest among those who are widowed or 
divorced/ separated [72]. 
Figure 5: Uganda with the regions and districts (2011).  
Source: Uganda AIDS indicator survey 2011 - final report [72] 
Available evidence indicates that HIV prevalence rates in Uganda also vary by region, 
place of residence and socio-economic status [72, 60]. In the nine 
regions of Uganda (figure 5), the HIV prevalence is highest in the central I region 
(10.6%) and lowest in mid-eastern region (4.1%). Over the past 6 years, there has been 
a slight decrease in the number of people living with HIV on only three regions of 
Uganda, namely Kampala, East Central and Mid Eastern (figure 6). Overall, women 
have a higher HIV-1 prevalence than men in all regions of Uganda. The HIV 
prevalence is higher among people who reside in urban areas than those in rural areas 
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in Uganda. This urban-rural difference is much stronger for women than for men [58, 
59]. 
Figure 6: HIV prevalence among age groups 15-49 years by Uganda’s sub-
regions. From: (a) Moving towards universal access: National HIV and AIDS 
strategic plan 2007/2008 to 2011/2012, (b) Ministry of Health final report of results of 
the 2011Uganda AIDS Indicator Survey [72, 76]. 
Findings from the 2006 Uganda Demographic and Health Survey showed that wealth 
and poverty can increase HIV risk and vulnerability independently [77]. The HIV 
prevalence is higher among those gainfully employed than those who are not and there 
is a gradual increase in the HIV disease burden with the wealth quintile [61]. 
According to the recent Uganda AIDS indicator survey report, the HIV prevalence 
among adults in the lowest wealth quintile is below the national average. However, 
HIV infection rates among those in the fourth and fifth quintiles are above the national 
prevalence level [59, 60]. 
Empirical evidence from Uganda shows that the higher the education level a person 
has, the lower the risk of being HIV positive [59, 78]. For example, a recent study 
among six universities in Uganda revealed that the overall HIV prevalence among the 
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university students is 1.2%, a figure much lower than the average national HIV 
prevalence of 6.7% among adults [79]. A recent report from the Uganda AIDS 
Commission indicates that the HIV prevalence is highest among the “most-at-risks 
populations”; these include female sex workers (FSW) and their partners, motorcycle 
taxi drivers (commonly known as “boda-boda” riders), workers in large commercial 
plantations,  the fishing communities and men having sex with men (MSM) [60].  
Compared to the overall HIV prevalence of 8.3% in Ugandan women [72],  the 
prevalence among FSW in Kampala was higher at 37%, though it increased with age 
from 29% in those aged 25 years or less to 48% among those aged 35 years or more 
[80]. Findings from Hladik’s study among MSM have revealed an HIV prevalence of 
13.7% which is higher than overall prevalence rate of 5.6% in Ugandan men in general 
[59, 81]. A recent publication reported a high prevalence of HIV among Uganda’s 
fishing community of 29% though it was higher in women (34%) than men (24%) 
[82]. The factors driving the HIV epidemic in Uganda are summarised in table 1.  
Table 1: Factors driving the HIV epidemic in Uganda.
Risk factors for HIV transmission Contextual factors of the HIV 
epidemic 
• Multiple partners 
• Discordance and non-disclosure 
• Lack of condom use 
• Transactional sex 
• Cross-generational sex 
• Presence of sexual transmitted 
diseases (STIs) especially HSV-2 
• Intact foreskin 
• Alcohol and illicit drug use 
• Behavioural disinhibition due to 
antiretroviral therapy (ART)  
• Socio-cultural factors 
• Wealth and poverty 
• Low status of women and girls 
• Human rights, stigma and 
discrimination 
• Inequity and access to prevention, 
care and treatment 
Source: Uganda modes of HIV transmission study [58]. 
1.6 Health system in Uganda 
The Ministry of Health provides leadership for the health sector and some of its 
functions include: policy formulation and policy dialogue with development partners, 
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setting standards and quality assurance, capacity development and technical support 
supervision, monitoring and evaluation of the overall health sector performance, and 
soliciting funding and budgeting. However, the health services are provided by both 
the public and private sectors, each contributing about 50% to health care delivery. 
The private sector includes: (a) private not for profit organisations (PNFPs) and these 
are mainly faith-based, (b) private health practitioners (PHPs), and (c) the traditional 
and complementary medicine practitioners (TCMPs) [83, 84]. 
The national health system consists of: (a) the district health system (communities, 
village health teams (VHTs), health centres (HCs) II, III and IV, and general hospitals) 
and (b) regional and national referral hospitals (figure 7). Currently, there are 13 
regional referral hospitals (RRHs) and 2 national referral hospitals (NRHs), namely 
Butabika hospital for psychiatric care and Mulago hospital for general care, both 
situated in the capital, Kampala city [85]. The national referral hospitals are the 
highest level of the health system pyramid. The RRHs and NRHs are semi-
autonomous and are answerable to the Ministry of Health headquarters. Currently, 
there are about 143 hospitals in Uganda (66 public hospitals, 61 PNFP and 16 PHP 
hospitals [85]. Ideally, all hospitals are supposed to provide technical back up for 
referral and support functions to lower level health facilities [83]. The village health 
teams, sometimes referred to as health centre I (HC I), are the lowest level of the 
health system and work as a link between the community and the health facilities; 
there is no physical infrastructure at this level. The district health system is further 
sub-divided into health sub-districts (HSDs), with the referral facility of each HSD 
being either a HC IV or general hospital [84]. The districts health services are 
managed by the Ministry of Local Government (MoLG) through the local district 
governments. 
The health services offered at each level of the health system are summarised in table 
2. Many (about 70%) households in Uganda live within 5 kilometres of a health 
facility; however, utilization of the facilities is limited due to poor infrastructure, 
inadequate supply of medicines and other materials with frequent stock-outs, and 
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shortage and low motivation of the health personnel [84]. The referral system from 
lower to higher levels of the health system is poor and it is common for patients to 
present to regional or national referral hospitals for treatment without any referral from 
lower level health facilities.  
Figure 7: The Uganda national health system.  
(Source: Health Strategic Plan II, 2005/6-2009/10, MOH; 2005) [86] 
1.7 Antenatal care 
Antenatal care (ANC) is the care given to a pregnant woman by a skilled health provider 
between conception and onset of labour. A skilled provider is a trained health professional 
that is proficient in skills required: (a) to manage  a normal (uncomplicated) pregnancy, 
childbirth and immediate postnatal period, and (b) to identify and manage and refer 
complications in  a woman and newborn [87, 88]. Therefore, a skilled provider includes: a 
nurse/midwife, medical assistant/clinical officer and a doctor. The aim of ANC is to improve 
pregnancy outcome, and to ensure the health of the mother and the foetus. It involves: (1) 
monitoring the health status of the mother and the foetus,  
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Table 2: Health services offered at each level of the health system in Uganda 
Type of 
health 
facility 
Location Standard 
population 
per facility
Current 
population 
served  
Services provided per health facility level
Health 
centre 
(HC) I 
Village 
level 
   1 000         • Community mobilization for health 
interventions such immunization, malaria 
control, sanitation. 
• Health education, promoting health 
seeking behaviour 
• Community-based management of 
common childhood illnesses including 
malaria, diarrhoea, pneumonia 
• Referral 
    
HC II Parish         5 000        15 000 • Outpatient care, antenatal care, 
immunization and outreach services. 
    
HC III Sub-
county 
     20 000        90 000 • All services provided at HC II, maternity 
care, general ward, laboratory services. 
• First referrals cover for the sub-county, 
support supervision for HC II and 
community. 
    
HC IV County    100 000      190 000 • All services provided at HC III, wards, 
theatre (surgical and obstetrical 
emergency care), blood transfusion. 
• Second level referral services for the 
health sub-district (HSD) 
    
General 
Hospital 
District   500 000      260 000 All services  provided at HC IV; more wards, 
more life-saving medical, surgical and 
obstetric emergency care 
X-ray services  
Second level referral services for HSD 
     
Regional 
Referral 
Hospital 
Regional 
level 
  3 Million   2.3 Million • All services provided at general hospital 
• Specialist services such psychiatry, ear, 
nose and throat (ENT), radiology and 
ultrasonography, pathology, orthopaedics, 
ophthalmology, higher level surgical, 
medical and obstetric/gynaecological, and 
paediatric services 
• Teaching and research 
• Tertiary level referral services 
     
National 
Referral 
Hospital 
National 
level 
(capital 
city) 
10 million 33 million • Comprehensive specialist services and 
care 
• Teaching and research, in addition to 
services provided by general and referral 
hospitals 
• Tertiary level referral services 
Adapted from: Health Sector Strategic and Investment Plan (HSSIP) 2010-2015 (MOH 
2010); The second National Health Policy (NHP II) (MOH 2010); 2011 Statistical Abstract 
(UBOS 2011) [84, 89, 90] 
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(2) providing the appropriate medical and psychosocial interventions and support, and (3) 
health promotion and helping the woman make a birth plan. ANC services are offered from 
HC IIs up to Mulago National Referral Hospital (Table 2). 
As per World Health Organization guidelines [91, 92], the Uganda Ministry of Health 
recommends 4 routine visits of goal-oriented (focused) antenatal care for women with low-
risk (normal) pregnancies [77, 93]. Focused ANC refers to ANC provided by skilled health 
staff or providers that emphasizes individualised, woman-centred care; quality versus quantity 
of visits; and evidence-based, goal-directed actions. It ensures that the pregnant woman gets 
adequate care from the time pregnancy is diagnosed to time of delivery. The ANC services 
offered to the woman depend on the timing and duration of pregnancy. Ideally, in an 
uncomplicated pregnancy, the woman should come for her first ANC visit in the first 
trimester; the second visit, in the second trimester; the third and fourth visits, in the third 
trimester. The goals for and the timing of the routine ANC visits for women with 
uncomplicated pregnancies are presented in table 3.
The Ministry of Health recommends that if a pregnant woman comes for her first antenatal 
visit later than the first trimester, the health provider should combine and attend to the 
preceding goals. At all the ANC visits, the woman’s blood pressure (BP) and weight should 
be checked, the symphysio-fundal height and foetal heart activity be measured, and the 
identified problems be addressed. The woman should be encouraged to bring her partner to at 
least one antenatal visit [93]. 
Overall, in Uganda, most women (about 95%) attend one antenatal visit [94, 95], however, 
less than half of all women (about 47%) attend four or more visits. Most women (about 84%) 
get ANC from nurses/midwives but only 9% of the pregnant women receive ANC from a 
doctor. In addition, the urban women are two times more likely than rural women to get ANC 
from a doctor (15% compared with 8%) [77]. Though most women receive ANC from a 
skilled health provider (doctor, nurse/midwife, medical assistant/clinical officer or nursing 
aide), only about 57% of the pregnant women deliver in a health facility. Overall, about 59% 
of the deliveries are assisted by a skilled health provider [96].  
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Table 3: Timing and goals of the recommended antenatal care (ANC) visits and the services 
offered to women with normal pregnancies (adapted from: Uganda Clinical Guidelines 2010 [93]). 
Antenatal care visit Antenatal care services offered
First visit
(a) Gestational age (GA):  
- 10-20 weeks  
(b) Goals of ANC visit: 
- Risk assessment 
- Health education 
- Plan for delivery 
History taking:  
- history (medical, surgical, obstetric/gynaecological)  
- social and family history 
- current pregnancy  
Examination: 
- complete physical examination and obstetric examination 
Laboratory investigations: 
- blood for haemoglobin (Hb) estimation, ABO and Rhesus grouping, 
RPR (syphilis), routine counselling and testing for HIV 
- urine for albumin, glucose 
- other tests – as appropriate for the individual patient 
Health promotion: 
- address any problems 
- draw up a delivery plan and involve husband in ANC
- educate on danger signs of pregnancy and future family planning 
- educate and counsel on PMTCT of HIV, malaria prevention and 
use of insecticide treated nets (ITNs) 
- educate on adequate nutrition and hygiene, infant feeding/ 
breastfeeding, breast care, avoidance of smoking and alcohol 
- discuss sexual activity during pregnancy, dual protection for FP 
(family planning) /HIV, and avoidance of smoking and alcohol. 
Management: 
- treat incidental ailments  
- give haematinics (ferrous sulphate & folic acid), tetanus toxoid (TT) 
Second visit
(a) Gestational age:  
- 20-28 weeks 
(b) Goals of ANC visit:  
- Action on abnormal 
laboratory results 
- Ensure TT vaccination 
- Exclude  multiple 
pregnancy and  anaemia 
- Assess for signs of 
pregnancy induced 
hypertension (PIH) 
- Check foetal growth
History taking: 
- history of any symptoms or problems, like vaginal bleeding, 
drainage of liquor etc. 
- date of first foetal movements 
Examination: 
- as for 1st antenatal visit  
- weight: amount and pattern of weight change 
Laboratory investigations: 
- as for first antenatal visit 
Health promotion: 
- advise the woman how to recognize and promptly report any 
problems for timely appropriate treatment (e.g. vaginal bleeding, 
draining of liquor, blurred vision etc.) 
- dual protection for FP/HIV 
Management: 
- give TT, haematinics, mebendazole and first dose of  IPT 
(intermittent presumptive treatment of malaria) 
- treat incidental ailments 
Third visit
(a) Gestational age:  
- 28-36 weeks 
(b) Goals of ANC visit:  
- Exclude anaemia 
- Assess for signs of PIH 
- Check foetal growth 
- Review delivery plan
History taking, laboratory investigations, examination: 
- as for 2nd antenatal visit 
Health promotion 
- as for antenatal visit 
- discuss labour signs (including early rupture of membranes) 
- review delivery plan 
- dual protection for FP/HIV 
Management: 
- give haematinics and second dose of IPT 
Fourth visit
(a) GA: above 36 weeks 
(b) Goals of ANC visit:  
- As for 3rd visit 
- Exclude abnormal lie
History taking, laboratory investigations, examination, health promotion: 
- as for 3rd antenatal visit 
Male involvement in a changing HIV policy context 
25 
1.8 Mother-to-child transmission of HIV 
In absence of any HIV prevention measures, the estimated risk of mother-to-child 
transmission (MTCT) of HIV is 5-10% during pregnancy, 10-20% during labour and 
delivery, and 5-20% through breastfeeding [97]. Hence, the rates of MTCT range from 
about 15 to 30% among non-breastfeeding HIV-infected women compared with rates 
of about 25 to 45% in breastfeeding populations in low-income countries [97]. The 
factors associated with MTCT of HIV include maternal and obstetric factors, and 
infant feeding methods (table 4) [98, 99]. 
1.9 Prevention of mother to child transmission of HIV (PMTCT) programme 
The PMTCT programmes were launched in several high HIV prevalence countries in 
the late 1990s, following the initial reports of efficacious antiretroviral (ARV) 
regimens [100-103]. However, the World Health Organization (WHO) issued the first 
guidelines for the use of ARV drugs for PMTCT and recommendations for infant 
feeding options for HIV infected mothers in resource-limited settings in 2000 [104]. 
The WHO guidelines help the national ministries of health in the selection and 
provision of antiretroviral therapy (ART) and ARV prophylaxis for the women and 
their infants taking into account the local health system context. These guidelines have 
been updated several times since then to incorporate new empirical evidence. The 
current guidelines on PMTCT and infant feeding practices were released by WHO in 
2010 [105]. 
The strategy for PMTCT is a United Nations (UN) comprehensive, four-pronged 
strategy that encompasses HIV-related prevention, care and treatment, and support 
needs of the pregnant women, the mothers, their children and their families [106]. The 
four prongs are: 
1) Prevention of HIV infection among women and their partners 
2) Prevention of unintended pregnancies among HIV infected women 
3) Prevention of HIV transmission from HIV-infected women to their infants 
4) Provision of treatment, care and support for HIV-infected mothers, their 
children and families 
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Table 4: Risk factors associated with mother-to-child transmission of HIV
Risk factor Possible mechanism of infection MTCT
Maternal Health 
   Advanced HIV disease High viral load and low CD4 T cells 
   Primary HIV infection High viral load, lack of immune response 
   No maternal ARV treatment High viral load 
Obstetric factors 
   Vaginal delivery Exposure to HIV-infected genital secretions 
   Episiotomies and vaginal tears Exposure to HIV-infected blood 
   Instrumental deliveries Exposure of breached infant skin to secretions 
containing HIV 
   Chorionic villus biopsy or  
   amniocentesis 
Increased risk of placental microtransfusion 
   Fetal electrode monitoring Breach in infant skin and exposure to infected 
secretions 
   Prolonged rupture of fetal  
   membranes 
Prolonged exposure to HIV-infected secretions 
   Chorioamnionitis  Ascending infection 
   Low birth weight Impaired fetal or placental membranes 
   Prematurity Impaired fetal or placental membranes 
Maternal co-infection 
   Malaria (placental malaria) Increased viral load, disruption in placental 
architecture 
   HSV-2 Increased plasma viral load, increased shedding of 
HIV in genital secretions, genital ulcers 
   Other STIs Genital ulcerations and exposure to HIV-infected 
blood or genital secretions 
Infant feeding 
   Breast-feeding Mastitis, cell-free and cell-associated virus 
   Mixed feeding Contaminated formula or water used in preparing 
formula may cause gastroenteritis leading to 
microtrauma to infant’s bowel and provides entry to 
HIV virus 
Miscellaneous factors 
   Infant–mother HLA concordance HLA molecules on the surface of HIV-infected 
maternal cells are recognized as ‘self’ by cytotoxic T-
lymphocytes or NK cells of the infant and are, 
therefore, less likely to be destroyed 
   Maternal HLA homozygosity Increased viral load 
   Presence of CCR5 delta 32  
   mutation in T-cell 
Decreased susceptibility to HIV infection 
ARV, antiretroviral; HLA, human leukocyte antigen; HSV-2, herpes simplex virus type 2; 
MTCT, mother-to-child transmission; NK, natural killer; STIs, sexually transmitted infections. 
Adapted/modified from Paintsil E et al, 2009 and Lehman D et al, 2007 [98, 99]. 
The prevention of mother-to-child transmission of HIV-1 (PMTCT) programme was 
launched in Uganda in the early 2000. In Mbale Regional Referral Hospital in Eastern 
Uganda it was launched in 2002. The programme was scaled up to almost all districts 
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of Uganda by the end of 2004 as a comprehensive, four-pronged strategy [107]. The 
availability of PMTCT services in Uganda varies by level of health facility. By the end 
of 2009, about 87% of the hospitals, 93% of HC IVs, 73% of HC IIIs and 21% of HC 
IIIs in Uganda were offering PMTCT services [61]. The Uganda Ministry of Health 
released the first PMTCT guidelines in 2002 with single dose nevirapine (for women 
during labour and for babies within 72 hours after birth) as the main drug [108]. The 
other recommended drug was zidovudine but was used in a few sites only and HIV 
positive mothers were advised to use replacement feeding for their babies. However, 
the Ministry of Health (MOH) revised the PMTCT guidelines in 2006 according to 
recommendations by WHO and UNAIDS [107]. The recommended antiretroviral drug 
for eligible women was Combivir® (zidovudine 300 mg/lamivudine 150 mg) – given 
twice a day from 32 weeks of pregnancy till delivery, boosted by single dose 
nevirapine (200 mg) at onset of labour, and then continue with Combivir® for a week 
after delivery. The babies were recommended to receive a single dose of nevirapine (2 
mg/kg body weight) within 72 hours after birth and zidovudine (4 mg/kg body weight) 
twice a day for one week. The recommended infant feeding option for HIV positive 
mothers was exclusive breastfeeding for 3-6 months. However, exclusive replacement 
feeding could be used if it was acceptable, feasible, affordable, safe and sustainable 
(AFASS) [107]. Currently, Uganda is scaling up the use of option B-plus which 
involves giving pregnant, HIV positive women Highly Active Antiretroviral Therapy 
(HAART) from 14 weeks of pregnancy for life irrespective of the CD4 count [109].  
The work in this thesis focuses on mainly the first and third prongs. Within the 
PMTCT programme, a continuum of PMTCT services is offered. The services include 
critical antenatal, intrapartum and postnatal services to the mothers and their infants.  
In the antenatal clinic, pregnant women and their male partners are counselled about 
and tested for HIV. The women who are found to be HIV negative are encouraged to 
adopt measures to reduce the risk of contracting HIV and other sexually transmitted 
infections during pregnancy and lactation. This requires the support of their male 
partners. Hence male partner involvement in ANC and the PMTCT programme is 
encouraged and promoted by the health care providers. The pregnant women who are 
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found to be living with HIV are offered a set of sequential measures or interventions 
[110], namely: 
(a) Clinical (WHO clinical staging; table 5) assessment and CD4+ count 
estimation to determine the eligibility of mothers for treatment 
(b) ART for eligible mothers for their own health or antiretroviral 
prophylaxis for both the mothers and their infants to prevent MTCT 
(c) Safe obstetric practices 
(d) Counselling and support for HIV infected pregnant women on feeding 
options for infants. 
Pregnant women who have clinical HIV disease stage 3 or 4 and those with a CD+ 
count below 350 cells/ml are eligible for highly active antiretroviral therapy 
(HAART). Those living with HIV but are either disease stage 1 or 2 and have a CD+ 
count above 350 cells are eligible for antiretroviral prophylaxis to prevent MTCT 
[105]. The success of the PMTCT programmes is dependent on the proper 
implementation and utilization of the four-pronged strategy. MTCT has been markedly 
reduced in high-income countries but is still a threat to child survival in resource 
limited settings [52]. 
Table 5: WHO clinical staging of HIV/AIDS for adults and adolescents
Primary HIV infection
     Asymptomatic 
     Acute retroviral syndrome 
Clinical stage 1
     Asymptomatic 
     Persistent generalized lymphadenopathy (PGL) 
Clinical stage 2
     Moderate unexplained weight loss (<10% of presumed or measured body weight) 
     Recurrent respiratory tract infections (RTIs, sinusitis, bronchitis, otitis media, pharyngitis) 
     Herpes zoster 
     Angular cheilitis 
     Recurrent oral ulcerations 
     Papular pruritic eruptions 
     Seborrhoeic dermatitis 
     Fungal nail infections of fingers 
Clinical stage 3
Conditions where a presumptive diagnosis can be made on the basis of clinical
signs or simple investigations
     Severe weight loss (>10% of presumed or measured body weight) 
     Unexplained chronic diarrhoea for longer than one month 
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     Unexplained persistent fever (intermittent or constant for longer than one month) 
     Oral candidiasis 
     Oral hairy leukoplakia 
     Pulmonary tuberculosis (TB) diagnosed in last two years 
     Severe presumed bacterial infections (e.g. pneumonia, empyema, pyomyositis, bone or 
     joint infection, meningitis, bacteraemia) 
     Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
Conditions where confirmatory diagnostic testing is necessary
     Unexplained anaemia (< 8 g/dl), and or neutropenia (<500/mm3) and or 
     thrombocytopenia (<50 000/ mm3) for more than one month 
Clinical stage 4
Conditions where a presumptive diagnosis can be made on the basis of clinical
signs or simple investigations
     HIV wasting syndrome 
     Pneumocystis pneumonia 
     Recurrent severe or radiological bacterial pneumonia 
     Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month)   
     Oesophageal candidiasis 
     Extrapulmonary TB 
     Kaposi’s sarcoma 
     Central nervous system (CNS) toxoplasmosis 
     HIV encephalopathy 
Conditions where confirmatory diagnostic testing is necessary
     Extrapulmonary cryptococcosis including meningitis 
     Disseminated non-tuberculous mycobacteria infection 
     Progressive multifocal leukoencephalopathy (PML) 
     Candida of trachea, bronchi or lungs 
     Cryptosporidiosis 
     Isosporiasis 
     Visceral herpes simplex infection 
     Cytomegalovirus (CMV) infection (an organ other than liver, spleen or lymph nodes) 
     Any disseminated mycosis (e.g. histoplasmosis, coccidiomycosis, penicilliosis) 
     Recurrent non-typhoidal salmonella septicaemia
     Lymphoma (cerebral or B cell non-Hodgkin) 
     Invasive cervical carcinoma 
     Visceral leishmaniasis 
Source: WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance 
[111] 
HIV counselling and testing  
HIV counselling and testing is the entry point to treatment, care and support for people 
living with HIV [112]. HIV counselling has been defined as a confidential dialogue 
between a client and a trained counsellor whose objective is to help the client make 
informed, personal decisions related to HIV/AIDS and cope with the psychological 
stress of the HIV test results [113]. There are two types of counselling according to the 
site where the HIV counselling is offered, namely: 
(a) Clinic-based counselling (in health facility) 
Robert Byamugisha 
30 
(b)  Community-based counselling (in a village or urban neighbourhood) 
Counselling is often offered to clients before HIV testing (pre-test counselling) and 
after an HIV test (post-test counselling). Pre-test counselling is a prerequisite for 
obtaining an informed consent from a client who is offered an HIV test [113, 114] and 
helps dispel myths, rumours and misinformation about HIV, and prepares the client 
psychologically for the HIV tests and its results [113]. Depending on the HIV test 
results, post-test counselling offers the counsellor an opportunity to discuss with the 
client HIV prevention methods, emphasize the need for a repeat test within 1-2 months 
because of the possibility of a “window period” and help the client adopt or sustain 
safer sexual practice if HIV negative. For those found to be living with HIV, the 
counsellor can provide emotional support on how to cope and accept their HIV status 
with a positive attitude, and provide the relevant referral information for treatment, 
care and support services [113]. Hence HIV counselling plays a vital role in HIV 
prevention, care and treatment efforts. For example, empirical evidence has showed 
that clients who received counselling were more likely to change their behaviour 
positively and adopt safer sexual practices, hence the decreased transmission of HIV 
and other sexual transmitted infections (STIs) [115, 116]. 
For the PMTCT programmes, HIV counselling and testing was first recommended in 
1985 by the Centers for Disease Control and Prevention [117]. When the PMTCT 
programme was launched in Uganda in 2000, HIV counselling and testing were 
provided in the antenatal clinics using voluntary counselling and testing (VCT) model, 
also known as client-initiated or opt-in approach [108]. The antenatal attendees were 
offered the HIV test only if they requested for it and given individual pre- and post-test 
counselling. Anecdotal evidence showed low HIV testing rates in antenatal clinics 
under VCT model. However, in 2006, the HIV counselling and testing policy was 
changed from VCT to provider-initiated testing and counselling (PITC) model, also 
known as opt-out or routine counselling and testing approach [107]. In this model, 
group pre-test counselling/education and routine offer of the HIV test are provided to 
all the antenatal attendees but the client can decline the HIV test (opt-out) if she/he 
desires. A recent WHO report has documented that about 63% of all pregnant women 
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in Uganda accepted to be tested for HIV in 2010 compared to 18% in 2005 (under 
VCT model)[118]. Similarly, a 2010 report from the Uganda AIDS Commission 
documented that over 90% of the ANC attendees in Uganda were counselled and 
tested for HIV [61]. A sequential HIV testing algorithm, with same day results, 
including 3 rapid tests is used on a single blood sample. The rapid tests are: Determine 
HIV 1/2 assay for screening, STAT-PAK HIV I/2 dipstick assay as a second test and 
Uni-Gold Recombigen HIV test as a “tie-breaker” [107].  
1.10 Male partner involvement in ANC/PMTCT 
A recent (2010) UNAIDS report highlights the importance of engaging men in the 
global HIV/AIDS response [52]. Male partner involvement in the PMTCT programme 
is vital since in many contexts men are the decision makers in most of the reproductive 
health issues of their spouses [119, 120]. However, men’s antenatal attendance and 
their participation in the PMTCT programme are still low [121-123]. The underlying 
factors include the perception that antenatal clinics are not “male-friendly” [124, 125], 
the fact that men are invited to participate [126], HIV-associated stigma [127, 128], 
men’s misconception that the HIV status of their partners is a proxy of theirs [129, 130]
and the belief that antenatal care is a woman’s activity[124, 125, 130-133]. Recent 
reviews have revealed that the determinants of male partner involvement in the 
PMTCT programme include health system, societal/cultural and individual (male or 
female) factors [134, 135]. 
Male involvement in the PMTCT programme increases the use of PMTCT 
interventions [136, 137]. It is associated with reduced risk of MTCT and a lower HIV-
associated infant mortality [138]. It may facilitate HIV sero-status disclosure among 
couples [139]. It may also enhance communication between couples about HIV and 
facilitate positive behavioural change such use of condoms and limiting sexual 
partners [129].  
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1.11 Rationale and focus of the studies 
HIV/AIDS is a public health problem and MTCT of HIV is the major cause of 
paediatric HIV. In Uganda, MTCT contributes about 22% of the new HIV infections 
that occur annually countrywide [60, 61]. Although the PMTCT programme has been 
implemented in Uganda for over 10 years, its performance is still inadequate to meet 
the national goal of eliminating HIV in children [61]. While many of the PMTCT 
intervention strategies require involvement of men, in actual practice they hardly 
participate or support the women in PMTCT of HIV. Antenatal clinics are the entry 
points to the PMTCT programme and yet anecdotal evidence shows that in Uganda 
few men accompany their spouses to attend antenatal care. Since men are the decision 
makers in most family matters, engaging men is a critical component of the PMTCT 
programme [140, 141]. Provider-initiated testing and counselling (PITC) for HIV was 
launched in the PMTCT programme in Uganda in 2006 in order to increase the testing 
rates among the antenatal attendees, although it had been practiced in high incomes 
countries since the late 1980s [142, 143]. However, antenatal HIV testing rates among 
the male partners have remained low despite the change in HIV testing policy. In 
addition, there is neither a standard operational definition of what “male involvement” 
entails nor standardized instruments to measure it. Within this context, the focus of the 
each of the four papers included in this thesis is described the following section. 
Paper I documents the performance of the PMTCT programme over a 7-year period 
and the effect of the change in HIV testing policy on HIV testing rates among 
antenatal attendees in Mbale Regional Referral Hospital. In Paper II, we explore the 
attitudes of the pregnant women to PITC for HIV and their knowledge about the 
PMTCT programme. Paper IIII documents the factors that either facilitate or hinder 
men’s participation in the PMTCT programme and reports some suggestions that 
could increase male involvement in the programme. It also documents the level of 
male partner involvement in the PMTCT programme in Eastern Uganda. In paper IV, 
we report findings from a randomized facility-based intervention trial we tested of the 
suggestions from paper III. The intervention was an invitation letter delivered to 
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spouses of new antenatal attendees and the control group received an information 
leaflet about antenatal care in general. 
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2.0 STUDY AIM AND OBJECTIVES 
2.1 Aim 
The overall objective of this research was to explore factors that determine women’s 
and male partners’ participation in the programme for prevention of mother-to-child 
transmission of HIV (PMTCT) in Eastern Uganda, and to identify an intervention to 
increase male partner participation and examine its effect on male partner participation
in the PMTCT programme. 
2.2 Specific objectives 
1. To describe the past performance of the PMTCT programme at Mbale Regional 
Referral Hospital with particular reference to lessons learnt in changing from 
voluntary counselling and testing (VCT) to routine counselling and testing 
(RCT) for HIV in the antenatal clinic (Paper I).
2. To evaluate the attitudes of pregnant women to routine HIV counselling and 
testing, and their knowledge about feeding options in the PMTCT programme 
to HIV infected women (Paper II). 
3. To determine level of male participation in the PMTCT programme and 
identify the factors associated with this participation, and suggest ways in 
which it could be increased (Paper III). 
4. To assess the effect of a written letter to spouses of antenatal attendees 
attending their first antenatal visit, on couple antenatal attendance and partner 
acceptance of HIV testing at the subsequent antenatal visit (Paper IV). 
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3.0 SUBJECTS AND METHODS 
3.1 Study area and geographical description 
Uganda is a landlocked country in Eastern Africa, situated astride the Equator west of 
Kenya, east of Democratic Republic of Congo and covering an area of approximately 
241 600 square kilometres. It also borders the Republic of South Sudan in the north, 
and Rwanda and Tanzania in the south (figure 8). Its terrain is mostly a plateau around 
1 100 metres above sea level with a rim of rift valley mountains. It has a tropical 
climate, generally rainy (around 700-2000 mm/year) with two dry seasons and average 
temperature of 24 degrees centigrade (range: 16-310 C) [95].
It has an estimated population of 34 million with an annual growth rate of 3.2 percent, 
one of the highest growth rates in the world [95]. The population is therefore very 
young, in fact more than half of Uganda’s population is below 15 years of age (52%) 
[95, 144].  
Uganda is a low income country and has a Gross Domestic Product (GDP) per capita 
of about $ 550 (US dollars) and 25% of the population lives below the poverty line 
[95, 145]. The Uganda government spends about 9% of the government’s total budget 
on health, inadequate in relation to the 2001 Abuja Declaration target of at least 15% 
Study area
Figure 8: Map of Uganda 
Source: http://goafrica.about.com/library/bl.mapfacts.uganda.htm
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[85]. Although there has been some improvement in the health service delivery, the 
health indicators are still poor (table 6). 
Table 6: Selected socio-demographic and health indicators for Uganda 
Indicator 2010/2011  
Population (total)  34 million inhabitants
Life expectancy  54 years 
Total fertility rate 6.2 children/woman  
Maternal mortality ratio  310 per 100 000 live births  
Infant mortality rate  54 per 1 000 live births  
Population growth  3.2% per year  
Adult literacy rate - overall (aged 15 years and above)  73%  
Population living below poverty, below US$ 1  25%  
Sources: 2012 Statistical abstract [95], Uganda poverty status report 2012 [145] and 
Trends in maternal mortality: 1990-2010 [146], 2011 Uganda Demographic and 
Health Survey (2011 UDHS) - preliminary report [94], The State of the World’s 
Children 2012 [147], The state of the world population 2011[148].
The studies included in this thesis were conducted in Mbale district (figure 8), one of 
the 111 districts in Uganda as of July 2010 [149]. Mbale is situated at the foothills of 
Mt Elgon in Eastern Uganda, just north of the Equator. The district was larger in 2002 
(Table 7) and had a population of about 721 240 people [150]. After being divided, the 
district had a population of 429,000 inhabitants (2011 estimate) [90]. The population 
are mainly subsistence farmers. Like the rest of Uganda, most of the population is 
rural. The main language spoken in the district is Lugisu, also known as Lumasaba.
The literacy rate among males was 75 % and 60 % in females [95]. Mbale district is 
administratively divided into Bungokho County (rural) and a municipality (urban). 
Mbale town is the main administrative and commercial centre in Eastern Uganda and 
had an estimated population of 92 000 inhabitants in 2011 [95]. 
Mbale Regional Referral Hospital, commonly known as Mbale hospital, is located in 
Mbale municipality, approximately 240 kilometres north-east of Kampala City by 
road. It is a regional referral hospital for the districts in eastern Uganda, which include: 
Budaka, Bududa, Bukedea, Bukwo, Bulambuli, Busia, Butaleja, Kapchorwa, Kibuku, 
Kumi, Kween, Manafwa, Mbale, Pallisa, Sironko, Tororo [95]. Mbale Regional 
Referral Hospital serves an estimated population of 3.5 million people. It is a public 
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health facility funded by the Uganda government (Ministry of Health) and the general 
care is free. The hospital has a bed capacity of 380 and also serves as a teaching 
hospital for clinical paramedical trainees (clinical officer trainees) and interns (junior 
house-officers). Antenatal services, including routine HIV counselling and testing, are 
offered daily, except for weekends and the average attendance is 50 to 60 pregnant 
women per day.  
Table 7: Mbale district’s area and estimated population before and after 2007
 Surface area Counties 
(subdivisions) 
Population
Before 2007 About 1 370 
square
kilometres
(km2)
Bubulo
Bungokho  
Manjiya
Mbale Municipality 
- 718 240 inhabitants 
(2002 Census) 
After 2007 About 470 
square
kilometres
Bungokho 
Mbale Municipality 
- 428,800 inhabitants 
(2011 mid-year estimate) 
Sources: The 2002 Uganda Population and Housing Census, Population Dynamics 
(UBOS 2006); 2010 Statistical Abstract released (UBOS 2010); 2011 Statistical 
Abstract (UBOS 2011). 
The former counties of Bubulo and Manjiya are now the districts of Manafwa and 
Bududa, respectively [90, 151, 152]. 
3.2 Study designs and study population  
The study designs for the studies in this thesis included a retrospective (secondary) 
analysis of data from hospital records about the prevention of mother-to-child 
transmission of HIV (PMTCT) programme in Mbale regional Referral Hospital (Paper 
I), two cross-sectional surveys (Papers II & III) and a randomised intervention trial 
(Paper IV). The study participants were antenatal attendees (Papers I, II & IV) and/or 
their male partners (Papers I-IV) except for the key informants who were health care 
providers (3 men and 2 women) and the men that participated in the focus group 
discussions (Paper III). We used purposive sampling during recruitment of the key 
informants and the focus groups’ participants (Paper III), convenience sampling for the 
cross-sectional surveys (Papers II & III) and simple random sampling was employed in 
the intervention trial (paper IV). Table 8 summaries the study designs and study 
populations, and types of data analyses used in the 4 papers in this thesis. 
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Table 8: Overview of the study designs, study population and types of analyses 
of data in the 4 papers in this thesis. 
Paper Study design Study population Data analysis Study period 
I Retrospective 
data analysis 
54 429 new 
antenatal attendees 
469 male partners 
- Descriptive
statistics
May 2002 to 
April 2009 
     
II Cross-sectional 
survey
388 new antenatal 
attendees
- Descriptive
statistics
- Multivariate 
logistic regression 
August to 
October 2009 
     
III Cross-sectional 
survey
388 male partners 
antenatal attendees 
5 key informants (3 
male & 2 females) 
76 men – in 8 focus 
group discussions 
- Descriptive
statistics
- Multivariate 
logistic regression 
- Content-thematic 
analysis of 
transcripts of key 
informant
interviews & focus 
group discussions  
July to August 
2004
     
IV Randomised 
intervention
trial
600 antenatal 
attendees (290 
intervention & 310 
non-intervention
groups)
Descriptive
statistics
Multivariate 
logistic regression 
October 2009
to February 
2010
In paper I, a retrospective analysis of routine data from all hospital records on HIV 
counselling and testing of 54 429 antenatal attendees and 469 male partners was 
carried out. Descriptive statistics were used to describe the performance of the 
PMTCT programme at Mbale hospital over a 7-year period. In paper II, 388 new 
antenatal attendees, who accepted routine HIV counselling and testing in the antenatal 
clinic, were consecutively enrolled in the cross-sectional survey from August to 
October 2009. Descriptive statistics and logistic regression analyses were done to 
assess the women’s attitudes to routine HIV counselling and testing, and their 
knowledge about feeding options in the PMTCT programme to HIV infected women.  
Paper III reports a cross-sectional survey conducted over a 2-month period among 388 
male partners of women attending antenatal care at Mbale hospital. In addition, 5 key 
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informants (3 males and 2 females) were interviewed, and 8 focus group discussions 
were conducted with a total of 76 men. Descriptive statistics were used to determine 
level of male participation in the PMTCT programme in Eastern Uganda; multivariate 
logistic regression analysis was used to identify the factors associated with male 
partner participation; and content-thematic analysis of the qualitative data carried out 
to identify barriers to male partner participation in the PMTCT programme and 
suggest ways how it could be increased. 
In paper IV, a randomized, parallel group, hospital-based intervention trial was 
performed among 1060 new antenatal attendees to evaluate the effect of a written 
letter addressed to their spouses on couple antenatal attendance and male partner 
acceptance of HIV testing at the subsequent antenatal visit from October 2009 to 
February 2010. The study was conducted in an antenatal clinic at Mbale Regional 
Referral Hospital, Mbale District in eastern Uganda. The intervention comprised an 
invitation letter delivered to the spouses of new antenatal attendees, while the control 
group received an information letter, a leaflet, concerning antenatal care. The 
randomization code was computer-generated by an independent statistician using a 
random sequence generator at RANDOM.ORG website. At enrolment into the study, 
the research assistants randomly assigned 1 060 eligible new antenatal attendees to the 
two parallel groups (intervention and non-intervention) with an allocation ratio of 1:1. 
The respondents, the health staff in the antenatal clinic and the research assistants were 
masked to group assignments and to letter allocation to the groups.
3.3 Data collection methods and data management 
In order to address the research questions stated in the objectives of this thesis, data 
were collected using mainly quantitative methods (papers I – IV), however, in paper 
III some qualitative techniques were also used. In paper I, data were obtained from 
copies of Mbale hospital’s monthly PMTCT programme reports submitted by the 
PMTCT coordinator to the national PMTCT programme manager in the Ministry of 
Health. We also got data from the VCT and HIV Registers, the Enrolment Registers
and Antenatal Summary Registers in the antenatal clinic and the Delivery Summary 
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Registers in the maternity ward covering a seven-year period of the PMTCT 
programme at Mbale Regional Referral Hospital. We also used the registers to verify 
the information in the PMTCT monthly reports. The data were extracted using a 
standardized data extraction form and entered into a Microsoft Excel sheet by the 
principal investigator. 
In papers II, III and IV, the data were collected by research assistants (social scientists) 
who were knowledgeable in the local language and interview techniques, and had been 
trained about the objectives of the studies. They interviewed the respondents using 
pre-tested structured questionnaires after obtaining written consent. The principal 
investigator checked filled questionnaires for completeness at the end of each day. 
Double-entry of the data was done by data-entry clerks using EpiData version 3.1. The 
data were validated by the principal investigator by checking for any errors in the 
EpiData file and exported to SPSS for analysis. In addition, for the qualitative part of 
the study in paper III, key informant interviews were conducted by the principal 
investigator with 5 senior health managers and 8 focus group discussions (FGDs) were 
conducted by two research assistants using an interview guide. The principal 
investigator participated in 4 FGDs as an observer. All the focus group discussions 
were tape-recorded. Data were transcribed by the research assistants and validated by 
the principal investigator (by listening to all the tape-recordings) before analysis. 
3.4 Sample size, study outcomes and statistical analysis 
In paper I, the sample size included all the antenatal attendees and their male partners 
who attended the antenatal clinic at Mbale hospital during a 7-year period (from May 
2002 to April 2009). The main outcomes were the proportion of pregnant women and 
their male partners who were (a) counselled for HIV and (b) tested for HIV, and (c) 
were found to be HIV positive. 
For the cross-sectional survey in paper II, the sample size calculated using OpenEpi, 
version 2.3.1 (open source calculator software for epidemiologic statistics): 
http://www.openepi.com/OE2.3/Menu/OpenEpiMenu.htm, based on the following 
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assumptions: (a) a two-sided level of significance of 5% (95% confidence interval), (b) 
80% power and (c) a 50% prevalence of positive attitude to routine HIV counselling 
and testing (RCT) among antenatal attendees. It was calculated to be 384 new 
antenatal attendees. The main outcome variable was the proportion of new antenatal 
attendees who had a positive attitude to RCT. In paper III, the sample size of the cross-
sectional survey was calculated based on an estimated proportion of male involvement 
(defined as men accompanying their spouses to the antenatal clinic) in the population 
of 10% and a 5% level of significance. It was estimated to be 422 men. The main 
outcome variable was the level of male involvement in the PMTCT programme. For 
the randomized intervention trial (paper IV), the sample size calculation was based on 
the assumptions that antenatal couple attendance would increase from about 4.5% 
(without intervention) to 9% (with intervention) with 80% power and 95% confidence 
intervals. It was estimated to 1060 new antenatal attendees (530 in each group). The 
primary outcome measure was the proportion of pregnant women who attended 
antenatal care with their male partners at their subsequent ANC visit at Mbale hospital 
during a follow-up period of four weeks. The secondary outcome measure was the 
proportion of male partners that were tested for HIV in the antenatal clinic. 
Microsoft Excel and SPSS for windows (version 13 and PASW Statistics 18) were 
used for analyses. We used descriptive statistics to examine demographic 
characteristics of participants and the main outcome measures (papers I-IV). As a 
measure of the level of male involvement in the PMTCT programme, a male 
involvement index was constructed from 6 variables with equal weight using principal 
component analysis (paper III). The Pearson chi-square test and the student’s t-test 
were used to compare selected indicators for the PMTCT programme before and after 
HIV testing policy change (paper I); and also to compare the participants socio-
demographic characteristics between the intervention and non-intervention groups 
(paper IV). Multicollinearity among the independent variables and outliers were 
checked. Binary logistic regression analyses were conducted to identify the factors 
associated with (a) positive attitude to routine antenatal HIV counselling and testing, 
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(b) male partner participation in the PMTCT programme (paper III) and (c) couple 
antenatal attendance and male partner antenatal HIV testing (paper IV).
3.5 Ethical considerations  
Ethical approval to conduct the studies was obtained from the Research and Ethics 
Committee of the School of Medicine, Makerere University College of Health 
Sciences; the Uganda National Council of Science and Technology, and the Mbale 
Regional Referral Hospital. Written informed consent was obtained from all the 
participants in the studies (papers II, III and IV). 
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4.0 SUMMARY OF RESULTS  
4.1 PAPER I: Increase in HIV testing rates among antenatal attendees after policy 
change from voluntary counselling and testing to routine counselling and testing for 
HIV
This paper describes the trends in antenatal HIV testing rates among pregnant women 
and their male partners at Mbale hospital during the first seven years of the prevention 
of mother-to-child transmission of HIV (PMTCT) programme. Overall, a total of 
54429 new antenatal attendees visited the antenatal clinic. Many of them (78.6%) were 
counselled, a half of them (51.6%) were tested for HIV and some (6.1%) were HIV 
positive. Of all the new attendees, only 469 (0.9%) were accompanied by their male 
partners. All the men were counselled, most of them (97.9%) accepted HIV testing and 
some of them (8.7%) tested HIV positive. 
Two approaches of HIV counselling and testing were used in the antenatal clinic. The 
voluntary counselling and testing for HIV (VCT) approach was offered from May 
2002 to May 2006. However, there was a change in the Uganda national HIV testing 
policy in June 2006 to provider-initiated testing and counselling (PITC), also known as 
routine counselling and testing, to date. Our study showed that there was a significant 
increase in HIV testing rates among new antenatal attendees from 22.0% (6570/29834) 
during the VCT period (May 2002 to May 2006) to 87.6% (21538/24595) in the PITC 
period (June 2006 to April 2009). Similarly, because more women were tested, more 
HIV-infected women (n = 1147) were identified in the antenatal clinic during the PITC 
period compared to 566 women in the VCT period (p = 0.012). Although the HIV 
testing rates among the male partners who accompanied their spouses to the antenatal 
clinic increased from 87.5% in the VCT period to 100% in the PITC period (p = 
0.010), the increase in the proportion of HIV-infected male partners identified from 
21% (VCT period) to 25% in PITC period was not statistically significant (p = 0.103). 
However, the absolute numbers of the male partners tested for HIV in the antenatal 
clinic remained very low despite the policy change in HIV testing.
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4.2 PAPER II: Attitudes to HIV counselling and testing, and knowledge about 
prevention of mother to child transmission 
Of the 388 pregnant women enrolled in the study, two-thirds were living in the rural 
areas and had a median age of 24 years (range 15-46 years). Most of them were Bagisu 
(64%), had no salaried employment (87%) and had had less than 11 years of 
education, that is incomplete secondary education or less (74%). Their male partners 
were older (median age 30 years; range, 18-72 years) and a half of them had 
completed secondary school education.  
All the pregnant women were given pre-test HIV counselling and many of them 
(86.3%) rated highly the pre-test counselling they had received. The new ANC 
attendees were more likely to have a positive attitude to pre-test counselling for HIV if 
they were residing in an urban area (Odds Ratio, OR: 3.0, 95% Confidence interval, 
CI: 1.4-6.6); having three or more pregnancies (OR: 3.0, 95% CI: 1.4-6.8); were 
among the least poor (OR: 1.9, 95% CI: 1.0-3.7); and were young (15 to 24 years of 
age) (OR: 2.5, 95% CI: 1.1-5.4). Almost all the women (99.5%, 386/388) attending 
their first antenatal visit at Mbale regional Referral hospital tested for HIV and 382 
(98.5%) received same-day HIV test results. The majority of the new ANC attendees 
(98.5%) had a positive attitude to routine antenatal HIV testing. In addition, more than 
half of the women (54%) sought their male partners’ permission to test for HIV. 
Our study also showed that many of the women (more than 60%) knew that mother-to-
child transmission (MTCT) of HIV could occur during pregnancy, delivery and 
through breastfeeding, and also knew MTCT of HIV could be prevented. About 63% 
of them knew that the risk of MTCT of HIV could be reduced if an HIV-infected 
mother exclusively breast-fed her baby for six months. The new antenatal attendees 
were likely to have knowledge of exclusive breastfeeding as an infant feeding option 
for an HIV-infected mother if they had completed secondary school (OR: 2.5, 95% CI: 
1.3-4.9); were non-Bagisu by ethnicity (OR: 1.7, 95% CI: 1.0-2.7); and had three or 
more pregnancies (OR: 2.5, 95% CI: 1.4-4.5).  
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4.3 PAPER III: Determinants of male involvement in the prevention of mother-to-child 
transmission of HIV programme  
In the cross-sectional survey, there were 387 male partners of new antenatal attendees 
with a median age of 32 years (inter-quartile range, IQR, of 28 to 37 years) and had a 
median period of education of 7 years (range 0 to 18 years). In addition, 76 men who 
participated in the focus group discussions had a median age of 34 years (IQR: 24-44 
years). Few of the male partners (4.7%) had attended the antenatal clinic with their 
spouses, however the majority (97%) had provided financial support to their spouses 
to attend ANC. The level of male involvement in the PMTCT programme was low; 
only twenty-six percent of the respondents had a high male involvement index.  
In logistic regression analysis, the factors associated with a high male involvement 
index were: male partners’ level of  education, occupation  and fear of disclosure of 
HIV results to wife. Men who had attained secondary education were two times more 
likely to have a high male involvement index (OR: 1.9, 95% CI: 1.1-3.3). However, 
those whose occupation were drivers or motocycle (locally known as Bodaboda)
cyclists (OR: 0.3, 95% CI: 0.1 0.9) and those who had fear to disclose their HIV 
results to their wives (OR: 0.4, 95% CI: 0.2-0.7) were likely to have a low male 
involvement index. In addition, the male partners who were professionals by 
occupation (OR: 5.4, 95% CI: 1.7-17) were aware about antenatal clinic (ANC) 
services (OR: 3.1, 95% CI:1.2-9.2); knew their women’s ANC appointment dates (OR: 
8.6, 95% CI: 1.0-72); and were willing to go with their spouses for HIV testing (OR: 
3.6, 95% 95% CI: 1.1-12), were more likely to accompany their wives’ to the antenatal 
clinic on their scheduled visits. This study also showed that barriers to male partner 
involvement in the PMTCT programme included health system, socio-economic and 
cultural factors. The male partners’ suggestions for increasing male participation in 
ANC and PMTCT activities hinged mainly around improvements in the health system. 
However, another suggestion by the men was that the midwives should formally invite 
them to attend the antenatal clinic using the antenatal cards of their wives. We decided 
to test this idea which we did in paper 4. 
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4.4 PAPER IV: Male partner antenatal attendance and acceptance of HIV testing  
In this facility-based intervention trial, a total of 1060 pregnant women attending their 
first antenatal visit to Mbale Regional Referral Hospital were enrolled and randomly 
assigned to the intervention and non-intervention groups (530 women in each group). 
During the follow-up period, 290 women in the intervention group and 310 in the non-
intervention group attended the scheduled antenatal clinic visits. The median age of 
the pregnant women was 24 years in both the intervention (IQR: 20-28 years) and non-
intervention (IQR: 21-29 years) groups. A total of 86 women in intervention group and 
75 women in the non-intervention group attended the antenatal clinic with their male 
partners. The median age of the male partners was 30 years in both the intervention 
group (IQR: 26-38 years) and non-intervention group (IQR: 26-35 years) respectively. 
The socio-demographic characteristics of participants in the two arms of the trial were 
similar.
Analysis by intention-to-treat demonstrated that male partner antenatal attendance 
(couple antenatal attendance) was 16.2% (86/530) in the intervention group and 14.2% 
(75/530) in the non-intervention group; partner attendance in the two trial arms was 
similar (OR = 1.2; 95% , CI: 0.8 to 1.6). Similarly, the majority of the male partners 
(95% in the intervention group and 91% in the non-intervention group) accepted HIV 
testing. However, in logistic regression analysis, there was no statistically significant 
difference between the intervention and non-intervention groups with respect to male 
partner antenatal HIV testing (OR = 1.6; 95% CI: 0.4 to 6.8). Surprisingly the male 
participation increased by 10% compared to what it was before the trial (5%) by 
simply inviting the spouses.
All the female antenatal attendees who participated in the trial accepted antenatal HIV 
testing and 25 of them (11 in the intervention and 14 in the control group) tested 
positive for HIV. Significantly, many of the male partners of these HIV positive 
pregnant women (84 %; 21/25) were not tested for HIV in the antenatal clinic (10 men 
did not attend the clinic; 11 men attended but declined to be tested). 
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5.0 DISCUSSION 
The overall objective of the studies included in this thesis was to explore factors that 
determine women’s and male partners’ participation in the PMTCT programme) in 
Eastern Uganda, and to identify an intervention to increase male partner participation 
and examine its effect on male partner participation in the PMTCT programme. The 
studies were: (a) a retrospective analysis of data from a single site (Mbale Regional 
Referral Hospital) in Eastern Uganda on coverage of antenatal care attendees (and 
their partners) with HIV testing, over a seven-year period, which included a switch in 
policy from an opt-in to an opt-out approach in HIV testing (Paper I), (b) two cross-
sectional surveys (Papers II & III) and (c) a randomised, hospital-based intervention 
trial (Paper IV).
This chapter will discuss the methodological issues, the findings and the overall 
conclusions that we can draw from this thesis. 
5.1 Methodological considerations 
The strengths and limitations of the papers included in this thesis are summarized in 
table 9 under two methodological characteristics, namely: (a) internal validity 
including precision, and (b) external validity. The internal validity of a study refers to 
the ability of a study to provide an unbiased estimate of what it sets out to measure 
[153, 154]. Internal validity depends on the study design used, how the study is 
conducted and how the data is analysed, and is a requirement for external validity. 
Precision refers to relative lack of random error (chance) [153]. Bias (systematic 
error), confounding and chance weaken the internal validity of a study [154]. External 
validity (generalizability) refers to the degree to which the findings from a study may 
be extrapolated or generalised to populations or groups that did not participate in the 
study [153, 154].  
Robert Byamugisha 
48
Table 9: Summary of strengths and limitations of the four studies as reported in 
papers I-IV. 
Methodological 
characteristics
Paper I Paper II Paper III Paper IV 
Relating to 
internal validity 
    
Sample size Large Adequate Adequate Reduced 
     
Precision of 
estimates of 
major findings 
High High
Narrow CIsa
High
Narrow CIs 
High
Narrow CIs 
     
Study subjects     
- enrolment All new ANCb
attendees
Consecutively;
new ANC 
attendees
Consecutively;
male partners of 
ANC attendees 
Randomly; new 
ANC attendees 
- attrition/refusals None None Few refusals High attrition 
- potential for 
selection bias 
minimal minimal minimal minimal 
     
Ways to minimize 
information bias 
Verifying data 
accuracy for 
various
registers
- training of data 
collectors 
- pre-testing 
data collection 
instruments 
- daily de-briefs 
with research 
assistants 
- PI in antenatal 
clinic daily 
- regular data 
quality controls 
- training of data 
collectors 
- pre-testing 
data collection 
instruments 
- daily de-briefs 
with research 
assistants 
- PI in field daily 
- regular data 
quality controls 
- training of data 
collectors 
- pre-testing 
data collection 
instruments 
- daily de-briefs 
with research 
assistants 
- PI in antenatal 
clinic daily 
- regular data 
quality controls 
-blinding 
     
Ways to minimize 
random error 
- Double data 
entry
- Data cleaning 
- use of 
statistics 
- Double data 
entry
- Data cleaning 
- use of 
statistics 
- Double data 
entry
- Data cleaning 
- use of 
statistics 
- Double data 
entry
- Data cleaning 
- use of 
statistics 
     
Ways to minimize 
confounding 
 Multiple logistic 
regression 
Multiple logistic 
regression 
- Randomization 
- Intention to 
treat analysis 
     
Relating to 
external validity 
    
Study design Retrospective 
records review 
Cross-sectional 
survey 
Cross-sectional 
survey 
Randomized,
facility-based 
intervention trial 
     
Generalizability ANC 
attendees
and/or their 
male partners 
New ANC 
attendees
Male partners ANC attendees 
and/or their 
male partners 
aCIs: Confidence intervals, bANC: antenatal care
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Paper I 
Our study was a retrospective analysis of routinely collected data in the antenatal 
clinics and the maternity wards at Mbale Regional Referral Hospital about the PMTCT 
programme and compared two different time periods, 4 years of voluntary counselling 
and testing for HIV, followed by 3 years of routine counselling and testing for HIV. 
The strengths of this study were: (a) the large study population of new antenatal 
attendees, (b) the study was cheap and easy to conduct because the data was already 
collected in a standardised way over the 7-year study period permitting comparisons of 
trends in HIV counselling and testing over time. 
The study had some limitations. Some of the data in the Antenatal and Delivery
Summary Registers was incomplete. Efforts were made to validate the accuracy and 
completeness of data in the summary registers by comparing the daily client records in 
the various registers in the antenatal clinic and maternity units. However, the main 
focus of our study was on trends in antenatal HIV counselling and testing rates among 
pregnant women and their male partners at Mbale hospital, indicators where complete 
data were available. Hence risk of information bias was most likely minimal. 
Information bias, also called misclassification, occurs when there are errors in the 
information collected about or from the study subjects and impacts on the internal 
validity of the findings of the study [154, 155]. In comparison to the number of women 
(new ANC attendees), very few men (male partners) accessed the PMTCT services. It 
is possible that the small number of the men may have affected the validity (both 
internal and external) of our findings on male partners in the study. The policy change 
in HIV testing strategy was implemented in 2006, a period during which free ARVs 
had become more available. This may be a potential confounder. It is possible the 
ANC attendees were more likely to accept the HIV test since they could access the 
required ARVs more easily than before in case of need. The above limitations 
notwithstanding, we consider our findings to be valid since none of the weaknesses 
could question our conclusions. 
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Papers II and III 
The methods in papers II and III were similar to each other and we handle them 
together. They were cross-sectional surveys and the sample size calculation for each 
study was done prior to conducting the survey. The sample size in both studies was 
adequate and the precision was high. One of the strengths of paper III study was that 
we interviewed the men themselves directly rather than getting the information about 
men indirectly by interviewing their spouses. The other strength was the use of both 
quantitative and qualitative methods during data collection. The qualitative findings 
helped to explain the quantitative findings by answering the question on what factors 
influenced men’s participation in the PMTCT activities.
Both studies had potential limitations. Being cross-sectional surveys, causality could 
not be inferred from our findings [155-157]. The participants in both studies were 
enrolled consecutively and not randomly. This may have introduced a selection bias, 
thus undermining the internal validity. However, since about 95% of pregnant women 
in Uganda attend at least one antenatal visit [94, 95], the effect of possible selection 
bias on our study findings is minimal. We collected the data in both studies using 
experienced, trained research assistants (males and females) and pre-tested 
questionnaires. Completeness of questionnaires was checked regularly. Therefore 
potential information bias is likely to have been limited. The new antenatal attendees 
were not asked about their HIV status in order to assure confidentiality and minimize 
information bias. We attempted to reduce social desirability bias by using data 
collectors who were not health staff, conducted the interviews in a private environment 
and appealed to the participants to give honest answers to the questions in the 
questionnaire. In paper III study, we determined the level of male involvement using 
an ad hoc male involvement index. It is possible this may have introduced some 
measurement bias. As far we are aware, there is no established instrument to determine 
the level of male participation in the PMTCT programme. To ensure good consistency 
of the data in the qualitative part in this study, a combination of note-taking and tape-
recording (verbatim) of the focus group discussions and the in-depth interviews was 
used. Double entry of data and data cleaning were done before data analysis, and 
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during data analysis, interactions were checked for and confounding adjusted for using 
multiple logistic regression technique. With the high number of participants studied, 
the confidence intervals of our results are narrow and our study findings are unlikely to 
be due to chance. Therefore, we consider the internal validity of our findings in the 
two studies to be high.  
The studies were conducted in Mbale district in eastern Uganda. Even though the 
study participants were from rural and urban areas they may not be representative of 
the whole population of Uganda. Therefore, our study findings may not be 
extrapolated to the rest of the population nationwide and it is not possible to generalize 
our findings to other sub-Saharan Africa countries, more so where the level of 
maturation of the HIV epidemic is different from that in Uganda. For the qualitative 
part of paper III study, the transferability of our findings to other populations beyond 
our study area may be limited.  
Paper IV 
A randomised controlled trial gives strong evidence for the effectiveness of an 
intervention [158, 159]. It also enables us to control for known and unknown 
confounding factors. This design – a parallel group, randomised health facility-based 
intervention – was appropriate for the study objective, that is: to evaluate the effect of 
a written invitation letter to the spouses of the new antenatal attendees on antenatal 
couple attendance and male partner acceptance of HIV testing.  
The baseline demographic characteristics of the study participants in this trial show 
that randomisation worked well and that the outcome variable (couple antenatal 
attendance) may not have been affected by participant assignment bias. Health staff 
and research assistants were blinded. It is assumed that randomisation and blinding 
dealt with known and unknown confounders in both arms of the trial [159]. However, 
the respondents were not blinded, which is impossible in behavioural interventions. It 
is possible that there could have been contamination between the two trial arms if the 
participants shared the information about the interventions. The main limitation of the 
trial was arguably the high loss to follow-up rate of approximately 40%, negatively 
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impacting on the precision (internal validity) of our findings, reducing the power (from 
80% to 30%) of the trial to detect real differences between the arms and introducing 
the potential of a differential loss to follow-up. There are several possible explanations 
for the high rate of loss to follow-up. First, we had a short follow-up period (coming 
back within 4 weeks). Second, women with low risk pregnancies may have decided to 
continue getting their antenatal care at lower level health facilities closer to home. 
Third, some may have come to the hospital in order to get a hospital antenatal card and 
access HIV counselling and testing services but thereafter continued attending 
antenatal clinics elsewhere or to be able to deliver in the hospital in case of problems. 
Fourth, due to financial constraints, some women may have failed to come back for 
their return ANC visits as scheduled.
Another strength was that being both a principal investigator for the trial and a 
clinician in the hospital, I intentionally did not directly participate in administering 
intervention to the trial participants in order to avoid the Hawthorne effect [153, 160, 
161] on the internal validity of the trial.
Behavioural interventions are inherently contextual and therefore it is difficult to know 
if the intervention will work as in our case in other places without trying. We consider 
that it is likely to have a similar impact in populations that are similar or close to the 
one in the trial area. 
5.2 Discussion of findings 
Paper I and II: Provider-initiated testing and counselling
At the time we carried out and published studies I and II, provider-initiated testing and 
counselling (PITC) was still under debate and mainly questioned from a human rights 
perspective, whether it was correct to push for HIV counselling and testing [162-166]. 
Our Paper I demonstrated a dramatic increase in the testing rates in the new antenatal 
attendees in the antenatal clinic. Paper II showed that almost all the participants were 
positive to PITC; the main reasons being that it considerably decreased stigma related 
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to the testing and the need to ask the husband for permission to be tested. Now (2013), 
a couple of years down the line, there is an overwhelming number of different studies 
in different settings, basically showing the same thing as our papers I and II: that PITC 
is highly acceptable to the women, that it increases testing considerably and that it 
decreases stigma [167, 168] and a recent review article supports our findings [169].  
One issue remains, however, as PITC did not lead to a similar increment in the male 
partner testing rates. This has led to an increase in the inequity in access to HIV testing 
between the sexes. We therefore went on to paper III and IV to see how this inequity 
in access to HIV testing between the antenatal attendees and their male partners could 
be reduced.  
PAPER III and IV: Male partner involvement in PMTCT 
The study Paper III showed that determinants of male participation in the PMTCT 
programme included social, economic, cultural and health system factors, and male 
partner involvement in the PMTCT programme was low. The intervention study in 
paper IV showed that the use of a letter addressed to male partners increased couple 
antenatal clinic attendance from 5% to 15% and most of the male partners accepted the 
HIV test. However, the outcome in the two study arms was similar. Other studies 
support our findings [138, 170]. We tried to remove some of the health system factors 
and had an encouraging effect in light of the fact that the letter did not change the 
social, economic or cultural factors. 
Why was the outcome in the two arms so similar? 
This study used a simple, cheap intervention (a letter) that was easy to administer. In 
the Mbale Regional Referral Hospital with its 10 000 new ANC attendees annually the 
cost of this intervention is 200 USD per year (not counting the extra workload). The 
effect was encouraging and should be tried in programmatic fashion in several other 
places. As mentioned above, behavioural interventions are inherently contextual and it 
is difficult to predict if it will work as well in other places without trying. It could be 
subjected to regular monitoring and evaluation and with more resources, the follow-up 
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period could be increased and the intervention could be introduced in a step-wise 
manner.  
So far, we have not found any similar study being carried out, neither as a trial nor as a 
programmatic intervention. It seems like the potential found in a single sheet letter to 
the partner in increasing the male participation has not been fully utilised and in this 
sense our findings are underutilised. More lobbying among strong stakeholders and 
programme organisers is needed.  
We know that a number of social, economic, cultural and health system factors are 
hindering the male partners to come forward for HIV testing. We tried to remove some 
of the health system factors and had an encouraging effect in light of the fact that the 
letter did not change the social, economic or cultural factors.  
Other ways than a letter to the partner to reduce the gender inequity in access to testing 
that have been proposed are:  couple counselling [171], community sensitisation to 
mobilise men [170], use of male peer counsellors , and HIV testing in other 
environments [172] such as: community based testing [173, 174] workplace testing, 
home-based testing [175, 176] and hot spot testing. Most likely, a combination of 
efforts will have a larger impact. 
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6.0 CONCLUSION 
PITC remarkably increased the HIV testing rates among the antenatal attendees and 
was highly acceptable to the antenatal attendees and can therefore be actively 
promoted in antenatal clinics and possibly other clinical settings. 
Although cheap and underutilised, the use of an invitation letter addressed to the male 
partners of the ANC attendees increased male antenatal attendance and HIV testing. It 
should be promoted in antenatal clinics in Eastern Uganda where it has been shown to 
work and tried in other areas with low male antenatal attendance, both in Uganda and 
beyond. 
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Abstract
Background: The burden of mother-to-child transmission of HIV in Uganda is high. The aim of this paper is to
describe the experience of the first 7 years of the prevention of mother- to- child transmission of HIV (PMTCT)
programme in Mbale Regional Hospital, Eastern Uganda, with particular reference to the lessons learnt in changing
from voluntary counselling and testing (VCT) to routine counselling and testing (RCT) for HIV testing in antenatal
services.
Methods: The study was a retrospective analysis of the PMTCT records of Mbale Regional Referral Hospital,
Uganda, from May 2002 to April 2009. The data on HIV testing of pregnant women and their male partners was
extracted from the reports and registers using a standardized data extraction form, and data was analysed using
descriptive statistics. Permission to conduct the study was obtained from School of Medicine, Makerere University
College of Health Sciences; Uganda National Council of Science and Technology, and Mbale Hospital.
Results: A total of 54 429 new antenatal (ANC) attendees and 469 male-partners accessed antenatal services at
Mbale Regional Referral Hospital. There was a sustained, significant increase in HIV testing among new ANC
attendees from 22% during the VCT period to 88% during the RCT period (p = 0.002), while among male partners,
HIV testing increased from 88% to 100% (p = 0.010) However, the overall number of male partners who tested for
HIV remained very low despite the change from VCT to RCT approach in HIV testing.
Conclusions: Routine offer of antenatal HIV testing dramatically increased HIV testing in pregnant women and
their partners in Uganda. Our findings call for further strengthening of the policy for routine HIV testing in
antenatal clinics. Our study also showed that male partner HIV testing in antenatal clinics is low and this area
needs further work through research and innovative interventions in order to improve male partner involvement.
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\Background
Over the last decade, large efforts have been used to
prevent mother-to-child transmission (MTCT) of HIV
in Sub-Saharan Africa. The prevention of mother-to-
child transmission of HIV (PMTCT) programme has
evolved over the past decade and currently comprises of
HIV counselling, HIV-testing, infant feeding counselling,
and antiretroviral prophylaxis.
In Uganda, the burden of mother-to-child transmis-
sion of HIV in Uganda is high because of the large
number of deliveries (1.3 million deliveries per year),
almost universal breastfeeding [1] and the high [6.0%]
antenatal HIV prevalence [2,3]. This implies that about
78 000 of the women who deliver annually are living
with HIV. Hence without any interventions for PMTCT,
about 30% of these women would pass the virus to their
babies. This translates to about 23 400 infected children
every year, at least half of would be prevented if there
were a nation-wide PMTCT programme. The national
PMTCT programme was launched as a pilot interven-
tion in 8 hospitals in the year 2000, and was integrated
into existing antenatal care services. The Government of
Uganda in collaboration with UNAIDS, UNICEF and
other partners scaled up the PMTCT programme to all
districts by December 2004. The programme was intro-
duced as a client-initiated approach where antenatal
care clients were encouraged to undergo counselling
and testing for HIV if they so wished. This approach is
also known as ‘opt-in’ or voluntary counselling and test-
ing (VCT).
The prevention of mother-to-child transmission of
HIV package consisted of interventions designed to
reduce the risk of HIV transmission during pregnancy,
labour, delivery and during the postnatal period. The
comprehensive PMTCT package comprises of the fol-
lowing:
• VCT that is integrated within the antenatal clinic
services
• Quality antenatal, intra-natal and postnatal care
services as well as follow-up support for both the
mother and baby
• Antiretroviral (ARV) drugs for HIV-positive
mothers and their babies
• Counselling and support on optimal infant and
young child feeding
• Promotion of family and community support
including the involvement of male partners and
spouses
The ARV prophylaxis regimen was a single dose of
Nevirapine (NVP) 200 milligrams (mg) to the mother at
onset of labour, and a single of NVP (2 mg/kilogram
[kg] body weight), to the baby within 72 hours of birth.
The infant feeding options to HIV infected mothers
were either breastfeeding only for 3 months with abrupt
weaning or replacement feeding if it was affordable, fea-
sible, acceptable sustainable and safe (AFASS). By
December 2005, the PMTCT programme was providing
HIV counselling to about 35% and HIV testing to about
20% of all pregnant women in the country. Only 15% of
the pregnant women living with HIV in the country
were identified and about 10% of them accessed prophy-
lactic antiretroviral drugs for PMTCT [4]
Following CDC and UNAIDS/WHO recommenda-
tions [5,6], there was a change in strategy in the year
2006. The provider-initiated approach that routinely
tests all antenatal attendees for HIV was introduced in
the PMTCT programme in Uganda in 2006. This
approach is also known as ‘opt-out’ or routine counsel-
ling and testing (RCT). Concurrently, new guidelines on
the use of ARV prophylaxis for PMTCT were issued.
The ARV regimen included: Zidovudine (AZT, ZDV)
300 mg given to the mother orally plus Lamivudine
(3TC) 150 mg twice a day starting from 32 weeks
through out labour and boosted by a single dose of NVP
200 mg at onset of labour. Then she continues with
AZT plus 3TC twice a day for one week after delivery.
The baby receives a single dose of NVP syrup (2 mg/kg
body weight) within 72 hours of birth and AZT syrup (4
mg/kg body weight, twice a day for seven days. The
HIV-infected mothers were recommended to either
exclusively breastfeed for 6 months instead of 3 months
or give replacement feeds if affordable, feasible, accepta-
ble sustainable and safe.
In Uganda, about 94% of the women attend the
antenatal clinic at least once during pregnancy but less
than half (47%) of them receive 4 or more visits for
antenatal care. Only about 17% of the women make
their first antenatal visit in the first three months of
pregnancy. However, a high proportion (41%) of women
makes their first antenatal care (ANC) visit in the fourth
or fifth months of pregnancy. The median gestational
age at the first visit is 5.5 months, when the opportunity
may have passed to diagnose problems early, provide
treatment, and prevent further complications. About
41% of women deliver in a health facility and about 58%
deliver at home [7]. The aim of this paper is to describe
the experience of the past 7 years of the PMTCT pro-
gramme in Mbale Regional Hospital, Eastern Uganda,
with particular reference to the lessons learnt in chan-
ging from the VCT to the RCT strategy for HIV testing
and counselling in antenatal services.
Methods
The study was conducted at Mbale Regional Referral
Hospital in Mbale district, Eastern Uganda. It was a ret-
rospective analysis of data from hospital records on HIV
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counselling and testing of antenatal attendees in the
hospital covering a seven year period (May 2002 to
April 2009). The hospital is located in Mbale town
approximately 240 kilometres North-East of Kampala
city by road. The district had a population of over
720 000 in the year 2002, with an annual population
growth rate of 2.5%. Like the rest of Uganda, 92% of the
people live in the rural areas and are predominantly
Bagisu or Bamasaba. The main language is Lumasaba
and the main economic activity is subsistence farming.
The literacy rate was 64% for men and 49% for women
[8]. In 2003, the HIV prevalence was reported to be
5.6% [9]. The PMTCT services are offered at Mbale
Regional Referral Hospital, Bufumbo Health Centre IV
and some of health centre III units in the district. It is a
regional referral hospital for 11 districts in Eastern
Uganda and serves an estimated population of 1.9 mil-
lion people. The hospital has a bed capacity of 380 and
serves approximately 6 000-9 000 new antenatal atten-
dees per year. The antenatal care services are provided
daily except weekends. The average attendance is 50-60
pregnant women per day, including those who come for
ANC return visits. The HIV testing policy is communi-
cated to women attending ANC by either nurses/mid-
wives or lay counsellors during the health talk given in
the morning after the mothers’ registration exercise in
the clinic. All the health workers involved in the
PMTCT programme underwent a basic two-week
course on counselling for PMTCT and a one-week
course on infant and young child feeding counselling,
though some of them are now fully-trained professional
counsellors. They also received a one-week refresher
course on updates about HIV counselling and testing
before the introduction of RCT in June 2006. Initially
the counsellors offered one-to-one pre and post-test
counselling, since the number of clients accessing the
PMTCT services was low. However, as the number
of antenatal attendees undergoing VCT increased, pre-
testing counselling was given to small groups of about 5
clients (from January 2003) but individual post-test
counselling was maintained. The pregnant women were
encouraged to come for HIV testing with their partners
but very few men showed up for VCT. However since
introduction of RCT in June 2006, the service-providers
give pre-test group counselling to large groups of ANC
attendees, but offer one-to-one post-test counselling to
the women. Couples who come for RCT are seen first
before attending to the mothers who come alone as one
way of encouraging couple attendance.
HIV testing is done on-site by the health staff in the
antenatal clinic who have received a five-day training on
HIV tests using rapid HIV testing kits. All the other
routine antenatal tests are performed by the laboratory
staff in the hospital’s main laboratory nearby. A
sequential HIV testing algorithm, with same day results,
including three rapid tests is used on one blood sample:
Determine HIV 1/2 assay (Abbott Laboratories, Abbott
Park, IL, USA) for first screening; STAT-PAK HIV 1/2
DIPSTICK assay (Chembio Diagnostic Systems Inc.) as a
second test and Uni-Gold (Trinity Biotech, Wicklow,
Ireland) as a “tie-breaker”. The ANC attendees are clas-
sified as uninfected if Determine is negative and as HIV-
infected if both Determine and STAT-PAK tests are
positive. Discordant Determine and STAT-PAK blood
samples are tested using the Uni-Gold test. The HIV
test result is reported as positive if the Uni-Gold test is
positive or as negative if both STAT-PAK and Uni-Gold
tests are negative. Since 2006 ANC attendees who test
HIV-positive undergo CD4 cell count before being given
appropriate treatment according to the national PMTCT
guidelines [10].
Several registers are used to monitor and evaluate the
performance of the PMTCT programme. The VCT and
HIV Register is used during counselling and testing for
HIV to collect data from all women who are counselled.
The Enrolment Register is used to collect information
from HIV positive mothers at the time of getting the
antiretroviral drugs (accessed free of charge in the
antenatal clinic or the labour ward). The Delivery and
Birth Register is used to collect information from all
HIV-positive women who have been enrolled on the pro-
gramme, at the time when they are in labour and imme-
diately after they have delivered. The Follow-up Register
is used to collect data during the postnatal period and
beyond while the mother and baby are being followed up
till the bay is at least eighteen months of age. In addition,
there are two summary registers, namely the Antenatal
Summary Register and the Delivery Summary Register,
for monthly antenatal activities as well as activities
related to labour and delivery. Every month, the PMTCT
coordinator in the hospital compiles a report about the
PMTCT activities in the hospital, a copy of which is sent
to the National PMTCT programme manager in the
Ministry of Health headquarters.
We analysed the monthly PMTCT programme
reports, the VCT and HIV Registers, the Enrolment Reg-
isters and the Antenatal Summary Registers in the
antenatal clinic, and the Delivery Summary Registers
and HIV registers in the maternity ward at Mbale Regio-
nal Referral Hospital covering a seven-year period (May
2002-April 2009). The data was extracted using a stan-
dardized data extraction form, and entered into an excel
sheet. The variables of interest were: total number of
new antenatal attendees per year, number of ANC
attendees counselled about HIV, number of ANC atten-
dees who underwent HIV-testing and number of ANC
attendees who obtained a positive HIV-test result.
The other variables were: number of male partners
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counselled for HIV, number tested for HIV and number
of those who obtained a positive HIV-test result, num-
ber HIV-infected mothers and their infants who
received ARV prophylaxis for PMTCT. The total num-
ber of new attendees and male partners who accessed
the ANC and PMTCT services, and the total number of
HIV-positive women and their infants that accessed
ARV drugs (ARVs) was computed annually. The percen-
tages of the ANC attendees or their male partners who
were counselled and tested for HIV and of those who
tested HIV-positive were calculated. The few pregnant
women who knew that they were HIV positive at their
first antenatal visit were recorded in the VCT and HIV
Registers as having been counselled about HIV and
infant feeding options, and we included them in the
analysis among the total number HIV-positive ANC
attendees. The Student’s t-test was used to compare
some selected indicators for PMTCT in the hospital
before and after the policy change in antenatal HIV-
testing approach. A p-value of < 0.05 was considered
statistically significant.
Ethical clearance to conduct the study was obtained
from the Research and Ethics Committee of the School
of Medicine, Makerere University College of Health
Sciences; the Uganda National Council of Science and
Technology; and the National PMTCT programme,
Ministry of Health, Uganda. Permission to use the hos-
pital records was obtained from the Mbale Regional
Referral Hospital administration through the local insti-
tutional review board.
Results
Overall results of HIV testing
From May 2002 to April 2009, a total of 54 429 new
ANC attendees and 469 male-partners accessed antena-
tal services at Mbale Regional Referral Hospital. Of all
the new ANC attendees, 42 754 (78.6%) were counselled
about HIV, 28 108 (51.6%) were tested for HIV and
1713 (6.1%) of those tested received an HIV-positive
result. During the same period, a total of 469 male part-
ners received HIV counselling while 459 (97.9%) of
them were tested for HIV and 40 (8.7%) of those tested
were HIV positive.
Trends of HIV testing in pregnant women
From May 2002 to May 2006 (VCT period), 6 570
(22.0%) out of 29 834 new ANC attendees were tested
for HIV as compared to 21 538 (87.6%) out of 24 595
new ANC attendees who were tested during the RCT
period from June 2006 to April 2009 (p = 0.002), with a
corresponding increase in numbers of HIV-infected
women identified antenatally (n = 1147, 5.3% sero-
prevalence as compared with 566, 8.6% sero-prevalence
in the VCT period, p = 0.012), Figure 1 and table 1.
During the period of May 2002 to April 2003, a total
of 6 298 pregnant mothers attended their first antenatal
visits. Of these, 1 903 (30%) were counselled and 209
(3%) were tested for HIV. A steady increase in pregnant
mothers accepting voluntary counselling and testing
(VCT) for HIV was observed during the first three years
of the PMTCT programme, Figure 2 and table 2. From
May 2004 to April 2005, out of 7 982 new ANC atten-
dees, 3 546 (44%) accepted HIV testing. However in the
following year (May 2005 - April 2006), 1 915 (22.9%)
out of 8 358 pregnant mothers were tested for HIV
though 5 811 (73%) new ANC attendees had been
counselled.
In the first year after the policy change from VCT to
RCT, there was a dramatic increase in the number of
mothers who were tested for HIV. Out of 7 286 new
ANC attendees, 6 393 (79%) of them were tested for
HIV. The number of mothers accepting an HIV-test
rose to 95% (7 792 mothers out of 8 245) in the period
from May 2008 to April 2009, table 2. The increase in
coverage of antenatal HIV testing among the pregnant
women led to a corresponding significant increase in
the use of PMTCT interventions, table 1.
Trends of HIV testing in men
During the VCT period, out of 80 male partners that
accompanied their spouses to the antenatal clinic, 70
(87.5%) of them were tested for HIV compared with 389
male partners (100%) who escorted their spouses for
antenatal care and accepted HIV testing (p = 0.010),
with a corresponding increase in the numbers of HIV-
infected male partners identified in the RCT period (n =
25, 6.4% sero-prevalence as compared with 15, 21.4%
sero-prevalence in the VCT period, p = 0.103), table 1
and table 3. In comparison with the new ANC atten-
dees, the number of male partners who underwent
counselling and testing for HIV at the antenatal clinic in
Mbale Regional Referral Hospital remained very low
despite the change from VCT to RCT approach in HIV
testing, table 1 and 3.
Discussion
Our study showed that the policy change from VCT to
RCT dramatically increased the number of mothers
tested for HIV. This change was sustained over the
3 years of observation. These findings are similar to
those reported elsewhere in Africa [11]. In rural Malawi,
the number of pregnant women who accepted HIV-test-
ing increased from 78.7% to 98.8% after changing from
VCT to RCT testing approach for HIV[12]. A study
from an urban area in Zimbabwe found that 99.9% of
the ANC attendees underwent HIV-testing during the
first 6 months of routine HIV-testing compared to 65%
of the women during the last 6 months of opt-in testing
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Figure 1 Trends in HIV testing among new antenatal attendees, Mbale Regional Referral Hospital, 2002-2009.
Table 1 Selected indicators of prevention of mother-to-child HIV transmission at Mbale Regional Referral Hospital,
2002-2009
Indicator Voluntary HIV testing period
n (%)
Routine HIV testing period
n (%)
P-value (two-tailed)
New ANC attendees
Booked for ANC 29834 24595 -
Counselled for HIV 18583 (62.3) 24171 (98.3) 0.042*
Tested for HIV 6570 (22.0) 21538 (87.6) 0.002*
HIV positive 566 (8.6) 1147 (5.3) 0.012*
Male Partners of the ANC attendeesa
Counselled for HIV 80 (100) 389 (100) 0.012*
Tested for HIV 70 (87.5) 389 (100) 0.010*
HIV positive 15 (21.4) 25 (6.4) 0.112
HIV- infected pregnant women
Used ARVs for PMTCTb 316 (55.8) 885 (77.2) 0.015*
Delivered in hospital 172 (30.4) 464 (40.5) 0.042*
Infants given ARVs for PMTCTc 184 (32.5) 451 (39.3) 0.050
* Statistically significant p-value of the independent-samples t-test at the 0.05 level.
a All male partners who accompanied their spouses for the antenatal care visit were counselled about HIV.
b During the VCT period the HIV- infected women and their infants received single dose Nevirapine (sdNVP), but in the RCT period the mothers received a
combination regimen of Zidovudine (ZDV, AZT) and Lamivudine (3TC) from 32 weeks plus sdNVP at onset of labour. The infants received sdNVP syrup and ZDV
syrup for one week. Women were started on HAART after 14 weeks gestation if they had a CD4 count of < 350 or WHO disease stage 3 or 4 clinically.
c Some babies were brought to hospital for the ARVs within 72 hours of birth outside the hospital and some babies born in the hospital missed getting ARVs
when out of stock.
Byamugisha et al. BMC Health Services Research 2010, 10:290
http://www.biomedcentral.com/1472-6963/10/290
Page 5 of 8
[13]. A study conducted in Botswana demonstrated an
increase in HIV testing rate from 75% in the last 3
months of VCT period to 91% in the first 4 months of
RCT period [6].
The high proportion of routine HIV-testing in our
study could be attributed to several factors. The new
ANC attendees were less fearful of accepting HIV-
testing because the opt-out approach was perceived by
their partners and families as “standard of care” given to
all pregnant women in the antenatal clinic. In addition,
the availability of rapid HIV-testing in the clinic and the
giving of same-day HIV test results may have contribu-
ted to the high proportion of HIV-testing. The refresher
courses given to the ANC providers/counsellors with
the launch of RCT in June 2006 may have equipped
them with improved HIV counselling and testing skills,
and thus may have had a positive impact on the testing
during the RCT period. Our study has also shown that
the high coverage of antenatal HIV-testing after policy
change significantly identified more HIV-infected preg-
nant women who easily accessed the free antiretroviral
drugs (ARVs) in the antenatal clinic and the maternity
ward. A similar finding was reported in study in
Zimbabwe [13].
During the first 3 years of the VCT period (May 2002
- April 2005), there was a substantial increase in HIV
Figure 2 Trend of HIV counselling, testing and sero-positivity among new antenatal attendees, Mbale Regional Referral Hospital,
2002-2009.
Table 2 Antenatal HIV counselling and testing among new attendees at Mbale Regional Referral Hospital, 2002-2009
Period HIV testing Approach New ANC attendees
N
Counselled
n (%)
Tested
n (%)
HIV-positive
n (%)
May 02 - April 03 VCT 6 298 1 903 (30.2) 209 (3.3) 45 (21.5)
May 03 - April 04 VCT 6 468 4 407 (68.1) 900 (13.9) 101 (11.2)
May 04 - April 05 VCT 7 982 5 811 (72.8) 3 546 (44.4) 288 (8.1)
May 05 - April 06 VCT 8 358 6 462 (77.3) 1 915 (22.9) 132 (6.9)
May 06 - April 07 RCT 8 079 7 286 (90.2) 6 393 (79.1) 356 (5.6)
May 07 - April 08 RCT 8 999 8 851 (98.4) 7 353 (81.7) 387 (5.3)
May 08 - April 09 RCT 8 245 8 034 (97.4) 7 792 (94.5) 404 (5.2)
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testing among the antenatal attendees from 3.3% to 44%,
but testing coverage halved in the following year (May
2005/April 2006). This decline was largely due to inade-
quate supplies of HIV-test kits and sundries during that
period and the HIV-test tests were completely out of
stock in the months of April and May 2006, Figure 2.
During those two months about 1400 new attendees vis-
ited the antenatal clinic but could not be offered HIV-
testing services, leading to missed opportunities as has
been documented elsewhere [14-16].
The apparent higher prevalence of HIV in the VCT
period is likely to be attributed to selection bias. It is
probable that the ANC attendees who perceived them-
selves to be at higher risk of HIV infection were the
ones that most likely opted to test for HIV voluntarily.
Coupled with the small number of pregnant women
that were tested for HIV, this may partly explain the
higher prevalence of HIV during the VCT period. The
shift from one-to-one pre-test counselling to group pre-
test counselling seems not to have impacted on the test-
ing rates since there was a substantial increase in
antenatal HIV-testing rates from 14% to 44% in the per-
iods May 2003/April 2004 and May 2004/April 2005
respectively.
Our study showed that the number of male partners
who tested for HIV at the antenatal clinic was low
(below 5%) compared to the total number of the ANC
attendees despite the change from “opt-in” to “opt-out”
approach in HIV-testing. Poor male partner involvement
in PMTCT programme has been documented elsewhere
in Africa, and studies in Tanzania, Kenya and Zambia
[17,7] have reported HIV testing rates among male part-
ners of 9% to 16%. Male partner involvement is essential
for improving PMTCT outcomes [17-19]. Thus the low
rate of HIV-testing among the male partners remains a
major challenge to the PMTCT programme in Uganda.
Overall, 98% of the male partners of the new ANC
attendees were tested for HIV. During the “opt-in” per-
iod, 88% of the male partners accepted HIV testing
while 100% accepted HIV testing in the “opt-out”
period. Although the number of male partners in our
study was small, the opt-out approach appears to
increase male partner testing for HIV.
The study revealed that the average prevalence of HIV
among the new ANC attendees over the 7-year study
period was 6.1%. Similarly, HIV prevalence rates of 6.0%
and 5.9% have been reported by Musinguzi et al and
the Uganda Demographic and Health Survey respec-
tively [2,3]
Our study had a number of limitations. It was a retro-
spective analysis of routinely collected data in the
antenatal clinic and made comparisons between two dif-
ferent time periods. Accordingly, the study may have
suffered from selection bias arising from differential
selection of the participants, and from confounding due
to inability to measure and control for potential con-
founders concurrently. For example, it was not possible
to measure and control for other possible factors like
media influence that may have contributed to the
increase in HIV testing that was observed in the study.
The change in HIV testing from VCT to RCT coincided
with a period of wide availability of free ARVs especially
for treatment. This may have been a potential confoun-
der since the ANC attendees knew they could easily
access the required ARVs in case they were found to be
HIV positive. It is also possible that the policy change in
HIV testing strategy may have introduced some mea-
surement bias but this is likely to have been minimal. In
addition, there was missing data and limited demo-
graphic data in the records that may also have impacted
on the study findings. Finally, the small number of male
partners who accessed the PMTCT services may also
have affected the validity of the data on male partners in
the study.
Conclusions
Despite these limitations, our study documented a dra-
matic and sustained increase in antenatal HIV testing
among pregnant women and their partners in Mbale,
Eastern Uganda following the change from VCT to
Table 3 Male partners counselled and tested for HIV at Mbale Regional Referral Hospital, 2002-2009
Period HIV testing approach Male partnersa counselled
N
Male partners tested
n (%)
Male partners HIV-positive
n (%)
May 02 - April 03 VCT 8 7 (87.5) 3 (42.9)
May 03 - April 04 VCT 6 6 (100) 1 (16.7)
May 04 - April 05 VCT 32 28 (87.5) 8 (28.6)
May 05 - April 06 VCT 34 29 (85.3) 3 (10.3)
May 06 - April 07 RCT 103 103 (100) 11 (10.7)
May 07 - April 08 RCT 92 92 (100) 9 (9.8)
May 08 - April 09 RCT 194 194 (100) 5 (2.6)
a All male partners who accompanied their spouses for antenatal care were counselled (100%) and most of them were tested for HIV in the antenatal clinic.
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RCT. Our findings call for further strengthening of the
policy for routine HIV testing in antenatal clinics. Our
study also showed that male partner HIV testing in
antenatal clinics is low and this area needs further work
through research and innovative interventions in order
to improve male partner involvement.
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Attitudes to routine HIV counselling and testing,
and knowledge about prevention of mother to
child transmission of HIV in eastern Uganda: a
cross-sectional survey among antenatal attendees
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Abstract
Background: HIV testing rates have exceeded 90% among the pregnant women at Mbale Regional Referral
Hospital in Mbale District, eastern Uganda, since the introduction of routine antenatal counselling and testing for
HIV in June 2006. However, no documented information was available about opinions of pregnant women in
eastern Uganda about this HIV testing approach. We therefore conducted a study to assess attitudes of antenatal
attendees towards routine HIV counselling and testing at Mbale Hospital. We also assessed their knowledge about
mother to child transmission of HIV and infant feeding options for HIV-infected mothers.
Methods: The study was a cross-sectional survey of 388 women, who were attending the antenatal clinic for the
first time with their current pregnancy at Mbale Regional Referral Hospital from August to October 2009. Data were
collected using a pre-tested questionnaire and analysed using descriptive statistics and logistic regression.
Permission to conduct the study was obtained from the Makerere University College of Health Sciences, the
Uganda National Council of Science and Technology, and Mbale Hospital.
Results: The majority of the antenatal attendees (98.5%, 382/388) had positive attitudes towards routine HIV
counselling and testing, and many of them (more than 60%) had correct knowledge of how mother to child
transmission of HIV could occur during pregnancy, labour and through breastfeeding, and ways of preventing it.
After adjusting for independent variables, having completed secondary school (odds ratio: 2.5, 95% confidence
interval: 1.3-4.9), having three or more pregnancies (OR: 2.5, 95% CI: 1.4-4.5) and belonging to a non-Bagisu ethnic
group (OR: 1.7, 95% CI: 1.0-2.7) were associated with more knowledge of exclusive breastfeeding as one of the
measures for prevention of mother to child transmission of HIV. Out of 388 antenatal attendees, 386 (99.5%) tested
for HIV and 382 (98.5%) received same-day HIV test results.
Conclusions: Routine offer of antenatal HIV counselling and testing is largely acceptable to the pregnant women
in eastern Uganda and has enabled most of them to know their HIV status as part of the prevention of mother to
child transmission of HIV package of services. Our findings call for further strengthening and scaling up of this HIV
testing approach in many more antenatal clinics countrywide in order to maximize its potential benefits to the
population.
Background
HIV counselling and testing is pivotal to HIV preven-
tion, care and treatment programmes as knowing one’s
HIV status is a precursor to accessing the appropriate
care and treatment services. However, data from surveys
conducted in 12 high-prevalence countries in sub-
Saharan Africa show that only 12% of men and 10% of
women know their HIV status [1]. Uganda has an esti-
mated adult HIV prevalence rate of 6.7%, and only 15%
of adults are aware of their HIV status [2]. It is
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estimated that in 2008, mother to child transmission of
HIV accounted for 15% of new HIV infections in
Uganda [3,4].
Routine antenatal counselling and testing for HIV, also
known as provider-initiated testing or an “opt-out”
approach, involves testing all antenatal attendees for HIV,
apart from those who decline the test (i.e., those who opt
out). This is the standard of care in Scandinavia and other
high-income countries [5-10]. In a bid to increase HIV
testing rates, routine antenatal HIV counselling and testing
was successfully introduced in the HIV prevention pro-
grammes of several countries in sub-Saharan countries
[11-15] in line with Centers for Disease Control and Pre-
vention (CDC) and Joint United Nations Programme on
HIV/AIDS (UNAIDS) and World Health Organization
(WHO) recommendations [16,17].
In Uganda, the policy change from antenatal volun-
tary HIV counselling and testing (VCT), also known as
the client-initiated or “opt-in” approach (where clients
are encouraged to undergo counselling and testing for
HIV if they so wish) to routine HIV counselling and
testing (RCT) was integrated into the prevention of
mother to child transmission (PMTCT) of HIV pro-
gramme in 2006 [18]. As a result, there has been a
sustained increase in HIV testing rates to more than
90% among the pregnant women at Mbale Regional
Referral Hospital since June 2006 [19]. We conducted
our study to assess: (a) attitudes towards routine HIV
testing among the new antenatal attendees in the hos-
pital; and (b) their knowledge about mother to child
transmission of HIV and infant feeding options for
HIV-infected mothers.
Methods
The study site was Mbale Regional Referral Hospital,
located in the town of Mbale, approximately 240 kilo-
metres north-east of the city of Kampala by road, in
Mbale District. The district has a population of about
410,600 (2010 estimate) [20] and an annual population
growth rate of 2.5%, according to the 2002 national cen-
sus. The majority (92%) of the people in this district live
in the rural areas. They are predominantly Bagisu or
Bamasaba people. The main language is Lumasaba and
the main economic activity is subsistence farming. The
literacy rate is 64% for men and 49% for women [21]. In
2003, HIV prevalence was reported to be 5.6% [22].
The hospital in Mbale is a regional referral hospital
for 11 districts in eastern Uganda and serves an esti-
mated population of 1.9 million people. The hospital
has a bed capacity of 380 and serves 6000 to 9000 new
antenatal attendees per year. Antenatal care services
(ANC) are provided daily, except for weekends. The
average attendance is 50 to 60 pregnant women per day,
including those who come for ANC return visits.
The prevention of mother to child transmission
(PMTCT) of HIV programme was launched at the hos-
pital in May 2002 as an integrated service in the
antenatal care services. The PMTCT programme was
introduced as a voluntary counselling and testing (VCT)
for HIV approach. In line with CDC and UNAIDS/
WHO recommendations [16,17], the Uganda Ministry
of Health issued new guidelines for HIV counselling
and testing of pregnant women in September 2005 [23]
and a revised edition of Policy Guidelines for Prevention
of Mother to Child Transmission of HIV in August
2006 [18]. VCT was replaced by routine counselling and
testing (RCT) in Mbale Regional Referral Hospital in
June 2006.
Currently, service providers give pre-test group coun-
selling to groups of ANC attendees. The counsellors in
the antenatal clinic first attend to couples who come for
RCT when the clinic opens in the morning before
attending to the mothers who have come alone: this is
one way of encouraging couple attendance. Routine HIV
testing is done with the client’s knowledge and verbal
consent. Mothers are free to decline (opt out of) HIV
testing if they so wish without fear of any retribution
from the clinic staff.
According to national guidelines, a sequential HIV
testing algorithm, with same-day results, including three
rapid tests is used on one blood sample: Determine HIV
1 ⁄ 2 assay (Abbott Laboratories, Abbott Park, IL, USA)
for first screening; STAT-PAK HIV 1 ⁄ 2 dipstick assay
(Chembio Diagnostic Systems Inc.) as a second test and
Uni-Gold Recombigen HIV (Trinity Biotech, Wicklow,
Ireland) as a “tie-breaker”. An ANC attendee is classified
as uninfected if Determine is negative and as HIV-
infected if both Determine and STAT-PAK tests are
positive. Discordant Determine and STAT-PAK blood
samples are tested using the Uni-Gold test. The HIV
test result is reported as positive if the Uni-Gold test is
positive, or as negative if both STAT-PAK and Uni-
Gold tests are negative. Since 2006, ANC attendees who
test HIV positive undergo CD4 cell count tests before
being given appropriate treatment according to the
national PMTCT guidelines [18].
A cross-sectional survey was conducted among 388 new
antenatal attendees in the antenatal clinic at Mbale Regio-
nal Referral Hospital from August to October 2009. The
targeted study population were all antenatal attendees
who were visiting the hospital for the first time within the
current pregnancy. Women, who were very sick, requiring
urgent medical attention, were excluded from the study.
Women attending ANC for the first time were identified
at reception, and tracked through RCT for HIV and
through routine antenatal assessment. All those who were
confirmed as having undergone RCT for HIV were conse-
cutively identified and approached for inclusion in the
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study after giving written informed consent for exit inter-
views about their attitudes regarding RCT until the
required sample size was obtained.
The sample size was calculated using the computer
programme, OpenEpi, version 2, open source calculator
(open source software for epidemiologic statistics:
http://www.openepi.com/SampleSize/SSCohort.htm),
based on the following assumptions: (a) a two-sided
confidence level or interval of 95% (level of significance
of 5%); and (b) a 50% prevalence of positive attitudes
about RCT among the antenatal attendees.
A standardized, pre-tested questionnaire was adminis-
tered in either English or Lumasaba by five trained
research assistants. The questionnaire was adapted from
a pilot project on routine HIV testing in Botswana [14]
and had 50 items. The structured interview covered
topics concerning the participant’s and her partner’s edu-
cation, occupation, religion, ethnic group, number of
pregnancies, household assets, opinions and experiences
about routine HIV counselling and HIV testing in the
antenatal clinic, and knowledge about mother to child
transmission of HIV and infant feeding options for HIV-
infected mothers. Exclusive breastfeeding (EBF) was
defined in this study as feeding an infant with only breast
milk and nothing else, even water, apart from prescribed
medicines or vitamins. During group counselling sessions
in the antenatal clinic, counsellors discussed the lacta-
tional amenorrhea that occurs as a result of EBF.
The research assistants were knowledgeable in
the local language and interview techniques, and
had received training about the study objectives and
methods. The principal investigator checked filled ques-
tionnaires for completeness at the end of each day.
Data-entry clerks entered data, using EpiData version
3.1; the principal investigator undertook validation of
data, checking for any errors in the data in EpiData file.
We exported the data file to PASW Statistics 18 (for-
merly SPSS) for analysis.
Ethical clearance to conduct the study was obtained
from the Research and Ethics Committee of the School
of Medicine, Makerere University College of Health
Sciences, and the Uganda National Council of Science
and Technology. Permission to conduct the study in the
antenatal clinic was also obtained from the Mbale
Regional Referral Hospital administration through the
local institutional review board.
The main outcome measure was a positive attitude of
pregnant women to routine counselling and testing for
HIV. The secondary outcome was participants’ knowl-
edge about mother to child transmission of HIV and
infant feeding options for HIV-infected mothers. We
used descriptive statistics to examine the demographic
characteristics of the participants and their experiences
with and attitudes towards RCT. The participants were
grouped into socio-economic quintiles based on a proxy
wealth index using principal component factor analysis
[24]. Housing characteristics and assets, including radio,
hurricane lamp, television set, mobile phone, bicycle,
motorcycle, motor vehicle, refrigerator, sofa and cup-
board, were included in the model.
Prior to performing the principal component analysis,
the suitability of the data for factor analysis was
assessed. The correlation matrix showed some coeffi-
cients of 0.3 and above. The Kaiser-Meyer-Oklin of
Sampling Adequacy value was 0.808, exceeding the
value of ≥ 0.6 recommended for this test to demonstrate
that factors are inter-correlated, and the Barlett’s test of
Sphericity was significant (p = 0.000), supporting the
factorability of the correlation matrix [25]. The quintiles
were based on the first principal component, a recog-
nized method to provide a good proxy for household
wealth [26,27]. Participants were asked, “Nowadays in
this clinic, all mothers are tested for HIV unless they
say no. What do you think about this system?”
Responses included “very bad”, “bad”, “fair”, “good” and
“very good”. The responses, “good” and “very good”,
were taken as positive attitudes towards routine HIV
testing.
Bivariate analysis was performed between knowledge
about exclusive breastfeeding as an infant feeding option
by HIV-infected mothers as the dependent variable and
each independent (predictor) variable. Bivariate analysis
was also performed between each independent variable
and the following dependent variables: positive attitude
to pre- and post-test HIV counselling and to HIV test-
ing; and having sought male partner permission to test
for HIV. Multicollinearity among the independent vari-
ables and outliers were checked for.
Age as a possible confounder and all variables that
were significant at the level of p < 0.2 in binary analysis
were retained in the multivariate regression model. All
p-values were two-tailed at a significance level of 5%. The
goodness-of-fit test (Omnibus Tests of Model Coeffi-
cients) of the final model for knowledge about exclusive
breastfeeding was significant [Chi-square statistic (c2) =
28.249, degrees of freedom (df) = 7, p = 0.000] and the
Hosmer and Lemeshow goodness-of-fit test was not sig-
nificant (c2 = 5.866, df = 8, p = 0.662) as indicators of
model appropriateness. The final models for positive atti-
tude to pre-test and post-test counselling, HIV testing
and having sought male partner permission for HIV tests
yielded Hosmer and Lemeshow goodness-of-fit test
results that were not significant (p-value > 0.05).
Results
Socio-demographic characteristics
Of the 388 new antenatal attendees enrolled in the study,
about two-thirds were living in rural villages, and they had
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a median age of 24 years (range 15-46 years, Table 1).
Most of them were Christians, had no salaried employ-
ment, were in a consensual relationship, and had less than
11 years of education (74%). The majority (64%) of the
participants were Bagisu, and most of them had had at
least one previous pregnancy. Their male partners had a
median age of 30 years (range 18-72 years) and about half
of them had completed secondary education.
Overall results
Almost all the new ANC attendees (98.5%, 382/388) had
a positive attitude towards routine HIV testing in the
clinic. They reported that it helped them to know their
HIV status and that this in turn enabled them to plan
for their future and that of their babies. They also
reported that mothers found to be HIV positive would
be able to easily access antiretroviral therapy to reduce
Table 1 Predictors of knowledge of exclusive breastfeeding among 388 new antenatal attendees, Mbale, Uganda;
logistic regression results
Participants’ characteristics Number, n (%) Exclusive breastfeeding knowledge
Unadjusted OR (95% CI) Adjusted OR (95% CI)
Age groups (years)
15-24 220 (56.7) 1.0 1.0
25 or more 168 (43.3) 1.1 (0.7-1.7) 1.5 (0.8-2.5)
Place of residence
Rural 252 (64.9) 1.0
Urban 136 (35.1) 1.5 (0.9-2.3) 1.4 (0.9-2.3)
Marital status
Single/divorced/separated 35 (9.0) 1.0
Married/cohabiting 353 (91.0) 1.4 (0.7-2.8)
Occupation
Not getting a salary 337 (86.9) 1.0 1.0
Salaried 51 (13.1) 2.6 (1.2-5.6) 1.9 (0.8-4.5)
Education level
None or incomplete primary 134 (34.5) 1.0 1.0
Completed primary 152 (39.2) 1.5 (0.9-2.4) 1.6 (1.0-2.7)
Completed secondary or more 102 (26.3) 2.5 (1.4-4.5) 2.5 (1.3-4.9)
Religion
Christian 234 (60.3) 1.0
Muslim 154 (39.7) 1.2 (0.8-1-9)
Number of pregnancies
1-2 201 (51.8) 1.0 1.0
3 or more 187 (48.2) 1.5 (1.0-2.3) 2.5 (1.4-4.5)
Socio-economic status
Poorest (quintiles: 4th, 5th) 159 (41.0) 1.0
Least poor (quintiles: 1st-3rd) 229 (59) 1.3 (0.8-1.9)
Ethnic group
Bagisu 247 (63.7) 1.0 1.0
Non-Bagisu 141 (36.3) 1.6 (1.0-2.5) 1.7 (1.0-2.7)
Tested for HIV today a
No 2 (0.5)
Yes 386 (99.5)
Received same-day HIV test results
No 6 (1.5) 1.0
Yes 282 (98.5) 1.9 (0.4-9.8)
I. aNo unadjusted odds ratio was calculated since one of the cells had less than 5 cases.
II. P-value (P) < 0.05 was statistically significant.
III. The goodness-of-fit test (Omnibus Tests of Model Coefficients) of the final model was significant [Chi-square statistic (c2) = 28.249, degrees of freedom
(df) = 7, p = 0.000] and the Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 5.866, df = 8, p = 0.662] as indicators of model appropriateness.
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the risk of transmitting HIV to their babies. However,
mothers with negative HIV test results would protect
themselves from getting infected with HIV.
Participants’ opinions and experiences of routine HIV
counselling and testing
The majority of the study participants reported that
their first visits to the antenatal clinic for the current
pregnancy had been good and that they were handled
well by the clinic staff (Table 2). Most of the women
rated highly the health education talk and the pre-test
and post-test HIV counselling they had received at the
clinic. The predictors of positive attitude to pre-test
counselling for HIV included: residing in an urban area
(OR: 3.0, CI: 1.4-6.6); being least poor (OR: 1.9, CI: 1.0-
3.7); having three or more pregnancies (OR: 3.0, CI:
1.4-6.8); and being 15 to 24 years of age (OR: 2.5, CI:
1.1-5.4) (Table 3).
Out of 388 new antenatal attendees, 386 (99.5%)
tested for HIV and 382 (98.5%) received same-day HIV
test results (Table 1). In addition, 54% (211/388) of the
women had sought their partners’ permission to test for
HIV in the antenatal clinic and almost all of them (209/
211, 99%) got this permission. The predictors for male
partner permission for the HIV test were: being married
or cohabiting (OR: 5.6, CI: 2.4-13.3); and having com-
pleted secondary school education or more (OR: 3.0, CI:
1.5-5.9) (Table 4). Nearly all the study participants rated
highly the routine HIV testing services offered as part of
standard antenatal care (Table 2).
Participants’ knowledge about PMTCT and infant feeding
options
More than 60% of the participants knew that HIV could
be passed from an infected mother to her child during
pregnancy; however, about 85% of the respondents
knew that mother to child transmission could occur
during labour and about 89% knew it could occur
through breastfeeding (Table 5). However, only 38%
(147/388) of women knew the correct number of chil-
dren who were likely to be infected with HIV through
breastfeeding out of 10 HIV-infected women. The
majority of the new antenatal attendees (89%, 347/388)
knew that a pregnant woman could do something to
reduce the risk of mother to child transmission of HIV
during pregnancy, and 86% (335/388) of mothers knew
that an HIV-infected mother could take some measures
to reduce the risk of infecting her child through
breastfeeding.
Out of 388 participants, 323 (83%) knew that taking
antiretroviral drugs if HIV infected reduced the risk of
vertical transmission of HIV during pregnancy. How-
ever, few mothers (46%, 177/388) knew that having pro-
tected sex with their partners (condom use) reduced the
risk of mother to child transmission of HIV during
pregnancy (Table 5). Many of the participants (63%,
244/388) knew that in order to reduce risk of vertical
transmission of HIV during the breastfeeding period, an
HIV-infected mother could use the infant feeding option
of exclusive breastfeeding for six months. Similarly,
more than 60% of respondents knew that by avoiding
breastfeeding and using either infant formula or diluted
cow’s milk instead, an HIV-infected mother would pre-
vent transmission of HIV to her baby through breast-
feeding (Table 5).
The predictors of having knowledge of exclusive
breastfeeding as one of the measures for prevention of
mother to child transmission of HIV were: having com-
pleted secondary school (OR: 2.5, CI: 1.3-4.9): belonging
to a non-Bagisu ethnic group (OR: 1.7, CI: 1.0-2.7); and
having three or more pregnancies (OR: 2.5, CI: 1.4-4.5)
(Table 1). However, only 24% (94/388) reported that
they would opt for exclusive breastfeeding for six
months as an infant feeding option if they were HIV
infected. Instead, 60% (233/388) of the participants said
they would hypothetically choose the option of using
diluted cow’s milk and no breast milk (Table 5).
Study participants’ suggestions for service improvement
in the antenatal clinic
Although many (79%, 308/388) of the antenatal atten-
dees rated their first visits to the antenatal clinic highly
Table 2 Participants’ opinions and experiences about
routine HIV testing among 388 new antenatal attendees,
Mbale, Uganda
Participant’s rating of Responses
Very good/good
n (%)
Fair/bad/very bad
n (%)
the visit to antenatal
clinic
308 (79.4) 80 (20.6)
the handling by clinic
staff
344 (88.7) 44 (11.3)
the total waiting time in
clinic
286 (73.7)a 102 (26.3)b
the clinic facilities 322 (83.0) 66 (17.0)
the health education talk 350 (90.2) 38 (9.8)
the pre-test HIV
counselling
335 (86.3) 53 (13.7)
the post-test HIV
counselling
369 (95.1) 19 (4.9)
the routine HIV testingc 382 (98.5) 6 (1.5)
a Not long waiting time.
b Too long waiting time.
c Participants were asked, “Nowadays in this clinic, all mothers are tested for
HIV unless they say no. What do you think about this system?” Responses
included “very bad”, “bad”, “fair”, “good” and “very good”. The responses,
“good” and “very good”, were taken as positive attitudes towards routine HIV
testing.
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(good or very good), some of them made some sugges-
tions for service improvement at the clinic (Additional
file 1).
Discussion
Overall, our study revealed that most of the study parti-
cipants had a positive attitude towards routine antenatal
HIV counselling and testing (RCT). This finding is simi-
lar to that reported in a study in Botswana [28], where
81% of participants reported that they were either extre-
mely or very much in favour of routine testing. The
high level of positive attitudes to RCT in our study
could be attributed to several factors. It is possible that
the pregnant women were less fearful of accepting HIV
testing because this approach was offered as part of the
“standard of care” given to all women in the antenatal
clinic. However, a study done in six health facilities (five
health centres and one hospital) in Dodoma, Tanzania,
showed that about a quarter of the women were not
satisfied with the counselling they received about pre-
vention of mother to child transmission of HIV (24.8%),
privacy (24%) or the waiting time spent in the clinic as
they accessed the PMTCT services (28%) [29].
The majority of the new antenatal attendees rated pre-
test and post-test HIV counselling highly, tested for HIV
and received same-day results. Similar findings were
documented in a study in urban Zimbabwe, where 100%
and 99.8% of the women received pre-test and post-test
HIV counselling, respectively, and 99.9% accepted rou-
tine HIV testing [12]. Similar findings were reported
from studies in rural areas of Zimbabwe [30,31] and
Lilongwe, Malawi [32]. The availability of rapid HIV
testing in the clinic and the giving of same-day HIV test
results may have contributed to the high participation in
the HIV testing. However, in our study, four pregnant
women tested for HIV but reported that they did not
receive the test results. It is possible that they actually
received their results but reported to the contrary,
thinking that they were being asked to reveal their HIV
sero-status. Use of rapid HIV screening tests in the
antenatal clinic ensures same-day results for all mothers
who accept HIV testing.
Table 3 Predictors of positive attitude to pre-test HIV counselling among 388 new antenatal attendees, Mbale,
Uganda
Participants’ characteristics Number n (%) Pre-test HIV counselling positive attitude
Unadjusted OR (95% CI) Adjusted OR (95% CI)
Age groups (years)
25 or more 168 (43.3) 1.0 1.0
15-24 220 (56.7) 1.2 (0.7-2.1) 2.5 (1.1-5.4)‡
Place of residence
Rural 252 (64.9) 1.0 1.0
Urban 136 (35.1) 3.0 (1.4-6.3) 3.0 (1.4-6.6)*
Education level
No or incomplete primary 134 (34.5) 1.0 1.0
Completed primary 152(39.2) 0.9 (0.5-1.9) 0.7 (0.4-1.5)
Completed secondary or more 102 (26.3) 1.8 (0.8-4.2) 1.3 (0.5-3.5)
Ethnic group
Non-Bagisu 141 (36.3) 1.0 (0.6-1.9)
Bagisu 247 (63.7) 1.0
Socio-economic status
Poorest (quintiles: 4th-5th) 159 (41.0) 1.0 1.0
Least poor (quintiles: 1st-3rd) 229 (59.0) 2.3 (1.3-4.1) 1.9 (1.0-3.7)‡
Occupation
Salaried 51 (13.1) 1.0 1.0
Not getting a salary 337 (86.9) 2.8 (0.8-9.3) 1.8 (0.5-7.0)
Number of pregnancies
1-2 201 (51.8) 1.0 1.0
3 or more 187 (48.2) 1.5 (0.8-2.3) 3.0 (1.4-6.8)*
I. P-value: ‡ = p < 0.05, * = p < 0.01.
II. Marital status and religion were not significantly associated with positive attitude to pre- and post-test HIV counselling.
III. The goodness-of-fit test (Omnibus Tests of Model Coefficients) of the final model for pre-test counselling positive attitude was significant [Chi-square statistic
(c2) = 17.219, degrees of freedom (df) = 7, p = 0.016] and the Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 9.620, df = 8, p = 0.293] as
indicators of model appropriateness.
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The study also found that the new antenatal attendees
aged 15 to 24 years were more likely to have positive
attitudes to pre-test HIV counselling. In a study done in
Zambia, it was noted that readiness to test for HIV was
higher among the young than among older people [33].
The positive attitude to pre-test HIV counselling among
pregnant women who were either residing in urban
areas or were least poor could be explained by the fact
they have more access to information about HIV coun-
selling through the print and electronic media. There-
fore, they are more likely to be aware of the benefits of
HIV counselling and testing.
Our finding that women who had three or more preg-
nancies had positive attitudes towards pre-test counsel-
ling could be explained by their previous interactions
with the healthcare system, which exposed them to
information on HIV testing and associated benefits. The
educated women were more likely to seek permission
from their male partners to test for HIV than the less
educated. This is probably due to the fact that the edu-
cated women are more likely to discuss issues concern-
ing their sexuality and health with their spouses. Those
who were either married or cohabiting were almost six
times more likely to ask for permission from the part-
ners. This could be linked to the desire to obtain sup-
port from their partners, including money for transport
to such health facilities. Our earlier study in the same
setting revealed that the majority of the men (97%) pro-
vided financial support to their wives to access antenatal
care [34].
Our study also showed that many of the antenatal
attendees had correct knowledge about mother to child
Table 4 Predictors of male partner permission to test for HIV and positive attitude to HIV testing among 388 new
antenatal attendees, Mbale, Uganda
Participants’ characteristics Number n (%) Male partner permission to test for HIV Positive attitude to HIV-testing†
Unadj.OR (95% CI) Adj.OR (95% CI) Unadj.OR (95% CI) Adj.OR (95% CI)
Age groups (years)
15-24 220 (56.7) 1.0 1.0 2.7 (0.5-14.7) 2.5 (0.3-22.3)
25 or more 168 (43.3) 1.2 (0.8-1.8) 1.0 (0.7-1.6) 1.0 1.0
Education level
No or incomplete primary 134 (34.5) 1.0 1.0
Completed primary 152 (39.2) 1.2 (0.8-1.9) 1.2 (0.7-2.0)
Completed secondary or more 102 (26.3) 2.7 (1.5-4.7) 3.0 (1.5-5.9)*
Socio-economic status
Poorest (quintiles: 4th-5th) 159 (41.0) 1.0 1.0 1.0 1.0
Least poor (quintiles: 1st-3rd) 229 (59.0) 1.5 (1.0-2.2) 1.2 (0.7-1.9) 2.9 (0.5-16.2) 1.9 (0.3-12.6)
Ethnic group
Bagisu 247 (63.7) 1.0 1.0 1.0 1.0
Non-Bagisu 141 (36.3) 1.6 (1.0-2.4) 1.6 (1.0-2.5) 2.9 (0.3-25.0) 2.6 (0.3-23.9)
Marital status
Single/divorced/separated 35 (9.0) 1.0 1.0 1.0 1.0
Married/cohabiting 353 (91.0) 4.6 (2.0-10.5) 5.6 (2.4-13.3)‡ 2.0 (0.3-18.0) 5.4 (0.4-73.1)
Religion
Christian 234 (60.3) 1.0 1.0 1.0 1.0
Moslem 154 (39.7) 1.3 (0.9-2.0) 1.4 (0.9-2.2) 1.3 (0.2-7.3) 1.2 (0.2-7.0)
Occupation
Not getting a salary 337 (86.9) 1.0 1.0
Salaried 51 (13.1) 1.9 (1.0-3.6) 1.1 (0.5-2.3)
Education level
No or incomplete primary 134 (34.5) 1.0 1.0
Completed primary or more 254 (65.5) 3.9 (0.7-21.4) 2.9 (0.4-19.7)
I. Unadj. OR: Unadjusted Odds Ratio, Adj. OR: Adjusted Odds Ratio, CI: Confidence Interval.
II. P-value: *p < 0.01, ‡p < 0.00. P-value < 0.05 was statistically significant.
III. †Pregnant women who had a positive attitude to routine antenatal HIV testing were 98.5%. Hence there were too few cases in some cells giving rise to the
wide confidence intervals of the odds ratios and inability to calculate the odds ratio for occupation.
IV. The goodness-of-fit test (Omnibus Tests of Model Coefficients) of the final model for male partner permission to test for HIV was significant [Chi-square
statistic (c2) = 41.434, degrees of freedom (df) = 8, p = 0.000] and the Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 5.563, df = 8,
p = 0.696] as indicators of model appropriateness.
V. The goodness-of-fit test (Omnibus Tests of Model Coefficients) of the final model for HIV testing was significant [c2 = 11.025, df = 8, p = 0.000] and the
Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 5.637, df = 8, p = 0.688] as indicators of model appropriateness.
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transmission (MTCT) of HIV and how to prevent it.
Women who had completed secondary school education
were more likely to have correct knowledge of exclusive
breastfeeding as a preventive measure for vertical trans-
mission of HIV. A similar finding was reported by the
Botswana study [28]. Our study has revealed that preg-
nant women who had completed secondary education
were approximately three times more likely to have
good knowledge about exclusive breastfeeding. The edu-
cated have better access to health information. An ear-
lier study done in the same region highlighted the
positive influence of higher education on infant feeding
practices [35].
Our study also revealed that women who had three or
more pregnancies were three times more likely to have
good knowledge about exclusive breastfeeding. This
Table 5 Participants’ knowledge about mother-to-child transmission of HIV and infant feeding options (N = 388),
Mbale, Uganda
Questions to participants Correct answer Correct responses n (%)
(1) Is it possible that when the mother or the father is HIV positive
and their newborn child can be HIV negative? Yes 296 (76.3)
(2) When can HIV be passed from a mother to her child?
- during pregnancy Yes 239 (61.6)
- during labour Yes 328 (84.5)
- through breastfeeding Yes 344 (88.7)
- othera Yes 129 (33.2)
(3) If there are 10 HIV infected pregnant women, how many do
you think would have babies born with HIV virus?(between 0-10) 1-4 226 (58.2)
(4) How many babies could get HIV infected through breastfeeding
out of 10 HIV infected mothers? ....(between 0-10) 1-3 147 (37.9)
(5) What can a mother do to reduce the risk of transmission of HIV
to her child during pregnancy?
- taking antiretroviral drugs Yes 323 (83.2)
- having protected sex with her partner (condom use) Yes 177 (45.6)
- other waysb Yes 83 (21.4)
(6)Can an HIV infected mother do anything to reduce the risk of
transmission of HIV to her child during breastfeeding period? Yes 335 (86.3)
(7) What can an HIV positive mother do to reduce the risk of getting
her baby infected with HIV during the breastfeeding period?
- exclusively breastfeed for 6 months Yes 244 (62.9)
- not breastfeeding, give infant formula Yes 240 (61.9)
- not breastfeeding, give diluted cow’s milk Yes 268 (69.1)
- good breast care (no sore or cracked nipples) Yes 139 (35.8)
- other waysc Yes 76 (19.6)
(8) If you were HIV positive, which infant feeding option would be
feasible to you? (Give only one answer)
(a) - infant formula, no breast milk 45 (11.6)
(b) - cow’s milk, no breast milk 233 (60.1)
(c) - breast milk only for 6 months 94 (24.2)
(d) - otherd 13 (3.4)
- asharing sharp instruments like needles and injection needles with the baby.
- babstaining from sexual intercourse, being faithful to your partner.
- cusing drugs to prevent HIV through breast milk.
- dbreastfeeding for 3 months, then giving either cow’s milk or porridge (from soya/millet flour)
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could be explained by their previous interaction with the
healthcare system, which exposed them to information
on exclusive breastfeeding and its associated benefits
Many of study participants (63%) reported that exclusive
breastfeeding (EBF) for six months reduced the risk of
MTCT. However, few (24%) of them thought it a feasible
infant feeding option if they were HIV positive; instead,
many (60%) reported that they would use cow’s milk.
At the time the study was conducted, modified cow’s
milk was one of the replacement feeding options for
infants of HIV-infected mothers, according to the
national policy guidelines[18], if affordable, feasible,
acceptable, sustainable and safe (AFASS). However,
according to the most recent WHO recommendations
[36], home-modified animal milk is not recommended
as a replacement food for infants in the first six months
of life. In a region where breastfeeding is almost univer-
sal [37], counselling about EBF in the antenatal clinic
should be intensified as studies in sub-Saharan Africa
have revealed that EBF reduces postnatal HIV transmis-
sion [38-40]. Knowledge is an important determinant
for behavioural change. Hence, good quality HIV coun-
selling is important for the success of PMTCT efforts.
The study also identified some challenges to the imple-
mentation of antenatal routine HIV testing. Although the
majority of the women were satisfied with the services in
the antenatal clinic, some gaps were identified. These
included the following: inadequate supply of drugs and
equipment; shortage of midwives and/or counsellors and
low male involvement in routine antenatal HIV testing
services. Some women felt that individual counselling
was inadequate while others felt they were pressured to
test for HIV. Similar challenges have been reported from
other studies in east Africa [29,41,42].
The factors hindering male involvement in the
PMTCT programme have been reported in a previous
study in this region [34]. As shown in this study, about
54% of the women sought permission from their
spouses to have an HIV test. However, some studies
have documented that some women refuse to test for
HIV because of the need to seek their partners’ assent
[43,44]. There is need for more male involvement in
antenatal HIV counselling and testing as this has been
shown to increase the use of PMTCT interventions in
resource-limited settings [45-47].
In a recent study in Uganda by Wabwire-Mangen
and his colleagues, many (43%) of the new HIV infec-
tions in adults (15-49 years) occurred among people in
discordant monogamous relationships [4]. Hence, there
is a need for increased couple counselling and testing
in the PMTCT programme, as recommended in the
Uganda national policy on HIV counselling and testing
[23]. This would most likely facilitate couples’ ability
to follow through on intentions and decisions made
during the HIV counselling and testing sessions [48].
One way of promoting men’s participation in antenatal
HIV counselling and testing could be by health staff
sending written notes inviting them to come to the
clinic, as suggested by participants. This suggestion
had been alluded to in a previous study in this study
population [34].
Our study had some potential limitations. Being a
cross-sectional survey, causality cannot be inferred from
our findings. Although the study participants were from
both rural and urban areas, they may not be representa-
tive of the whole population of Uganda. Therefore,
country-wide generalization of our study findings is not
implicit and it is not possible to generalize our findings
to other sub-Saharan Africa countries. Since we enrolled
the antenatal attendees consecutively, our study may
have suffered from selection bias, thus affecting the
internal validity of the study. In addition, participants’
self-reports could have introduced misclassification and
bias. We attempted to reduce social desirability bias by
presenting study aims to the respondents in general
terms. In our study, we deliberately did not ask the
women about their HIV status in order to assure confi-
dentiality and also maximize validity.
Conclusions
Our study findings have demonstrated that antenatal
routine HIV counselling and testing seems to be largely
acceptable to the pregnant women in eastern Uganda
and has enabled most of them to know their HIV status
as part of the PMTCT package of services. To ensure
good quality service in the antenatal clinic, there is a
need for adequate supplies of drugs, sundries, HIV test
kits and equipment, and enough numbers of health
workers equipped with good counselling skills. More
concerted efforts by programme managers are needed to
scale up this service to antenatal clinics in lower level
health units in order to maximize its potential benefits
for the population. Finally, further work through
research and innovative interventions is needed in order
to improve male partner involvement in HIV testing in
antenatal clinics.
Additional material
Additional file 1: Study participants’ suggestions about service
improvement in antenatal clinic in Mbale Regional Referral
Hospital, Uganda.
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ResearchDeterminants of male involvement in the 
prevention of mother-to-child transmission of HIV 
programme in Eastern Uganda: a cross-sectional 
survey
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Abstract
Background: Mother-to-child transmission of HIV (MTCT) accounts for over 95% of all paediatric HIV infections 
worldwide. Several studies have shown that male participation in the antenatal care of their spouses together with 
couple counselling and testing for HIV, increases use of the interventions for HIV prevention. The prevention 
programme of MTCT (PMTCT) was launched in Uganda in 2000 and Mbale in 2002. Less than 10% of the pregnant 
women accepted antenatal HIV testing at Mbale Regional Referral Hospital in 2003; couple counselling and testing for 
HIV was low. Therefore, we conducted the study to determine the level of male involvement and identify its 
determinants in the PMTCT programme.
Methods: A cross-sectional survey of 388 men aged 18 years or more, whose spouses were attending antenatal care at 
Mbale Regional Referral Hospital, was conducted in Mbale district, Eastern Uganda. A male involvement index was 
constructed based on 6 questions. The survey was complemented by eight focus group discussions and five in-depth 
interviews.
Results: The respondents had a median age of 32 years (inter-quartile range, IQR: 28-37). The majority (74%) had a low 
male involvement index and only 5% of men accompanied their spouses to the antenatal clinic. Men who had attained 
secondary education were more likely to have a high male involvement index (OR: 1.9, 95% CI: 1.1-3.3) than those who 
had primary or no formal education. The respondents, whose occupation was driver (OR: 0.3, 95% CI: 0.1-0.7) or those 
who had fear of disclosure of their HIV sero-status results to their spouses (OR: 0.4, 95% CI: 0.2-0.8), were less likely to 
have a high male involvement index. Barriers to male involvement in the PMTCT programme were related to both the 
poor health system, to socio-economic factors and to cultural beliefs.
Conclusions: Structural and cultural barriers to men's involvement in the PMTCT programme in Mbale district were 
complex and interrelated. Community sensitization of men about the benefits of antenatal care and PMTCT and 
improving client-friendliness in the clinics needs to be prioritised in order to improve low male participation and 
mitigate the effect of socio-economic and cultural factors.
Background
It is estimated that about 25 million HIV-infected people
are living sub-Saharan Africa. About 2 million of them
are children below the age of 15 years and account for
about 90% of all the HIV-infected children worldwide.
Over 1700 children become infected with HIV worldwide
each day. Over 95% of them get it through mother-to-
child transmission (MTCT) [1,2]. In high-income coun-
tries, MTCT of HIV has been virtually eliminated
through effective voluntary counselling and testing
(VCT) for HIV or routine testing of HIV, the use of anti-
retroviral therapy and the use of safe, affordable and
accessible breast-milk substitutes. Since the year 2000,
prevention of mother-to-child transmission of HIV
(PMTCT) programmes have been initiated in many
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resource-poor countries as an integrated service in the
antenatal care. Nevirapine has been the most commonly
used antiretroviral drug in many of the programmes
because it is cheap and easy to administer [3,4]. Studies
have shown that the utilisation of PMTCT services by the
pregnant women is influenced both by factors related to
the health system such as accessibility of VCT services,
and by individual factors such as fear of disclosure of HIV
results, lack of male partner support, fear of domestic
violence, abandonment and stigmatization [5-11].
The Uganda National PMTCT programme started as a
pilot intervention in the year 2000 and by the end of 2003
it had expanded to cover 38 sites in 56 districts. It was
launched in Mbale Regional Referral Hospital in May
2002. In the year 2003, less than 10% of the pregnant
women accepted antenatal testing and couple VCT was
low [12,13]. Participation of men in the antenatal care of
their spouses and couple VCT increase the utilisation of
interventions to prevent HIV-1 transmission [14,15].
From July to August 2004, we conducted this study to
determine the level of participation of male partners in
the PMTCT programme and to identify factors that
determine male participation in this programme.
Methods
Mbale district is situated at the foothills of Mt Elgon in
the eastern region of Uganda. It is divided into three
counties (rural) and one municipality (urban); namely
Bubulo, Bungohko and Manjiya counties and Mbale
municipality. In 2003, the district had a population of
over 720,000, of which about 90% were rural and the aver-
age household-size was 7 people. About 80% of the resi-
dents depend on agriculture (subsistence farming) [16].
Its population is predominantly Bagisu and the main lan-
guage is Lumasaba/Lugishu. The HIV prevalence rate in
2002 at the Mbale antenatal sentinel site was 5.9% [17].
The study was carried out in Mbale municipality and
the surrounding Bungokho County. These were purpo-
sively selected to provide a rural and an urban popula-
tion. The study consisted of two parts. The quantitative
part was a cross-sectional survey of men aged 18 years or
more, whose spouses were attending antenatal care at
Mbale Regional Referral Hospital and resided in the study
area. The qualitative part consisted of 8 focus group dis-
cussions and 5 in-depth interviews. We calculated the
sample size based on the estimation of the proportion of
male involvement (defined as men attending antenatal
care with their spouses) in the population of 10%, an
absolute precision of 3% and a 5% level of significance.
We increased the sample size by 10% to cater for antici-
pated non-response. Hence the total sample size was esti-
mated to be 422 men.
The participants were recruited into the study through
their wives. In July and August 2004, all mothers who
were coming for their second antenatal visit at Mbale
Regional Referral hospital, and resided in the study area,
were informed about the study by the midwives. They
were requested to provide information concerning their
partners' place of work and residential addresses. Subse-
quently, the men were traced and 388 of them accepted to
participate in the study and they were interviewed (par-
ticipation rate of 92%). The non-response rate was 8% (6
declined, 28 absent). A pre-tested, structured, inter-
viewer-administered questionnaire used to collect the
quantitative data consisted of three parts: (1) socio-
demographic characteristics (age, marital status, religion,
level of education, occupation, place of residence, owner-
ship of a radio, land and livestock, and type of housing),
(2) general perceptions and experiences about the
PMTCT programme, and (3) perceptions and experi-
ences about antenatal and postnatal care.
The quantitative data was collected by 10 research
assistants, entered using EPIDATA http://www.epi-
data.dk and exported to SPSS version 13 for analysis.
Incomplete data of one respondent was not included in
the analysis (Figure 1: study profile). The data was sum-
marised and the odds ratios (OR) estimated; and their
corresponding 95% confidence intervals (95%CI) were
computed. The level of male involvement in PMTCT was
determined using an ad hoc male involvement index. This
index was constructed using six variables with equal
weight in the score:
1. The man attends antenatal care with his partner
Figure 1 Study profile of the cross-sectional survey in Mbale, 
Eastern Uganda.
ANC mothers 
interviewed
418 men 
recruited
388 men 
interviewed
387 included 
in analysis
6 men declined
24 men absent
1 excluded 
(incomplete
data)
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2. The man knows the partner's antenatal appoint-
ment
3. The man discusses antenatal interventions with his 
partner
4. The man supports his partner's antenatal visits 
financially
5. The man has taken time to find out what goes on in 
the antenatal clinic
6. The man has sought permission to use a condom 
during the current pregnancy
The involvement score for each respondent could range
from 0 = no involvement to 6 = involved in all 6 activities.
A total score of 4-6 was considered as a 'high' male
involvement score and 0-3 as 'low' relative to this particu-
lar population.
Bivariate analysis was performed between high male
involvement index as the dependent variable and each
independent variable. Since the number of variables was
small, they were all entered into the binary logistic
regression model at a go. Interaction and confounding
between the ages of respondents, their place of residence
and the significant variables (after bivariate analysis) were
checked for.
We also conducted 8 focus group discussions (FGDs)
and 5 in-depth interviews. The purpose of the FGDs was
to explore and obtain information about the factors hin-
dering male involvement in PMTCT and its influence on
the utilisation of the PMTCT programme.
The participants in the FGDs were not selected from
male partners of women attending antenatal clinics.
Instead participants included men purposively selected
from the Aids Information Centre (AIC), the Aids Sup-
port Organization (TASO) and the four administrative
divisions in Bunghoko county and Mbale municipality.
In each division, two FGDs were held, one for young
men aged 18-35 and another for men 36 years and above.
The participants were divided into two age groups
because we assumed that the young participants would
not feel free to discuss or express issues regarding sexual-
ity amidst older participants. The contact person in each
of the four administrative divisions assisted in recruiting
the participants. Each FGD consisted of 6 to 12 partici-
pants. Overall, 76 men participated in the 8 focus group
discussions. The FGDs were moderated by an experi-
enced social scientist using a topic guide. Another
research assistant (a note taker) recorded the discussions
by hand and by tape recorder. Each discussion was con-
ducted in a comfortable place away from distraction with
participants seated in a circle. The data was transcribed
and summarized into themes.
The topics covered in the focus group discussion
included HIV in general - terminology, frequency, causes,
prevention, and treatment; HIVin children - terminology,
occurrence, causes, prevention, treatment; voluntary
counselling and Testing for HIV; stigma and discrimina-
tion in HIV; cultural issues; social networks and support
for mothers; the health care system; suggestions as to
how to involve men in the PMTCT programme.
In addition to the FGDs, in-depth interviews of health
care providers were conducted bringing up the following
issues about PMTCT: views about voluntary counselling
and testing for HIV for pregnant mothers (VCT); testing
using the opt-in or opt-out approach; how to increase
acceptance of VCT by men; the role of men in promoting
VCT in pregnancy, and the acceptability and feasibility of
couple VCT. The key informants were also asked about
factors influencing male participation in antenatal and
PMTCT services in the hospital. Finally, they made sug-
gestions as to how to get male partners more involved in
both antenatal care and PMTCT programme.
The health care providers who were interviewed
included 3 men and 2 women, namely the Nursing Offi-
cer in charge of ANC/PMTCT; the Medical Superinten-
dent of Mbale Hospital; the Reproductive Health
Coordinator (Eastern region); the managers of AIC and
TASO, Mbale branches respectively. The focus group dis-
cussions and the in-depth interviews were conducted
mainly in English. However four FGDs were conducted in
the local language (Lugishu/Lumasaba). The sessions
lasted one to two hours. The data was transcribed, coded
using the OpenCode program, version 2.1: June, 2001 and
examined for the main themes.
Research and ethical clearances were obtained from
Makerere University Faculty of Medicine Research and
Ethics Committee, the Uganda National Council of Sci-
ence and Technology and Mbale District Local Govern-
ment. Informed consent was obtained from all
participants in the study.
Results
Socio-demographic characteristics
Of the 387 respondents included in the analysis, 199
(51%) were in the 25-34 age group. The median age was
32 years with inter-quartile range (IQR) of 28-37 years.
Thirty-five percent of the participants were urban,
while the rest were rural. The literacy rate was 80% in the
urban population and 74% among the rural participants,
table 1.
The median period of the completed years of schooling
by the respondents was 7 years (range: 0-18 years). Fifty
percent of the respondents were Muslims. The respon-
dents in the urban areas were more educated compared
to those in the rural areas; 8 years compared to 7 years (p-
value < 0.001: Mann-Whitney U test). There were more
participants whose occupation was farmer in the rural
areas than in urban areas, 21% versus 5% (Odds Ratio
[OR] = 5.1; 95% Confidence Interval [CI]: 2.3 - 11.5). For
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the men who participated in the FGDs, their median age
was 34 years with an inter-quartile range of 24-44 years.
Level of male involvement in PMTCT programme
The level of male involvement in PMTCT was assessed
using the variables shown in Table 2. Only 18 (4.7%) of
the 387 men had attended ANC with their partners, but
most of them (377 [97%] out of 387) provided financial
support to their spouses to attend ANC. The majority of
respondents (236 [61%] out of 387) had not asked their
partners whether they (the men) could use condoms dur-
ing sexual intercourse with them (the women). Only 99
(26%) of the 387 respondents had a high male involve-
ment index.
Determinants of male involvement in the PMTCT 
programme and antenatal care
In univariate analysis, the determinants of male involve-
ment in PMTCT programme included: education level,
knowing HIV sero-status and having heard about
PMTCT.
Men who had had 8 or more years of education were 2
times more likely to get involved in the PMTCT pro-
gramme than those with less education. Those who knew
their HIV sero-status were 4 times more likely to get
involved in the PMTCT programme. In addition those
who had heard about the PMTCT programme were 2
times more likely to get involved. Those who feared to
disclose their HIV status to their spouses were less likely
to get involved (Table 3).
On logistic regression, the respondents who had
attained secondary education or higher were twice as
likely to have a high male involvement index (Table 3).
However, those who had fear of disclosure of HIV results
to their spouses and men whose occupation was driver
were less likely to have a high male involvement index.
Age, religion and place of residence of the respondents
were not associated with male involvement in PMTCT of
HIV (Table 3). Of the 31 professionals, 6 (19.4%) had
attended ANC with their wives compared to only 12
(3.4%) of the 356 non-professionals (Table 4). This differ-
ence was statistically significant. Men who knew their
HIV sero-status or knew their wives' ANC appointments
or those willing to go for VCT were more likely to attend
ANC with their wives (Table 4).
Barriers to male participation in the PMTCT programme
Factors hindering men's participation in the PMTCT pro-
gramme that were identified in the focus group discus-
sions were related to the health system, to socio-
economic status and to culture.
Health system factors
Several factors related to the health system were identi-
fied as barriers to male participation in the ANC. The
first major factor consistently identified by all the focus
groups was rudeness and rough handling of the pregnant
women by the health-workers in the antenatal clinics, as
reflected in the following men's responses:
"Medical personnel handling pregnant mothers are very
rough especially when it comes to examination of the
abdomen", said a respondent from Bongokho sub-county.
Another one from the AIC focus group said, "During
check-ups midwives over-press the pregnant mother's
abdomen. We are fed up with the female health-workers.
These midwives are very rude to the mothers. They are too
harsh and abuse the pregnant women".
Table 1: Socio-demographic characteristics of the 387 
respondents who participated in the survey in Mbale, 
Uganda.
Variable Respondents
N (%)
Age (years)
19-24 49 (13)
25-34 199 (51)
35-44 113 (29)
45 or more 26 (07)
Place of residence
Rural 250 (65)
Urban 137 (35)
Highest level of education
No formal education 25 (07)
Primary 206 (53)
Secondary 127 (33)
Tertiary 29 (07)
Religion
Catholic 69 (18)
Protestant 110 (28)
Muslim 193 (50)
Other 5 (04)
Marital status
Unmarried (single) 11 (03)
Married 376 (97)
Occupation
Builder 26 (07)
Casual labourer 26 (07)
Driver 47 (12)
Farmer 61 (16)
Mechanic 32 (08)
Professional 31 (08)
Trader 143 (37)
Other 21 (05)
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The second factor reported by the respondents was that
in some instances the health-workers do not allow them
to enter the antenatal clinics with their pregnant women.
A third factor cited as one of the barriers to male par-
ticipation was the charging of un-official user-fees. Lack
of adequate space in the antenatal clinics was cited as a
fourth factor. One respondent said: "The clinics are con-
gested. There is not enough space to accommodate the
women and their husbands. Men will not feel comfortable
sitting with women who are strangers to them. They will
rather wait outside and if the procedures take long they
will leave". The last factor was the geographical distance
to the services, one respondent said: "The antenatal clin-
ics are far from the local people"
Socio-economic factors
The second area mentioned as an obstacle to male partic-
ipation was socio-economic. Several of the men reported
that due to socio-economic difficulties, they did not have
time to attend ANC with their partners as demonstrated
by the following quotations: "I am busy trying to make
ends meet. I don't have time to go with her to the antenatal
clinic. I don't have enough money for transport for two
people", said a respondent from a rural village. "We have
to struggle to look for money to provide for our families",
said a respondent from Bongokho FGD.
Cultural factors
The third hindrance to male participation was cultural
beliefs. A negative attitude of some men was common, as
demonstrated by the AIC focus group discussion: "I
believe it is not good to follow your wife to the antenatal
clinic. Even though she exposed her privacy to you at home
but when you reach the antenatal clinic it is different. So it
is better she goes alone". Another one said, "If I accompa-
nied my wife to hospital every time she goes for her ante-
natal check up, my friends would think I am a weakling.
They would laugh at me". One of the key informants said:
"Because of cultural beliefs, most men do not like to
accompany their wives to the antenatal clinics. Men who
accompany their wives to ANC are perceived to be weak-
lings by their peers".
Respondents' suggestions for improving male involvement 
in ANC/PMTCT activities
The suggestions as to how improvements could be made
came from mainly health care providers (key informants).
However the participants (males) in the FGDs were also
emphatic on their recommendations as to how to
improve the situation and their suggestions included the
following:
1. Sensitize men about ANC and PMTCT, and their 
benefits
2. Conduct refresher courses for midwives and nurses
3. Men should be invited by staff to attend ANC using 
the ANC cards of their wives
4. Government should bring services closer to the people
5. Welfare of the staff should be improved
6. More staff be recruited into the health service
Specifically, the respondents suggested that retraining
of the health-care providers should include customer-
care skills. In addition they suggested provision of better
remuneration to the health workers and building more
health units by the government closer to the local people
where antenatal care could be offered.
Some respondents suggested that midwives should
write on the antenatal cards informing the men to come
with their wives on subsequent ANC visits. A respondent
from the Bungokho focus group said: "Men should be
identified from the communities, trained on PMTCT and
then sent back to the communities to inform and mobilize
other men. Health workers should use all fora to inform
men about PMTCT; the churches and mosques are good
entry points". Another one said:
"Midwives should be given refresher courses because
they seem to be losing direction. Nurses and midwives
should become friendlier to the mothers in ANC than they
are at the moment"
Table 2: Level of involvement of the 387 men in ANC activities.
Item (variable) Respondents' responses
N (%)
Yes No
Ever attended ANC with partner 18 (05) 369 (95)
Knows partner's ANC appointments 214 (55) 173 (45)
Provides financial support to partner to attend ANC 377 (97) 10 (03)
Discusses with partner information or interventions given in ANC 114 (30) 273 (70)
Asked partner if he could use a condom 151 (39) 236 (61)
Takes time to find out what goes on in ANC 105 (27) 282 (73)
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Discussion
In this study, conducted to establish determinants of male
involvement in the PMTCT programme in Eastern
Uganda, we found that only 1 in 4 male partners were
involved in the PMTCT programme. This level of
involvement is low but higher than what is reported from
other studies from East Africa [18]. For example one
study from Mulago Hospital in Kampala, Uganda,
showed that male participation in the PMTCT activities
was low (16%) [14,18]. Similarly, a study conducted at a
Nairobi antenatal clinic, Kenya revealed that male part-
ner participation in antenatal VCT with their spouses
Table 3: Factors influencing men's involvement in the prevention of mother-to-child transmission of HIV programme 
(N = 387).
Factor (Variable) Respondents with high involvement index
n/N (%)
Unadjusted Odds Ratio
(95% CI)
Adjusted Odds Ratio
(95% CI)
Age (years)
19-29 37/146 (25) 1.0 1.0
30+ 62/241 (26) 1.0 (0.6-1.6) 1.1 (0.6-1.8)
Education (years)
0-7 45/231 (20) 1.0 1.0
8+ 54/156 (35) 2.2 (1.4-3.5)** 1.9 (1.1-3.3)*
Residence
Rural 65/250 (26) 1.0 1.0
Urban 34/137 (25) 0.9 (0.6-1.5) 0.8 (0.5-1.5)
Religion
Muslim 43/193 (22) 1.0 1.0
Christian 56/194 (29) 1.4 (0.9-2.2) 1.1 (0.6-1.9)
Occupation
Others 82/309 (26) 1.0 1.0
Driver/Bodaboda cyclists 4/47 (08) 0.3 (0.1-0.7)* 0.3 (0.1-0.9)*
Professional 13/31 (42) 2.0 (0.9-4.3) 1.1 (0.5-2.7)
Fears disclosure of HIV results to wife
No 78/252 (31) 1.0 1.0
Yes 14/100 (14) 0.4 (0.2-0.7)** 0.4 (0.2-0.7)**
Knows his HIV sero-status
No 78/347 (22) 1.0 1.0
Yes 21/40 (52) 3.8 (2.0-7.4)** 1.9 (0.9-4.4)
Ever heard of PMTCT
No 51/257 (20) 1.0 1.0
Yes 48/130 (37) 2.4 (1.5-3.8)** 1.6 (0.9-2.7)
I. * is 0.01 ≤ P ≤ 0.05 and ** is P < 0.01. II. The variables in the final multivariate logistic regression model were: age, education, place of residence, 
religion and occupation of the respondents; fears disclosure of HIV sero-status results to his wife, knows his sero-status and ever heard of PMTCT. 
III. The sample size was 387 men (analysed for male involvement index). IV. OR, odds ratio; CI, confidence interval; PMTCT, prevention of mother-
to-child transmission of HIV; HIV, Human immunodeficiency virus.
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Table 4: Factors influencing men's participation in antenatal care with their partners in Mbale district, Uganda (N = 387)
Factor (Variable) Not Attended ANC
n = 369
Attended ANC
n = 18
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Age (years)
19-29 142 4 1.0
30+ 227 14 2.2 (0.7-6.8)
Residence
Rural 236 14 1.0
Urban 133 4 0.5 (0.2-1.6)
Education (years)
0-7 222 9 1.0
8+ 147 9 1.5 (0.6-3.9)
Religion
Other 188 5 1.0
Christian 181 13 2.7 (0.9-7.7)
Occupation
Other 344 12 1.0 1.0
Professional 25 6 6.9 (2.4-20)** 5.4 (1.7-17)**
Knows his HIV sero-status
No 335 12 1.0
Yes 34 6 4.9 (1.7-14)**
Bothers to know what goes on in ANC
No 276 6 1.0 1.0
Yes 93 12 5.2 (1.9-14)** 3.1 (1.2-9.2)*
Knows his wife's ANC appointments
No 172 1 1.0 1.0
Yes 197 17 14.8 (2 - 110)** 8.6 (1.0-72)*
Discussed with wife ANC interventions
No 267 6 1.0
Yes 102 12 5.2 (2.0-14)**
Willing to go for HIV test
No 122 1 1.0
Yes 247 17 8.4 (1.1-63)*
Ever heard of PMTCT
No 249 8 1.0
Yes 120 10 2.6 (1.0-6.7)*
Would go with wife for VCT
No 205 4 (2) 1.0 1.0
Yes 164 14 (8) 4.4 (1.4-13) 3.6 (1.1-12)
Notes: I. * is 0.01 ≤ P ≤ 0.05 and ** is P < 0.01. II. All variables in the above table were entered in the final multivariate logistic regression model. 
III. OR, odds ratio; CI, confidence interval; PMTCT, prevention of mother-to-child transmission of HIV; HIV, Human immunodeficiency virus; 
ANC, antenatal care.
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was low (15%) [14]. The difference between our findings
and these other studies could be attributed to the differ-
ent methods used.
In this study we have found a number of factors associ-
ated with male participation in the PMTCT programme.
These included heath system, socio-economic and cul-
tural factors. First the structural set up of the ANC clinics
is not male user-friendly. Furthermore, our findings from
the qualitative data have indicated that the health-provid-
ers in the ANC clinics were perceived by the men not to
be client-friendly. Similar observations have also been
made by others. For example focus group participants in
Kenya mentioned rude health care staff as a hindrance to
participation in PMTCT services [19].
Other factors hindering male involvement in the
PMTCT programme were socio-economic. Although the
majority of the men expressed willingness to go for HIV
counselling and testing, they said that they either lacked
time or money to facilitate their involvement in the ANC/
PMTCT activities. Similar constraints have been found in
Dodoma, Tanzania [20]. In addition, the level of educa-
tion and occupation of the respondents influenced male
participation in the PMTCT programme. Similar studies
in Uganda and elsewhere have found that education level
is an important determinant of participation in PMTCT
services [21,22].
Increased access to information, knowledge and aware-
ness facilitates good choices. In our study men who had
heard about PMTCT programme were 2 times more
likely to get involved in PMTCT activities than those who
had not. This is consistent with results of a similar study
in Mambwe district in Zambia [23].
In addition, another study from Chipata in Zambia
revealed that males were not fully participating in
PMTCT programmes and reasons given were lack of
information and lack of a direct link between PMTCT
staff and males [24].
Cultural factors were also found to be hindering male
involvement in the PMTCT programme in Mbale. For
example antenatal care was perceived a women's affair.
As has been shown in other studies [25], it is conven-
tional in many African cultures for men not to accom-
pany their partners to antenatal and postnatal care
consultations as pregnancy and child birth are regarded
as a women's affair [26,27].
One of the strengths of this study is that we interviewed
men and not their spouses. The information collected in
this study is likely to reflect the men's views better than
information obtained from women. The other strength is
that we used both quantitative and qualitative methods
during data collection. The qualitative findings assisted in
explaining the findings from the quantitative part of the
study.
There are some potential weaknesses, though, in the
methodology. First, the recruitment of respondents
through their spouses in the ANC in a hospital setting
could have introduced selection bias. In this study, the
level of non-response was modest (7%), unlikely to have
biased our estimates in any major way. Second, it is possi-
ble that husbands of the women attending ANC were dif-
ferent from the partners of the women who did not
attend ANC. However, since over 90% of women in
Uganda attend at least one ANC visit [28], the potential
selection bias is limited.
Third, our male involvement index has not been used
before and its validity and reliability have not been estab-
lished in this environment. To our knowledge, there
exists no established instrument to assess male involve-
ment. We still believe this index is likely to divide the men
in the two groups of high and low involvement relative to
this population, but not in absolute terms as even the
'high involvement' group represents a modest involve-
ment in absolute terms.
PMTCT programmes have been started at different
times in the different African countries. The programmes
with the longest history demonstrate many similarities in
their development from start-up to a mature programme.
Men's involvement and understanding of any PMTCT
programme is likely to develop along with the maturation
of the programme. This study was conducted in the early
days of the programme and the study results may in part
reflect this. In a follow-up study it would be interesting to
assess how much has changed since 2003.
Conclusions and recommendations
The level of male involvement in PMTCT programme in
Mbale was low in 2003. Several factors appear to contrib-
ute including health system factors such as: health work-
ers' behaviour and unfriendly environment and clinics
designed for women. Socio-economic factors such as
costs of transport, education level, occupation and cul-
ture also contribute.
Improvements in the health care system and commu-
nity sensitization of men about the benefits of antenatal
care and the PMTCT programme are essential for miti-
gating the effect of socio-economic and cultural factors.
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Male partner antenatal attendance and HIV
testing in eastern Uganda: a randomized
facility-based intervention trial
Robert Byamugisha1,5*, Anne N Åstrøm2, Grace Ndeezi3, Charles AS Karamagi4,5, Thorkild Tylleskär5 and
James K Tumwine3
Abstract
Background: The objective of the study was to evaluate the effect of a written invitation letter to the spouses of
new antenatal clinic attendees on attendance by couples and on male partner acceptance of HIV testing at
subsequent antenatal clinic visits.
Methods: The trial was conducted with 1060 new attendees from October 2009 to February 2010 in an antenatal
clinic at Mbale Regional Referral Hospital, Mbale District, eastern Uganda. The intervention comprised an invitation
letter delivered to the spouses of new antenatal attendees, while the control group received an information letter,
a leaflet, concerning antenatal care. The primary outcome measure was the proportion of pregnant women who
attended antenatal care with their male partners during a follow-up period of four weeks. Eligible pregnant
women were randomly assigned to the intervention or non-intervention groups using a randomization sequence,
which was computer generated utilizing a random sequence generator (RANDOM ORG) that employed a simple
randomization procedure. Respondents, health workers and research assistants were masked to group assignments.
Results: The trial was completed with 530 women enrolled in each group. Participants were analyzed as originally
assigned (intention to treat). For the primary outcome, the percentage of trial participants who attended the
antenatal clinic with their partners were 16.2% (86/530) and 14.2% (75/530) in the intervention and non-
intervention groups, respectively (OR = 1.2; 95% CI: 0.8, 1.6). For the secondary outcome, most of the 161 male
partners attended the antenatal clinic; 82 of 86 (95%) in the intervention group and 68 of 75 (91%) in the non-
intervention group were tested for HIV (OR = 2.1; 95% CI: 0.6 to 7.5).
Conclusions: The effect of the intervention and the control on couple antenatal attendance was similar. In
addition, the trial demonstrated that a simple intervention, such as a letter to the spouse, could increase couple
antenatal clinic attendance by 10%. Significantly, the majority of male partners who attended the antenatal clinic
accepted HIV testing. Therefore, to further evaluate this simple and cost-effective intervention method, adequately
powered studies are required to assess its effectiveness in increasing partner participation in antenatal clinics and
the programme for prevention of mother to child transmission of HIV.
Trial Registration: ClinicalTrials.gov Identifier: NCT01144234.
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Background
Approximately 370,000 children were newly infected
with HIV during 2009 through mother to child trans-
mission [1]. Sub-Saharan Africa, the region most
affected by HIV, accounts for 67% of HIV infections
worldwide and 91% of new infections among children
[2]. HIV counselling and testing is the access point to
HIV prevention, care and treatment programmes. How-
ever, access to services for preventing mother to child
transmission of HIV in low- and middle-income coun-
tries remains limited, with only 26% of pregnant women
in such countries receiving HIV tests during 2009 [1].
Following World Health Organization (WHO) recom-
mendations [3], routine antenatal counselling and test-
ing for HIV has been introduced into prevention of
mother to child transmission (PMTCT) of HIV pro-
grammes in resource-limited settings; this has increased
HIV testing rates among antenatal attendees in several
sub-Saharan countries [4-10]. Engaging men as partners
is a critical component of the PMTCT programme, but
their involvement in antenatal care (ANC) and PMTCT
services has remained low [11-15]. However, men exer-
cise a huge influence on their wives regarding sexual
and reproductive health issues [16,17]. Male involve-
ment in antenatal HIV counselling and testing increases
the use of PMTCT interventions in resource-limited set-
tings [18-21] and is associated with reduced mother to
child transmission of HIV-1 and reduced infant mortal-
ity [22].
In Uganda, HIV is a major public health problem and
there was an estimated adult HIV prevalence rate of
6.7% in 2006 [23], yet only 15% of adults know their
HIV status. The PMTCT programme was launched in
Uganda in 2001 and is currently integrated into main-
stream antenatal care services. However, the proportion
of male partners of pregnant women tested in antenatal
clinics for HIV is low. Further, the proportion of HIV
discordance among couples who test is high, ranging
from 35% to 50% [23-26]. One objective of the Uganda’s
policy change from antenatal voluntary counselling and
testing (VCT) to routine antenatal counselling and test-
ing in June 2006 was to increase the proportion of male
partners of pregnant women offered HIV counselling
and testing services from the PMTCT programme from
3% to 25% by 2010 [27].
A study in Mbale Regional Referral Hospital in Mbale
District, eastern Uganda, revealed high antenatal HIV
testing rates (more than 90%) among pregnant women
[5] as a result of routine antenatal counselling and test-
ing. Nonetheless, antenatal attendance and HIV testing
among their male partners remained very low (4.7%)
[28] despite the fact that counsellors encouraged the
antenatal attendees to invite their male partners for
clinic attendance and HIV testing [29]. However, mea-
sures to increase male partner participation in PMTCT
programmes in Uganda have not been investigated.
Therefore, this trial was conducted to evaluate the effect
of a written invitation letter delivered to the spouses of
women attending their first antenatal visit on couple
attendance and partner acceptance of HIV testing at
subsequent antenatal clinic appointments within a four-
week follow-up period.
Methods
A randomized, parallel group, health facility-based inter-
vention trial was conducted among 1060 new attendees
(530 individuals in the intervention group and 530 in
the control group) at the antenatal clinic in Mbale
Regional Referral Hospital from October 2009 to Febru-
ary 2010. The trial setting has been described elsewhere
[29]. Routine HIV counselling and testing were carried
out according to the Uganda Ministry of Health guide-
lines (2006) [27].
A sequential HIV testing algorithm with same-day
results, which includes three rapid tests, is carried out
using one blood sample: Determine HIV 1 ⁄ 2 assay
(Abbott Laboratories, Abbott Park, IL, USA) for first
screening; STAT-PAK HIV 1 ⁄ 2 dipstick assay (Chembio
Diagnostic Systems Inc.) as a second test; and Uni-Gold
Recombigen HIV (Trinity Biotech, Wicklow, Ireland) as a
“tie-breaker”. An ANC attendee is classified as unin-
fected if Determine is negative and as HIV infected if
the Determine and STAT-PAK tests are positive. Discor-
dant Determine and STAT-PAK blood samples are
further tested using the Uni-Gold test. The HIV test
result is reported as positive if the Uni-Gold test is posi-
tive and as negative if the STAT-PAK and Uni-Gold
tests are negative.
Since 2006, ANC clinic attendees who are HIV-posi-
tive undergo CD4 cell counts before being administered
appropriate treatments according to the national
PMTCT guidelines [27]. The sample size for this trial
was calculated using a computer programme, OpenEpi,
version 2 (http://www.openepi.com/SampleSize/SSCo-
hort.htm). Based on the assumptions that antenatal cou-
ple attendance and HIV testing would increase from
4.5% (without intervention) to 9% (with intervention)
with 80% power and 95% confidence intervals, 1060 new
antenatal attendees, 530 in each group, were enrolled
into the trial. The trial was completed four weeks after
enrolment of the last participant.
Eligible trial participants were new attendees, aged 15
years or above, who agreed to attend subsequent
antenatal visit(s) within the four-week follow-up period
at Mbale Hospital, and were willing to give the invita-
tion and information letters to their male partners.
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A male partner was defined in this trial as the male who
impregnated the antenatal attendee in the current preg-
nancy. The exclusion criteria included women who
attended with their spouses at the first antenatal visit or
did not consent to participate in the trial, or had
spouses who were inaccessible.
Women attending without spouses at the first antena-
tal visit were identified at reception in the antenatal
clinic. They were tracked until they had undergone all
the standard clinic procedures (namely registration,
health education, pre- and post-test counselling for HIV,
HIV testing, obstetric examination and treatment). Indi-
viduals were approached by research assistants and
informed about the trial’s objective and the intervention.
Those who agreed to participate in the trial by providing
written consent were enrolled into the trial using an
enrolment form with a randomly generated identifica-
tion number.
Each woman was provided with a letter addressed to
her spouse and given an appointment for a return visit
two weeks later. If the participant was not able to attend
with her partner on the scheduled visit, she was given
another appointment for a return visit two weeks later.
Their identification numbers were marked on their
antenatal cards to aid follow up at the next clinic visit.
The importance of adhering to their ANC visits was
uniformly emphasized. Women who did not return to
the antenatal clinic for their scheduled visits during the
four-week follow-up period were classified as “lost to
follow up”.
At enrolment into the trial by the research assistants,
participants were randomly assigned to two parallel
groups, the intervention and non-intervention groups,
with an allocation ratio of 1:1. The intervention com-
prised an invitation letter addressed to the male partner
of the woman attending her first ANC visit, requesting
him to accompany her on the next ANC visit. The com-
parative arm (non-intervention group) received a letter
containing information concerning services offered in
the antenatal clinic at Mbale Regional Referral Hospital.
Detailed in the invitation letter was the following
information: the appointment date of the woman’s next
antenatal visit; that the antenatal and PMTCT services
are free (no user charges); that these services are benefi-
cial to the couple and their unborn baby, and that their
utilization by men is low; that he was cordially invited
to accompany the woman at her next scheduled antena-
tal visit to discuss important issues concerning her
antenatal care; and that the time spent in hospital
would be minimal.
The information letter, the leaflet, contained details
concerning services provided in the antenatal clinic, and
these included checking the woman’s blood pressure to
detect and manage high blood pressure during
pregnancy. It explained that the woman’s urine is tested
for protein, sugar and infections, that her blood is
checked for low haemoglobin levels, and that her abdo-
men is examined to investigate the wellbeing of the
baby. Lastly, the leaflet informed the woman and her
partner that PMTCT services in the clinic were free of
charge. The letters were of similar length, and content
was comparable, with one being an invitation and the
other being an information leaflet only. Each letter was
duly signed by the principal investigator.
The random allocation list of the identification num-
bers was randomly generated by an independent statisti-
cian from TASO Uganda (The AIDS Support
Organisation). A random sequence generator (computer
programme) at the RANDOM.ORG website [30], which
employed a simple randomization procedure, was uti-
lized. The random numbers were hand-written at the
bottom of the back page of the letters for the interven-
tion and non-intervention groups by the principal inves-
tigator. Each letter was inserted into an opaque
envelope and sealed with adhesive glue to ensure that
participants would not open their husbands’ letters.
The corresponding randomization number was written
on the back of the envelope. No antenatal clinic staff,
co-investigators, research assistants or pregnant women
knew whether the sealed envelopes contained the inter-
vention or non-intervention letters. The randomization
code was kept securely by the principal investigator.
Each woman enrolled into the trial by the research
assistants was given an identification number (serial
number). The appropriate envelope, whose randomiza-
tion number corresponded to the serial number, was
selected and given to the participant to give to her
spouse. The randomization code was revealed to the co-
investigators during data analysis.
Data were collected by five trained research assistants
using a standardized, pre-tested questionnaire, adminis-
tered to participants in English or Lumasaba (local lan-
guage) during exit interviews at subsequent clinic visits
during the four-week follow-up period. Four weeks after
enrolment into the trial, women who had not returned
for their subsequent antenatal visits were deemed to
have been lost to follow up. The research assistants
were knowledgeable in the local language and interview
techniques, and had been trained in terms of the trial
objectives and methods.
The structured interview covered topics concerning
the participant’s education, occupation, religion, ethnic
group, number of pregnancies, household assets, opi-
nions and experiences relating to routine HIV counsel-
ling and HIV testing in the antenatal clinic, and
knowledge of mother to child transmission of HIV and
infant feeding options for HIV-infected mothers.
Furthermore, her partner’s age, occupation and
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education was discussed. Participants were asked about
partner clinic attendance and partner antenatal HIV
testing acceptance. Questionnaires were checked for
completeness at the end of each day by the principal
investigator and clarification sought from research assis-
tants when queries arose. Data were entered using Epi-
Data version 3.1 [31] by two data entry clerks and were
validated by the principal investigator. The data file was
exported to PASW Statistics 18 [32] (formerly SPSS) for
analysis.
Ethical clearance to conduct the trial was obtained
from the Research and Ethics Committee of the School
of Medicine, Makerere University, and from the Uganda
National Council of Science and Technology. Permission
to conduct the trial in the antenatal clinic was obtained
from the Mbale Regional Referral Hospital administra-
tion through the local institutional review board. Writ-
ten informed consent was provided by all trial
participants. The trial was registered with the Clinical-
Trials.gov registry (Identifier: NCT01144234).
The pre-specified primary outcome measure of the
trial was the proportion of pregnant women who
attended ANC with their partners at the subsequent
antenatal visit. The secondary outcome measure was the
proportion of men who accepted routine antenatal HIV
testing. All participants were included in the analysis for
the primary outcome measure in the groups to which
they were originally assigned (intention to treat); analysis
for the secondary outcome included only participants
who attended their scheduled return clinic visits during
the follow-up period (per protocol analysis).
The socio-demographic characteristics of the trial par-
ticipants in the intervention and non-intervention
groups were compared using independent sample t-test
for continuous variables and the Pearson chi-square test
for categorical variables. Correlates of couple ANC
attendance (male antenatal clinic attendance) and male
partner antenatal HIV-testing in the intervention and
non-intervention groups was determined using the Pear-
son Chi-square test and the independent t-test. Multi-
collinearity among the independent variables and out-
liers were investigated. Interactions were explored and
binary logistic regression was used to test for confound-
ing variables.
All variables that were significant at the level of p <
0.2 in binary analysis, and the age of participants, were
retained in the multivariate regression model. All p
values were two-tailed at a significance level of 5%. As
indicators of model appropriateness, the goodness-of-fit
test (Omnibus Tests of Model Coefficients) of each the
final models for male partner antenatal attendance and
for partner antenatal HIV-testing in the trial groups was
significant (p < 0.05), and the Hosmer and Lemeshow
goodness-of-fit test was not significant (p value > 0.05)
(see tables 1 and 2).
Results
Trial population and follow up
A total of 1060 new antenatal attendees were enrolled
and randomly assigned to the intervention and
non-intervention groups (530 women in each group)
(Figure 1). Of these, 290 and 310 pregnant women in
the intervention and non-intervention groups, respec-
tively, attended the subsequent two antenatal visits as
scheduled; response rates were 55% (290/530) for the
intervention group and 58% (310/530) for the non-inter-
vention group. No major differences in the socio-demo-
graphic characteristics of the trial participants were
recorded between the groups (Table 3).
Analysis by intention to treat demonstrated that the
proportions of participants who attended with their
partners were 16.2% (86/530) and 14.2% (75/530) in the
intervention and non-intervention groups, respectively
(Odds Ratio, OR = 1.2; 95% Confidence Interval, CI: 0.8
to 1.6) (see Table 4). There was no difference between
the intervention and control groups with respect to the
main outcome variable using bivariate analysis [Pearson
chi-square value (c2) = 0.35, p-value = 0.55]. The major-
ity of male partners in the intervention group (95%) and
non-intervention group (91%), who attended the antena-
tal clinic with their spouses, accepted HIV testing.
There was no statistically significant difference between
the intervention and non-intervention groups with
respect to male partner antenatal HIV testing using
bivariate analysis (OR = 2.1; 95% CI: 0.6 to 7.5) and
multivariate analysis (OR = 1.6; 95% CI: 0.4 to 6.8),
table 4. The men in the two groups were similar (p-
value = 0.39).
The majority of male partners (93%, 150 out of 161)
in both trial arms who accepted antenatal HIV counsel-
ling and testing were HIV sero-negative. Three men in
the intervention group tested positive for HIV (Table 4).
All the female antenatal attendees who participated in
the trial accepted antenatal HIV testing. Twenty-five (11
in the intervention group and 14 in the control group)
tested positive for HIV (Table 4). Significantly, the male
partners of most of these HIV-positive women (84%; 21/
25) were not tested for HIV in the antenatal clinic (10
men did not attend the clinic; 11 men attended, but
declined to be tested). Of the five couples with known
HIV test results, three were discordant: in one couple,
the woman was HIV negative and male partner was
HIV positive; in two couples, the women were HIV
positive and the partners were HIV negative. Two cou-
ples were concordant (both partners had HIV-positive
test results). Therefore, in this trial, of the 150 couples
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who accepted antenatal HIV testing, 2% (three of 150)
were identified as HIV sero-discordant.
Correlates of couple antenatal attendance and male
partner antenatal HIV testing
Using multivariate logistic regression analysis, partici-
pants having asked for their partner’s permission to test
for HIV was the only variable significantly associated
with couple antenatal attendance in the intervention
group [adjusted OR (AOR) = 1.9; 95% CI: 1.1 to 3.3]
and the comparative group (AOR = 1.8; 95% CI: 1.0 to
3.2) (see Table 1). The likelihood of partner antenatal
attendance increased if the partner had completed pri-
mary school education (AOR = 1.7; 95% CI: 0.8 to 3.8),
but this association was not statistically significant.
The trial demonstrated that the likelihood of male
partner HIV testing increased if the participant had
asked their partner for permission to test for HIV, and
Table 1 Correlates of couple antenatal attendance among 600 pregnant women at Mbale Regional Referral Hospital
Study participants’
characteristics (Variables)a
Male partner antenatal clinic attendance in
intervention group (N = 290)b
Male partner antenatal clinic attendance in non-
intervention group (N = 310)c
Attended
n (%)
Did not
attend
n (%)
Unadjusted
ORd (95% CI)
Adjusted OR
(95% CIe)
Attended
n (%)
Did not
attend
n (%)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI
Age (years)
15-24 42 (28) 111 (72) 1 1 40 (24) 130 (77) 1 1
25 or more 44 (32) 93 (68) 1.3 (0.8-2.1) 1.2 (0.7-2.1) 30 (25) 105 (75) 1.1 (0.6-1.8) 1.0 (0.6-1.8)
Education level
No or incomplete primary 34 (28) 86 (72) 1 28 (24) 88 (76) 1
Completed primary 52 (31) 118 (69) 1.1 (0.7-1.9) 47 (24) 147 (76) 1.0 (0.6-1.7)
Occupation
Not salaried 47 (30) 109 (70) 1 59 (22) 207 (78) 1 1
Salaried 39 (29) 95 (71) 1.0 (0.6-1.6) 16 (36) 28 (64) 2.0 (1.0-4.0) 1.5 (0.7-3.2)
Ethnic group
Bagisu 55 (30) 128 (70) 1 41 (21) 151 (79) 1 1
Non-Bagisu 31 (29) 76 (71) 0.9 (0.6-1.6) 34 (29) 84 (71) 1.5 (0.9-2.5) 1.6 (0.9-2.9)
Religion
Muslim 30 (24) 93 (76) 1 1 29 (23) 97 (77) 1
Christian 56 (34) 111 (67) 1.6 (0.9-2.6) 1.6 (0.9-2.6) 46 (25) 138 (75) 1.1 (0.7-1.9)
Asked partner permission to test
for HIV
No 27 (22) 95 (78) 1 1 24 (17) 119 (83) 1 1
Yes 59 (35) 109 (65) 1.9 (1.1-3.2)f 1.9 (1.1-3.3)f 51 (31) 116 (69) 2.2 (1.3-3.8)g 1.8 (1.0-3.2)f
Partner’s age (years)
19-29 28 (29) 68 (71) 1 27 (26) 76 (74) 1
30 or more 49 (37) 82 (63) 1.5 (0.8-2.6) 32 (26) 92 (74) 1.0 (0.3-1.8)
Partner’s occupation
Not salaried 47 (30) 109 (70) 1 34 (20) 134 (80) 1 1
Salaried 39 (29) 95 (71) 1.0 (0.6-1.6) 41 (29) 101 (71) 1.6 (1.0-2.7) 1.4 (0.8-2.5)
Partner’s education level
No or incomplete primary 16 (27) 43 (73) 1 9 (16) 47 (84) 1 1
Completed primary 62 (32) 133 (68) 1.3 (0.7-2.4) 59 (29) 147 (71) 2.1 (1.0-4.5) 1.7 (0.8-3.8)
aOther variables not statistically significant in univariate analysis were: Participant’s place of residence, marital status and total number of pregnancies. Age as a
possible confounder and all variables that were significant at the level of p < 0.2 in univariate analysis were retained in the multivariate regression model.
Multicollinearity and interaction among the independent variables, and outliers were checked for.
bThe goodness-of-fit test (Omnibus tests of Coefficients) of the final logistic regression model in the intervention group was significant [Chi-square statistic (c2) =
9.376, degrees of freedom (df) = 3, p = 0.025] and Hosmer and Lemeshow goodness of fit test was not significant [c2 = 2.785, df = 6, p = 0.835] as indicators of
model appropriateness.
cFor the non-intervention group, the goodness-of-fit test (Omnibus tests of Coefficients) of the final logistic regression model was significant [c2 = 13.018, df = 6,
p = 0.043] and Hosmer and Lemeshow goodness of fit test was not significant [c2 = 5.617, df = 8, p = 0.690 as indicators of model appropriateness.
dOR: odds ratio
eCI: confidence interval
fStatistically significant: p < 0.05 (two-tailed)
gStatistically significant: p < 0.01(two-tailed)
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this was the case for the intervention (AOR = 2.0; 95%
CI: 1.2 to 3.5) and non-intervention groups (AOR = 1.9;
95% CI: 1.0 to 3.6). In addition, the participant being a
Christian (AOR = 1.7; 95% CI: 1.0 to 3.0) and their part-
ner being salaried (AOR = 1.8; 95% CI: 1.0 to 3.3) were
significantly associated with male partner acceptance of
antenatal HIV testing (Table 2).
Discussion
As far as we are aware, this is the second randomized
clinical trial to evaluate the effects of a written invitation
letter to spouses of antenatal attendees on partner
antenatal clinic attendance in sub-Saharan Africa. The
effect of the intervention (invitation letter) and the con-
trol (information leaflet) on couple antenatal attendance
Table 2 Correlates of male partner HIV testing in the antenatal clinic at Mbale Regional Referral Hospital, eastern
Uganda
Study participants’
characteristics (variables)a
Male HIV testing in antenatal clinic in intervention
group (N = 290)b
Male HIV testing in antenatal clinic in non-
intervention group (N = 310)c
Tested
for HIV
n (%)
Not tested
for HIV
n (%)
Unadjusted
ORd (95% CI)
Adjusted OR
(95% CIe)
Tested
for HIV
n (%)
Not tested
for HIV
n (%)
Unadjusted
OR (95% CI)
Adjusted OR
(95% CI)
Age (Years)
5-24 40 (26) 113 (74) 1 1 33 (19) 137 (81) 1 1
25 or more 42 (31) 95 (69) 1.2 (0.7-2.1) 1.2 (0.7-2.1) 35 (25) 105 (75) 1.4 (0.8-2.4) 1.3 (0.7-2.3)
Education level
No or Incomplete
primary
33 (28) 87 (72) 1 23 (20) 93 (80) 1
Completed Primary 49 (29) 121 (71) 1.0 (0.9-1.2) 45 (23) 149 (77) 1.2 (0.7-2.1)
Occupation
Not salaried 72 (28) 188 (72) 1 53 (20) 213 (80) 1 1
Salaried 10 (33) 20 (67) 1.3 (0.6-2.9) 15 (34) 29 (66) 2.1 (1.0-4.2) 1.4 (0.6-3.1)
Ethnic group
Bagisu 52 (28) 131 (72) 1 37 (19) 155 (81) 1 1
Non-Bagisu 30 (28) 77 (72) 1.0 (0.6-1.7) 31 (26) 87 (74) 1.5 (0.9-2.6) 1.6 (0.9-2.9)
Religion
Muslim 27 (22) 96 (78) 1 1 25 (20) 101 (80) 1
Christian 55 (33) 112 (67) 1.7 (1.0-3.0)f 1.7 (1.0-3.0)f 43 (23) 141 (77) 1.2 (0.7-2.1)
Asked partner permission to
test for HIV
No 25 (21) 97 (79) 1 1 21 (15) 122 (85) 1 1
Yes 57 (34) 111 (66) 2.0 (1.2-3.4)g 2.0 (1.2-3.5)f 47 (28) 120 (72) 2.3 (1.3-4.0)g 1.9 (1.0-3.6)f
Partner’s age (years)
19-29 26 (27) 70 (73) 1 22 (21) 81 (79) 1
30 or more 47 (36) 84 (64) 1.5 (0.8-2.7) 31 (25) 93 (75) 1.2 (0.7-2.3)
Partner’s occupation
Not salaried 45 (29) 111 (71) 1 28 (17) 140 (83) 1 1
Salaried 37 (28) 97 (72) 0.9 (0.6-1.6) 40 (28) 102 (72) 2.0 (1.1-3.4)f 1.8 (1.0-3.3)f
Partner’s education level
No or incomplete
primary
16 (27) 43 (73) 1 9 (16) 47 (84) 1 1
Completed primary 58 (30) 137 (70) 1.1 (0.6-2.2) 53 (26) 153 (74) 1.8 (0.8-3.9) 1.5 (0.7-3.4)
aOther variables not significant in univariate analysis were: participant’s place of residence, marital status, and total number of pregnancies. Age as a possible
confounder and all variables that were significant at the level of p < 0.2 in univariate analysis were retained in the multivariate regression model.
Multicollinearity and interaction among the independent variables, and outliers were checked for.
bThe goodness-of-fit test (Omnibus tests of Coefficients) of the final logistic regression model in the intervention group was significant [chi-square statistic (c2) =
11.362, degrees of freedom (df) = 3, p = 0.010] and Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 3.585, df = 6, p = 0.733] as indicators of
model appropriateness.
cFor the non-intervention group, the goodness-of-fit test (Omnibus tests of Coefficients) of the final logistic regression model was significant [c2 = 15.412, df = 6,
p = 0.017] and Hosmer and Lemeshow goodness-of-fit test was not significant [c2 = 8.774, df = 8, p = 0.362 as indicators of model appropriateness.
dOR: odds ratio
eCI: confidence interval
fStatistically significant: p < 0.05 (two-tailed)
gStatistically significant: p < 0.01 (two-tailed)
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in the trial was similar. The invitation letter and the
information leaflet increased couple attendance at the
antenatal clinic from approximately 5% [28] to 16% and
14%, respectively. A simple intervention letter to the
spouse could increase couple attendance by 10%. This
cost-effective intervention could be implemented in
almost all African ANC clinics with PMTCT.
The surprisingly equal effect in both arms of the trial
could be because the invitation letter (intervention) and
the information letter (control) had an official connota-
tion and were perceived by the male partners to be
credible as they originated from hospital. Therefore,
these letters influenced male antenatal attendance deci-
sions in similar ways, irrespective of the detailed
content.
A recent study, carried out in northern Uganda, has
documented that the likelihood of male partner antena-
tal attendance was increased if men were knowledgeable
about antenatal care services and if they obtained health
information from health workers [33]. The lack of any
significant difference between the intervention and the
control letter on couple antenatal attendance could be
explained by the low power of the trial as a result of the
high loss to follow up of trial participants.
The level of male antenatal attendance in this trial is
higher than one carried out in northern Tanzania [11],
but lower than those documented in studies from north-
ern Uganda [33], central Kenya [22] and Khayelitsha,
South Africa [34]. The age groups of the men in these
studies were comparable with those of the male partners
Assessed for eligibility:
1083
Enrolled/randomized:
1060
Allocated to intervention group:
530
Allocated to non-intervention group:
530
Excluded (n=23)
- Declined to participate: 4
- Husband far away: 12
- Husband too busy: 3
- Husband fears testing for HIV: 4
Analyzed per protocol for secondary 
outcome:
310
Analyzed per protocol for secondary 
outcome:
290
Analyzed by intention to treat for 
primary outcome:
530
Analyzed by intention to treat for primary 
outcome:
530
Lost to follow up: did not 
return on subsequent 
antenatal visit (s) within the 
4-week follow-up period: 240
Lost to follow up: did not 
return on subsequent 
antenatal visit (s) within the 
4-week follow-up period: 220
Figure 1 Trial profile.
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in the current trial. It was also reported in the northern
Uganda study that the likelihood of male antenatal
attendance was higher if men had attained secondary or
higher level education [33], but partner education level
was not significantly associated with male antenatal
attendance in the current trial. The level of partner
attendance in this trial was similar to that reported in a
study in Nairobi, Kenya [35].
Significantly, the current trial demonstrated that the
majority (more than 90%) of male partners who
attended the antenatal clinic accepted HIV counselling
and testing for HIV. A similar finding has been reported
in other studies in the region [22,35]. The implication of
this finding is that increasing male antenatal clinic
attendance is vital for involving spouses of antenatal
attendees in the PMTCT programme. A woman having
sought a partner’s permission for HIV testing was signif-
icantly associated with partner antenatal attendance and
HIV testing, as demonstrated using multivariate analysis.
A similar finding was reported in the Nairobi antenatal
clinic study [35]. This suggests that improved communi-
cation between couples regarding HIV is an important
factor in increasing the number of men accompanying
their spouses to antenatal clinics and accessing HIV
counselling and testing services.
However, there was a differential effect because the
HIV sero-status of approximately 80% of the HIV-posi-
tive women’s partners remained unknown, which consti-
tutes a missed opportunity to investigate couple HIV
sero-discordance and a failure of the intervention to
reach the intended recipients.
The trial demonstrated that at least 2% of the couples
were HIV sero-discordant. However, because of the low
numbers of male partners tested, this figure is likely to
be higher. Other studies in Uganda have reported rates
of couples’ HIV sero-discordance at 30% to 50% [23-26].
HIV sero-discordance is a key factor that influences
rates of new infections among couples [36], thus
increasing the risk of mother to child transmission of
HIV during pregnancy, delivery and lactation.
The strength of this trial was the surprisingly compar-
able effect of a letter - a simple, cheap intervention that
was easy to administer - in both arms. It could be
argued that the main limitation of this trial was the high
loss to follow up rate of approximately 40%, reducing
the precision (internal validity) and the power of the
trial to detect differences between the effect of the invi-
tation letter and the information letter.
There are several possible reasons for the high rate of
loss to follow up. Some pregnant women may have con-
tinued receiving antenatal care at lower level health
units (health centres) nearest to their place of residence
on learning from the midwives on their first antenatal
clinic visit that they had low risk pregnancies. Others
may not have attended follow-up ANC visits owing to
transportation problems as the trial site was a referral
hospital. Others could have attended clinics for HIV
counselling and testing services and decided to continue
with ANC elsewhere.
Table 3 Demographic characteristics of study participants
compared between intervention (N = 290) and non-
intervention groups (N = 310)
Characteristics Study groups P
value
Intervention
n (%)
Non-
intervention
n (%)
Age in yearsa
15-24 153 (52.8) 170 (54.8) 0.64
25 or more 137 (47.2) 140 (45.2)
Place of residence
Rural 197 (67.9) 207 (66.8) 0.83
Urban 93 (32.1) 103 (33.2)
Number of pregnancies
One 64 (22.1) 72 (23.2) 0.48
Two or more 226 (77.9) 238 (76.8)
Education level
No education/incomplete
primary
120 (41.4) 116 (37.4 0.43
Completed primary or
more
170 (58.6) 194 (62.6)
Marital status
Single/divorced/widowed 4 (1.4) 6 (1.9) 0.75
Married/cohabiting 286 (98.6) 304 (98.1)
Occupation
Salaried 30 (10.3) 44 (14.2) 0.19
Not salaried 260 (89.7) 266 (85.8)
Ethnic group
Bagisu 183 (63.1) 192 (61.9) 0.83
Non-Bagisu 107 (36.9) 118 (38.1)
Religion
Muslim 123 (42.4) 126 (40.6) 0.72
Christian 167 (57.6) 184 (59.4)
Partner’s age in yearsb
19-29 96 (42.3) 103 (45.4) 0.51
30 or more 131 (57.7) 124 (54.6)
Partner’s education level
No education/incomplete
primary
59 (23.2) 56 (21.4) 0.45
Completed primary or
more
195 (76.8) 206 (78.6)
Partner’s occupation
Not salaried 156 (53.8) 168 (54.2) 0.99
Salaried 134 (46.2) 142 (45.8)
aThe median age of the pregnant women was 24 years in both the
intervention [interquartile range (IQR): 20-28 years] and non-intervention (IQR:
21-29 years) groups.
bThe male partners’ median age was 30 years in the intervention group (IQR:
26-38 years) and non-intervention group (IQR: 26-35 years), respectively.
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It is possible that community sensitization activities to
encourage men to participate in ANC activities, as car-
ried out in the Khayelitsha trial in South Africa [34],
could have helped reduce the loss to follow up in our
trial. Being a randomized, health facility-based trial, it is
assumed that random allocation of the trial participants
to the comparison groups, and masking of research
assistants, health staff in the antenatal clinic and the
participants, dealt with known and unknown confoun-
ders. As one of the health providers in the hospital, the
principal investigator (RB) did not directly participate in
administering intervention to the trial participants in
order to avoid the Hawthorne effect on the internal
validity of the trial. The findings of this trial could be
generalized country-wide to populations that are similar
to the one in the trial area.
Conclusions
The effect of the intervention and the control on couple
antenatal attendance was similar in both arms of the
trial. In addition, this trial demonstrated that a simple
intervention, such as a letter to the spouse, formulated
as an invitation or as an information letter, could
increase couple attendance by 10%. This intervention
could be implemented in almost all African ANC clinics
with PMTCT at a modest cost.
The trial also demonstrated that the majority (more
than 90%) of the male partners who attended the
antenatal clinic accepted HIV counselling and testing
for HIV. Therefore, there is a requirement to evaluate
this simple, cheap intervention further elsewhere in ade-
quately powered studies to assess its effectiveness in
increasing partner participation in antenatal clinics and
the prevention of mother to child transmission of HIV.
Such studies would better define the trial’s implications
for the PMTCT programme.
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Title of study: Facility-based intervention to increase male involvement in antenatal care 
and the prevention programme of mother-to-child transmission of HIV in Eastern 
Uganda  
Investigators: 
Dr Robert Byamugisha, Mbale Regional Referral Hospital, P O Box 921 Mbale – Uganda. 
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Prof. Thorkild Tylleskär, Centre for International Health, University of Bergen 
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P O Box 7072, Kampala – Uganda 
Introduction and purpose of the study of the cross-sectional survey 
This study is being conducted by doctors from Mbale Regional Hospital, the Department of 
Paediatrics and Child Health, Makerere University and the Centre for International Health, 
University of Bergen. The purpose of the cross-sectional study (survey) is to explore the 
attitudes of women attending antenatal clinic (ANC) at Mbale Regional Referral hospital 
about the antenatal care and PMTCT services at the hospital. A total of 384 pregnant women 
attending their first antenatal visit in present pregnancy will be enrolled.  
Procedures to be followed 
If enrolled in the study, you will be tracked from the reception to the time you exit the clinic. 
The interview concerning this study will be done at the time of exit. You will be asked 
questions concerning you, your living conditions and your opinions about issues regarding 
antenatal care, routine counselling and testing for HIV and prevention of mother to child 
transmission of HIV services in this hospital.  
Risks 
There are no anticipated risks arising from this study. 
Potential benefits
It is hoped that the results of the study will be used to improve the delivery of antenatal and 
prevention of mother to child transmission of HIV services, which will be of benefit to you 
and your unborn child. 
Costs or payments
There are no costs or payments to you for participating in this study. 
Confidentiality
Your and your spouse’s personal information will be strictly kept confidential. We will not 
give this information to anyone unless we get your permission to do so. You will not be 
personally identified in any publication or presentation about this study. However, the 
Makerere University College of Medicine Research and Ethics Committee, and the Uganda 
National Council for Science and Technology may check your records and the consent form 
you signed to make sure all rules and guidelines were followed. 
Your rights as a research participant/volunteer 
Your participation in this study is entirely voluntary. You will be asked to sign the consent 
form only when you have understood and agreed to participate in the study. You may decide 
to withdraw from the study at any stage. Such a decision will not affect your medical care or 
possible participation in future research studies in any way. 
Problems or questions 
If you have any questions about this study you can ask them now or at anytime during the 
course of the study. You are free to contact the following persons at any time; Dr. Robert 
Byamugisha on Telephone 256 772 68 90 28 or Prof James Tumwine on telephone 
256 772 494 120 or Dr Grace Ndeezi on telephone 256 772 453191. You are also free to 
contact the Chairman of the Ethics committee of Makerere College of Medicine on telephone 
+256 412 530 020. 
Respondent’s consent
I have understood the information given to me about this study. I understand that my decision 
to participate in this study is voluntary and my decision not to participate will not alter the 
care I receive from this hospital. I also understand that my identity will remain anonymous in 
the use of the information generated from this study. I am aware that I may withdraw from 
this study any time. 
If I have any questions concerning my rights as a research subject, I may contact Makerere 
University College of Medicine Research and Ethics Committee or the Uganda National 
Council of Science and Technology (Tel: +256 412 250 499 or +256 412 250 431). 
I understand that by signing this consent form, I do not waive my legal rights nor does it 
relieve investigators of liability but merely indicates that I have been informed about the 
research study in which I am voluntarily agreeing to participate. 
_____________________________  ____________________ _____________ 
Respondent’s Names    Signature/ thumb print  Date 
_____________________________  ____________________ _____________ 
Person administering consent  Signature   Date 
_____________________________      _____________ 
Principal Investigator’s Signature      Date 
Questionnaire for Paper II 
Title: Facility-based intervention to increase male involvement in antenatal care and the 
prevention programme of mother-to-child transmission of HIV in Eastern Uganda 
Hello, I come from Makerere University, Uganda and the Centre for International Health,
University of Bergen, Norway. The title of study is:  Facility-based intervention to increase 
male involvement in antenatal care and the prevention programme of mother-to-child 
transmission of HIV in Eastern Uganda 
The purpose of the study is to obtain information on women's views on the current service 
delivery at the antenatal clinic at Mbale Regional Referral Hospital. The results of the study 
will be used to improve the delivery of health services. The information you give shall be 
confidential and you will not be personally identified in any publication or presentation about 
this study. 
I.  IDENTIFICATION       
1. Date of interview                 <dd/mm/yyyy> .…/.…/……… 
2.   Name of Interviewer               ………………………………………… 
3.   Participant’s ID Number         ………………. 
4. Participant’s names …………………………………………………… 
II.     SOCIO-DEMOGRAPHIC CHARACTERISTICS 
5.  Where do you live?      --------- 1=rural, 2=urban 
6 (a) How old were you on your last birthday?  --------- (completed years), 99= do not 
know ……. 
(b) When were you born? ................ (Year) 
7.  What is your current   marital status?       ………. 1=single, 2=divorced/separated,
                                             3=widower, 4=cohabiting, 5=married   
8.  Is this your first pregnancy?     1=Yes (skip to 10), 2= No ……… 
9. If no, how many pregnancies have you had before the current one?  …………. 
10.  What is your religion?  ------ 1=Protestant/Lutheran, 2=Catholic,
                                                      3=Muslim, 4=other, specify: --------- 
11.  What is your tribe (ethnic background)? ------ 1=Mugisu, 2=Mugwere, 3=Atesot,
                   4=Musoga, 5=Muganda, 6=other, specify: ---------- 
12. Did you attend school? …….. 1=Yes, 2=No (skip to 15) 
13. If yes, what level of schooling did you achieve? ................ 
14 How many completed years of schooling have you had? /do you have? (Exclude 
repeated years and pre-school) ……… 
15 What do you do for a living? ---- 1=housewife, 2=farmer, 3=service,
            4=business, 5=professional, 6=student, 7=other, specify: ----------  
16.  How old is your husband/ partner? ----- (completed years), 99=do not know 
18.  How many completed years of schooling does your husband/partner have? (Exclude 
repeated years and pre-school)    -------- 99= do not know
19. What does your husband/partner do for a living? ----- 1=farmer, 2=business, 3=skilled
worker, 4=unskilled worker, 5=service, 6=official, 7=professional, 8=unemployed, 
9=student, 0=other, specify: ----------  
20.  Do you own the house you live in? ---- 1=Yes,  
2=No, rent the house,
3=No, house of my parents,  
4=No, house of spouse's parents,  
5=No, other: -------------- 
21.  What type of house is it?  ---- 1=permanent, 2=semi-permanent, 3= other, 
specify……….,.
22.  Does your household own any of the following items (functioning)?    
       (i) Radio                            ----    1=yes, 2=no   
       (ii) Bicycle                        ----    1=yes, 2=no  
       (iii) Sofa                            ----    1=yes, 2=no  
      (iv) Hurricane lamp           ----    1=yes, 2=no  
       (v) Cupboard                     -----   1=yes, 2=no  
       (vi) TV                               ----    1=yes, 2=no  
       (vii) Mobile phone             ----   1=yes, 2=no   
       (viii) Refrigerator               ----    1=yes, 2=no
      (ix) Car/truck                      ----    1=yes, 2=no  
       (x) Motorcycle/scooter       ----    1=yes, 2=no
II. CLINICAL ACTIVITIES 
Now I will ask you some questions about the ANC clinic  
23.  How was your visit to the antenatal clinic today? ---- 1=very bad, 2=bad, 3=fair, 
   4=good, 5=very good 
24. If a score of 10 is very good and 1 is very bad, please give me your score (out of 10) 
for how the following worked out for you: 
(i) Handling/treatment by the midwives (staff)   …… 
(ii) Waiting                                                           …… 
(iii) Facilities                                                        …… 
(iv) Health education talk/lection                     …… 
25.  Have you heard about a programme at the clinic regarding prevention of mother-to-
child transmission of HIV?  ------- 1=yes, 2=no
26. Did you get any information about HIV at the antenatal clinic today? ----- 1=yes,  
                                                                                                                       2=no (skip to 28) 
27. If yes, in which form? 
       (i) TV                                       ---- - 1=yes, 2=no    
      (ii) General information          ------ 1=yes, 2=no    
      (iii) Group counselling            ------ 1=yes, 2=no    
       (iv) Individual counselling      ------ 1=yes, 2=no  
28.  Were you offered testing for HIV? ---- 1=yes, 2=no (skip to 34) 
29.  Did you ask your husband/partner for permission to be tested before testing? ---- 
1=yes, 2=no (skip to 33) 
30.  Did he agree?                    ----- 1=yes, 2=no  
31.  Did you test for HIV?       ----- 1=yes, 2=no  
32.  Did you receive the results of the test today?  ---- 1=yes (skip to 35), 2=no
33.   If no, were you told when to come back for the result? ---- 1=yes, 2=no 
34. If you did not test, have you ever tested for HIV? ---- 1=yes, 2=no 
35.  Do you think your husband/partner knows you are being tested for HIV? …… 1=yes,  
        2=no
36 Did they suggest your husband/ partner to be tested as well? ....  1=yes,  
2=no (skip to 39) 
37.  How was your pre-test counselling at the antenatal clinic? ----- 1=very bad, 2=bad, 
3=fair,   good, 5=very good 
38.  How was your post-test counselling at the antenatal clinic? …. 1=very bad, 2=bad, 
3=fair,   4=good, 5=very good 
39. Nowadays in this clinic all mothers are supposed to be tested for HIV unless they say 
no. What do you think about this system? Is it: ----- 1=very bad, 2=bad, 3=fair,  
4=good,5=very good 
40. Why do you think it is good or bad?    --------------------------------------------
  VI.  HIV AND INFANTS  
  Now I will ask you some questions about HIV and infants 
41.  Is it possible that when the mother or the father is HIV positive and their newborn 
child can be HIV negative?                                        …… 1=Yes, 2=No
42.  When can HIV be passed from a mother to her child? 
 (i) During pregnancy                    ----- 1=yes, 2=no  
 (ii) Labour                                    ------ 1=yes, 2=no    
 (iii) Through breastfeeding           ------ 1=yes, 2=no  
 (iv) Sexual intercourse                  ------ 1=yes, 2=no
 (v) Other                                       ------ 1=yes, 2=no, (specify :----------) 
43.  If there are 10 HIV infected pregnant women, how many do you think would have 
babies born with HIV virus?        ------- (number between 0 and 10) 
44.  If the baby gets breast milk from the mother and the mother is HIV positive, can the 
baby get HIV?          -------- 1=yes, 2=no (skip to 46) 
45. How many babies could get HIV infected through breastfeeding out of 10 HIV 
infected mothers?                         -------- (number between 0 and 10)  
46.  Can a mother who HIV positive do anything to reduce the risk of transmission of HIV 
to her child during pregnancy?              -------- 1=Yes, 2=No, 3=Do not know
47.  If yes, what can a mother do to reduce the risk of transmission of   HIV to her child 
during pregnancy? 
 (i) Take medicine             -------- 1=yes, 2=no      
 (ii) Use condoms              --------- 1=yes, 2=no  
 (iii) Other                          --------- 1=yes, 2=no (specify :----------) 
48.  Can an HIV infected mother do anything to reduce the risk of transmission of HIV to 
her child during the breastfeeding period?         -------- 1=Yes, 2=No, 3=Do not know
49.  If yes, what would an HIV positive mother do to reduce the risk of her baby becoming 
infected with HIV during the breastfeeding period? 
(i) Give breast milk only and no other feeds up to 6 months (exclusive breastfeeding)  
------ 1=yes, 2=no 
(ii)  Use of condom by partner    ------ 1=yes, 2=no 
(iii)  Stop breastfeeding; give infant formula  ------ 1=yes, 2=no 
(iv)  Stop breastfeeding; give diluted cow’s milk ------ 1=yes, 2=no 
(v)  Breast care      ------ 1=yes, 2=no (specify :-------) 
(vi)  Other       ------ 1=yes, 2=no (specify :-------) 
50.  If you hypothetically were HIV positive, what infant feeding option would be 
feasible? -----------    1=Infant feeding formula, 2=Cow milk, 3=Give breast milk only 
and no other feeds, other (specify) ----------
V.  SERVICE IMPROVEMENT 
52.  What would you wish done differently?--------------------------------------------------------
--------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------
Remind her about her next ANC visit and the importance of adhering to the visits. 
Complete the interview and thank her cooperation and for participating. 
Signature of the interviewer---------------------------                               Date----------- 
Consent form Paper III 
Factors influencing male participation in the Prevention of Mother to Child 
Transmission of HIV (PMTCT) Programme in Mbale, Uganda 
Investigators:  
Robert Byamugisha, M.B.Ch.B., DTM/PH 
Department of Obstetrics and Gynaecology, Mbale Hospital  
P. O. Box 921, Mbale Uganda 
Nulu Bulya Semiyaga, M. B. Ch. B., MSc. CEB, Mount Elgon International Centre for Health 
Research, P. O. Box 187, Mbale Uganda.
Mike. N. Kagawa, M.B.Ch.B., M.Med (Obs and Gyn) 
Department of Obstetrics and Gynaecology, Mbale Hospital P. O. Box 921, Mbale 
Uganda
Charles Karamagi, M.B.Ch.B., M.Med (Paed) 
Department of Paediatrics and Child Health, Makerere University, Kampala, 
UGANDA
James K.Tumwine, PhD 
Associate Professor, Department of Paediatrics and Child Health,  
Makerere University, P.O.Box 7072, Kampala, Uganda. 
Thorkild Tylleskar, PhD 
Professor of International Health 
Centre for International Health, University of Bergen 
P.O.Box 7800, N-5020 Bergen, Norway 
INFORMED CONSENT 
This study is being conducted by doctors from Mbale Regional Hospital, the Department of 
Paediatrics and Child Health, Makerere University and the Centre for International Health, 
University of Bergen. Before I can decide whether or not to volunteer for this study, I must 
understand its purpose, how it may help me and any risks to myself and what is expected of 
me if I decide to participate in this study. This process is called informed consent. 
My rights as a research volunteer:
This consent form gives me information about the study which will also be discussed with 
me. Once I understand the study and agree to participate, I will be asked to sign this consent 
form. I understand that my participation in this study is entirely voluntary. I may decide to 
withdraw from the study at any stage. Such a decision will not affect my medical care or 
possible participation in future research studies in any way. 
Purpose of the study:
The purpose of the study is to obtain information that will be used to understand the factors 
that influence male participation in the Prevention of Mother to Child Transmission of HIV 
programme. Interviews will last about one hour while group discussions will last 2 hours. I 
will only be required to participate in either the interview or the group discussion. 
Study procedures:
I understand that if I decide to participate in the study, I will participate in the discussion on 
questions that will be asked by the moderator. The responses will be recorded, both in writing 
and by an audio tape recorder. If I decide to participate in the interview, I will be asked some 
questions.
Risks to me:
I understand that there are no risks to me, except for the temporary anxiety that may arise 
from the questions to be asked and for the time that I will spend here. 
Potential benefits to me:
There are no immediate benefits from this study. However, I understand that the results of the 
study will be used to improve the delivery of health services, which will be of benefit to my 
child (ren) and to me. 
Costs or payments to me: 
There are no costs or payments to me. 
Confidentiality: 
I understand that the information that I give shall be confidential. I will not be personally 
identified in any publication or presentation about this study. 
Problems or questions:
If I have any questions about this study, I am free to contact the following at any time; Dr. 
Robert Byamugisha on 077-689028, Dr. Mike. N. Kagawa on 077449613. If I have any 
questions on my rights as a research volunteer I may also contact Professor E. Katabira on 
041-530020.
Respondents consent:
………………………………………… has described to me what is going to be done, the 
risks, hazards and benefits involved. I understand that my decision to participate in this study 
or not to do so will not alter my usual health care. In the use of the information generated 
from this study such as publications, my identity will remain anonymous. I am aware that I 
may withdraw from this study any time. 
Further information on research subjects’ rights is available from the National Council of 
Science and Technology (Tel: 014- 250499 or 250431). 
I understand that by signing this consent form, I do not waive my legal rights nor does it 
relieve investigators of liability but merely indicates that I have been informed about the 
research study in which I am voluntarily agreeing to participate. 
Respondent’s Name:………………………….Age in completed years……...…….   
Volunteer's Signature or Thumbprint:……………………………………………. 
Witness’ Name……………………………..  Signature:………………………… 
Date:…………………………….  ID No. [  ][  ][  ]
Questionnaire Paper III 
Factors influencing male participation in the Prevention of Mother to Child 
Transmission of HIV (PMTCT) Programme in Mbale, Uganda. 
Interview of Males 
I. IDENTIFICATION       
1.  ID Number [  ][  ][  ] 
2.  Local Council 1  
3.  Name of respondent  
4.  Status of head of household [  ] Husband 
[  ] Mother 
[  ] Grandmother 
[  ] Grandfather 
[  ] Other (specify) 
5.  Name of youngest child       
6.  Age of youngest child (completed months)
7.  Name of Interviewers  
8.  Date of interview  
II SOCIO-DEMOGRAPHIC CHARACTERISTICS 
1. How old are you? 
2. In which year were you born? 
(probe if Q1 and Q2 are inconsistent)
Years_______ (completed years)
[  ] Do not know 
19 ____
[  ] Do not know 
3. Are you married? [  ] Yes   
[  ] No  
4. How did you get married? [  ] Religious 
[  ] Traditional 
[  ] Civil 
[  ] Cohabiting 
[  ] Other (specify) ____________ 
5.What is your highest level of 
education? 
Level __________ 
6. How many completed years of 
schooling have you had? (exclude
repeated years and pre-school)
Years of schooling [  ] [  ] 
7. What is your occupation? (tick all 
 that apply)
[  ] Driver   
[  ] Farmer   
[  ] Trader (specify)______________ 
[  ] Shopkeeper  
[  ] Teacher  
[  ] Tailor   
[  ] Health worker  
[  ] Other (specify) ___________ 
9.  How old is your wife? (if 
 possible check with the wife) 
[  ] [  ] (in completed years) 
[  ] Don’t know 
10. In which year was your wife 
 born? 
19____
[  ] Don’t know 
11.  What is the highest level of _________________ 
 education of your wife? [  ] Don’t know 
12. How many completed years of 
 schooling has your wife had? 
 (probe and exclude repeated 
 years and pre-school) 
[  ] [  ] (in completed years) 
[  ] Don’t know 
13.  What is your wife’s occupation?      
tick all that apply) 
[  ] Farmer   
[  ] Trader (specify)___________  
[  ] Shopkeeper  
[  ] Teacher  
[  ] Tailor   
[  ] Health worker  
[  ] Other (specify) ___________ 
14.  How many rooms are there in 
 your house? 
[  ][  ] rooms 
15. Do you have a working (read the 
 alternative) in your home)? 
[  ] Lantern 
[  ] Radio 
[  ] Television 
[  ] Cupboard 
[  ] Refrigerator 
[  ] Bicycle 
[  ] Motorcycle 
[  ] Car/truck 
[  ] IGA Machine (specify) _________ 
[  ] None 
16. What is the main fuel for lighting 
 in your house? 
[  ]  Wood 
[  ]  Oil lamp (tadooba) 
[  ]  Kerosene lamp 
[  ]  Candle light 
[  ]  Gas light 
[  ]  Electric light 
[  ]  Other (specify) __________ 
17. What is the main fuel for cooking 
 in your house? 
[  ]  Wood 
[  ]  Charcoal  
[  ]  Kerosene 
[  ]  Gas  
[  ]  Electricity 
[  ]  Other (specify) __________ 
18. What is your usual source of 
 drinking water? 
[  ] Stream/River/Dam 
[  ] Well 
[  ] Unprotected spring 
[  ] Protected spring 
[  ] Borehole pump 
[  ] Piped water 
[  ] Other (specify) ____________ 
19. What is your religion? [  ] Protestant 
[  ] Catholic 
[  ]  SDA 
[  ]  Pentecostal 
[  ]  Muslim 
[  ]  Traditional 
[  ]  Other (specify) ______________ 
20. How many of the following 
 animals/birds do you have in your 
 home? 
[  ] Chicken _______ 
[  ] Turkeys _______ 
[  ] Goats _________ 
[  ] Sheep _________ 
[  ] Pigs __________ 
[  ] Cattle _________ 
[  ] Other (specify and No.) 
____________
21. Does your family own land? [  ] Yes  [  ]  No 
22. What is the floor of the main         
        house made of? 
[  ]  Mud 
[  ]  Stone 
[  ]  Cement and sand 
[  ]  Wood 
[  ] Other(specify)_____________ 
23. What are the walls of your main    
           house made of?  
[  ]  Mud and poles 
[  ]  Earth bricks 
[  ]  Burnt bricks and cement 
[  ]  Wood 
[  ]  Other (specify)__________ 
24. What is the roof of your main 
            house made of? 
[  ]  Grass/banana fibre 
[  ]  Iron sheets 
[  ] Tiles 
[  ]  Other (specify) ___________ 
25.         How many people live in your 
              household? 
0-5years:                 No._____ 
More than 5 years:  No.____ 
Total:                       No._____ 
III GENERAL PERCEPTIONS AND EXPERIENCES  
1.  How many times has your wife     
been pregnant to date?  
No._____
2. Did your wife attend antenatal 
clinic  during her last pregnancy? 
[  ]  Yes 
[  ]  No Skip to Q4
3. If yes, where did your wife go for 
 antenatal care? 
[  ] Mbale Regional Hospital 
[  ] Other Government health unit 
[  ] Private health unit 
[  ] TBA 
[  ] Other (specify) 
4. Have you heard about the 
PMTCT programme?  
[  ]  Yes 
[  ]  No (skip to 8)
5. How did you get information on 
the PMTCT programme?  
[  ]  Health care provider 
[  ]  News papers 
[   ] Radio Programme/ advert 
[   ]Friend 
[   ] Wife 
6. What do you know about  
PMTCT? 
7. Would you encourage your wife 
to participate in PMTCT? 
[  ]  Yes (explain)
[  ]  No (explain) 
8. Did you discuss HIV testing 
during  your wife’s last 
pregnancy?
 [  ]  Yes 
[  ]  No 
9. Do you know your HIV status? [  ]  Yes 
[  ]  No  
10. Are you willing to go for HIV 
counselling and testing? 
[   ] Yes 
[   ] No 
11. Would you fear taking the test for 
 HIV?   
[  ]  Yes (explain)
[  ]  No (explain 
12. Would you fear taking HIV drugs 
if you were tested HIV positive? 
[  ]  Yes (explain) 
[  ]  No (explain) 
13. Do you have fears about 
disclosure of HIV positive status 
 to? 
Wife              [  ] Yes  [  ] 
No
Mother [  ] Yes  [  ] 
No
Other relative [  ] Yes  [  ] 
No
Friend  [  ] Yes  [  ] 
No
Neighbour [  ] Yes  [  ] 
No
Health worker [  ] Yes  [  ] 
No
Other people [  ] Yes  [  ] 
No
14.  Would you go for VCT with your 
wife?
[   ] Yes 
[   ] No 
15. Would you fear giving HIV drugs 
to your baby if you or your wife 
were tested  HIV positive? 
[  ]  Yes (explain)
[  ]  No (explain) 
16. Would you fear not to
 breastfeed  your baby if 
you or your wife were tested HIV 
 positive? 
[  ]  Yes (explain)
[  ]  No (explain) 
17. Who decided/would decide on use 
of HIV drugs in pregnancy if you 
or wife were tested HIV positive? 
Wife             [  ] Yes  [  ] 
No
Self  [  ] Yes  [  ] 
No
Both  [  ] Yes  [  ] 
No
Other (specify) 
V ANTE NATAL CARE AND POST NATAL 
1. Have you ever visited the ante 
natal clinic with your wife? 
[  ] Yes   
[  ] No (Skip to Q5)
2. If yes, why did you go to ANC? 
3. Would you encourage other men 
to go to the ante natal clinic with 
their wives? 
[   ] Yes (explain) 
[   ] No (Explain) 
4. What are the problems with the 
current set up of the ANC? 
5. Do you have to provide your wife 
with financial support to enable 
her attend the ANC? 
[   ] Yes 
[   ] No 
6. Would you provide your wife 
with financial support to attend 
ANC? 
[   ] Yes (explain) 
[   ] No (explain) 
7. Are you aware of your wife’s 
ANC appointments? 
[  ] Yes   
[  ] No  
8. Would you remind your wife to 
honour her ANC appointments? 
[   ] Yes 
[   ] No 
9. Have you ever bothered to know 
your wife’s ANC appointments? 
[  ] Yes   
[  ] No 
10. Have you ever taken the time to 
find out what goes on in the 
ANC? 
[  ] Yes (specify) ___________  
[  ] No 
11. Do you discuss the interventions 
and information given in the ANC 
with your wife? 
[  ] Yes  (specify)___________  
[  ] No 
12. Have you ever withheld financial 
support for any of the following 
from your wife? 
[  ] Food                   [  ] Yes [  ] No 
[  ] Fuel          [  ] Yes       [  ] No 
[   ] Clothing       [  ] Yes       [  ] No 
[   ] Medical treatment      [  ] Yes [  ] No 
13. Do you have children with other 
women? 
[  ] Yes  (specify no of 
wives)_____________
[  ] No 
14.  If yes, How many children? [  ] wife 1    __________no of children 
[  ] wife 2         ________no of children 
[  ] wife 3          _________no of children 
15. Since you got married, have you 
ever had sexual intercourse with a 
woman other than your wife 
(ves)?
[  ] Yes  (why?)
[  ] No 
16. How do you feel about your  
marriage?  
17. Do you have someone to talk to 
about your marital relationship? 
[  ] Yes   
[  ] No Skip to Q19
18. If yes, who? 
19.  Since you got married have you 
ever used condoms? 
[  ] Yes 
[  ] No Skip to Q21
20.  If yes, who decided to use the 
condoms? 
[  ] Wife 
[  ] Self (why)
[  ] Other (specify) _________ 
21.  Would you use a condom if your 
wife asked you to use one? 
[  ] Yes   
[  ] No (why?)
22.  Have you ever asked your partner 
to use a condom? 
[   ] Yes 
[   ] No (why?)
23. If yes, what happened?  
Thank you very much for your cooperation. 
Interview guide for Paper III 
Factors influencing male participation in the Prevention of Mother to Child 
Transmission of HIV (PMTCT) Programme in Mbale District, Uganda 
In-depth interview of Health Care Providers 
I. IDENTIFICATION AND SOCIO-DEMOGRAPHICS 
ID Number ________ 
Name   ________________________ 
Age  ________  
Sex  Male  Female 
Position ________________________ 
Interviewer ________________________ 
Date of Interview __________________ 
II PMTCT 
1. How long have you been working in your present post? 
2. Do you work with pregnant mothers? 
3. What are your views regarding voluntary counselling and testing for HIV of pregnant 
mothers?
4. Should pregnant mothers be tested using the opt-in or opt-out approach? 
5. What can be done to increase acceptance of VCT by males? 
6. What is the role of men in promoting VCT in pregnancy? 
7. Is couple VCT acceptable and feasible? 
8. What can be done in the health care system to encourage males to accept VCT? 
9. What factors discourage males from accepting VCT? 
10. What can be done in the health care system to encourage males to support their 
partners during pregnancy (ANC) and child birth? 
Topic Guide for Focus Group Discussions 
Factors influencing male participation in the Prevention of Mother to Child 
Transmission of HIV Programme in Mbale District, Uganda 
Instructions:
With the help of the local guide, you meet the participants assembled for the group 
discussion. Find a comfortable place to sit preferably in a circle and away from distraction. 
The local guide can help to keep away distracters. Greet the participants and thank them for 
having agreed to come. Introduce yourselves including the participants. Use name tags (tape) 
for identification of participants and research team. Explain the purpose of the study and the 
procedures that will be used including use of the tape recorder. Obtain informed consent from 
each participant. Set the ground rules for the group discussion (respect, input from everyone, 
honesty, start and end time etc). Emphasize that the discussion will be confidential and 
participants will remain anonymous. At the end of the session, give participants opportunity 
to ask questions. Attend to administrative issues (refreshments transport etc). Finally thank 
the participants and officials and take your leave. 
Participants 
Number of FGDs:  2 per zone = 8 FGDs 
Number of participants: 6 to 12  
Type of participants: Men whose partners have gone through or are attending ANC 
Topics
I HIV in general - terminology, frequency, causes, prevention, treatment
What are the local names used for HIV?  
What is their meaning?  
Why are the names used to describe HIV? 
How common is HIV?  
Do participants know persons with HIV?  
Do they know persons who may have died of HIV? 
What are the causes of HIV? 
How can HIV be prevented? 
How can HIV be treated? 
II HIV in children – terminology, occurrence, causes, prevention, treatment 
What are the local names used for HIV?  
What is their meaning?  
Why are the names used to describe HIV? 
How common is HIV?  
Do participants know persons with HIV?  
Do they know persons who may have died of HIV? 
What are the causes of HIV? 
How can HIV be prevented? 
How can HIV be treated? 
III Voluntary Counselling and Testing for HIV 
Do you know about VCT? 
What do you know about VCT? 
Do you know people who have had VCT?  
What were their feelings after going for VCT? 
What do you feel about VCT? 
What do you feel about VCT for pregnant women? 
What are the problems with VCT? 
What are your feelings about couple testing?  
Should husbands be counselled and tested for HIV together with their wives? 
What are your feelings about disclosure of HIV results?
Should wives who test for HIV disclose their results to their husbands?  
Should husbands who test for HIV disclose their results to their wives?  
IV Stigma and discrimination in HIV 
What are your feelings about HIV positive people?  
Are they responsible for being HIV positive?  
Are they immoral?  
Should they be sanctioned (penalised)?  
Are they contagious and threatening to the community?  
Is HIV death undesirable and unclean? 
What are your feelings about pregnant mothers who test for HIV? 
What are your feelings about HIV positive pregnant mothers? 
What are your feelings about pregnant mothers taking HIV drugs? 
What are your feelings about giving HIV drugs to newborn babies? 
What are your feelings about mothers who do not breastfeed their infants? 
What are your feelings about mothers being visited in their homes by health officials 
e.g. TASO 
What are your feelings about having VCT in hospital compared to another place e.g. 
AIC, JCRC? 
What are your feelings about disclosure of HIV positive status to your partner, 
relatives, friends, and other people? 
V Culture Issues 
What is the sexual division of labour?  
What is the sexual division of sex?  
What is the sexual division of power (making decisions, controlling resources?  
What is the sexual division of social status? 
What is the perception of masculinity?  
What is the perception of femininity?  
Can women negotiate for safer sex e.g. use of the condom?  
What is the social status of married versus unmarried women?  
How does polygamy affect the situation of women?  
What does it mean for a woman not to be married?  
How do women feel about being abandoned by their husbands?  
Do married women have the right to refuse sex from their husbands? 
If a man forces his wife to have sex with him, is it acceptable or not? 
Do men have the right to have multiple sexual partners?  
Do women have the power to reject multiple sexual partners of their husbands? 
VI Social networks and support for mothers (list and rank)
If a pregnant mother is asked to test for HIV, can she accept to test without 
consultation?  
If she consults, whom does she consult?  
If the pregnant woman is HIV positive, does she tell others?  
If yes, whom does she tell?  
Whom does she consult when she is choosing the method of feeding her infant soon 
after delivery?  
Who advises her when to introduce other feeds for the child?  
Who advises her on her own health?  
Who advises her on use of HIV prevention e.g. condoms?  
Who advises her on use of HIV drugs?  
Who advises her on marital issues?  
VII  Health Care System 
What do you know about ANC? 
What are your feelings about attending ANC with your partner?  
What are the problems with the current set up in the ANC? 
What could be done to make it more user friendly for the men? 
VIII Suggestions 
What can be done to support mothers to test for HIV, use HIV drugs, and use 
appropriate infant feeding methods to prevent HIV in children?  
What should be done to involve the men in the PMTCT programme?
Consent forms for paper IV
Informed consent form for intervention study 
Title of study: Facility-based intervention to increase male involvement in antenatal care 
and the prevention programme of mother-to-child transmission of HIV in Eastern 
Uganda  
Investigators: 
Dr Robert Byamugisha, Mbale Regional Referral Hospital, P O Box 921 Mbale – Uganda. 
Tel: +256 772 68 90 28 
Prof. Thorkild Tylleskär, Centre for International Health, University of Bergen 
Arstadveien 21, N-5009 Bergen – Norway. 
Prof. James K Tumwine, Department of Paediatrics and Child Health, Makerere University, 
P O Box 7072, Kampala – Uganda 
Dr Grace Ndeezi, Department of Paediatrics and Child Health, Makerere  University, 
P O Box 7072, Kampala – Uganda 
Introduction and purpose of the intervention study 
This study is being conducted by doctors from Mbale Regional Hospital, the Department of 
Paediatrics and Child Health, Makerere University and the Centre for International Health, 
University of Bergen. The study is a health facility-based intervention to increase male 
involvement in antenatal care and the prevention programme of mother-to-child transmission 
of HIV in Eastern Uganda. The study has two components: a cross-sectional survey and 
clinical trial. The purpose of the intervention study is to obtain information that will be used 
to understand the impact of a letter to the spouses of pregnant women attending antenatal 
clinic (ANC) at Mbale Regional Referral hospital on ANC attendance, couple counselling 
and/or testing for HIV (under the PMTCT programme). A total of 1060 women will be 
enrolled in the study.
Procedures to be followed 
You will be tracked from the reception to the time you exit the clinic. You will be asked 
questions concerning you and your living conditions. If you are selected for the intervention 
you will be given a letter to take to your spouse. You will also be requested to attend at least 2 
subsequent antenatal visits under the study. An exit interview will be conducted on issues 
regarding antenatal care, routine counselling and testing for HIV and prevention of mother to 
child transmission of HIV services.
Risks 
There are no anticipated risks arising from this study. However, some questions may address 
sensitive issues concerning your sexuality such as condom use. This may cause temporary 
anxiety.
Potential benefits
It is hoped that the results of the study will be used to improve the delivery of antenatal and 
prevention of mother to child transmission of HIV services, which will be of benefit to you 
and your unborn child. 
Costs or payments
There are no costs or payments to you for participating in this study. 
Confidentiality
Your and your spouse’s personal information will be strictly kept confidential. We will not 
give this information to anyone unless we get your permission to do so. You will not be 
personally identified in any publication or presentation about this study. However, the 
Makerere University College of Medicine Research and Ethics Committee, and the Uganda 
National Council for Science and Technology may check your records and the consent form 
you signed to make sure all rules and guidelines were followed. 
Your rights as a research participant/volunteer 
Your participation in this study is entirely voluntary. You will be asked to sign the consent 
form only when you have understood and agreed to participate in the study. You may decide 
to withdraw from the study at any stage. Such a decision will not affect your medical care or 
possible participation in future research studies in any way. 
Problems or questions 
If you have any questions about this study you can ask them now or at anytime during the 
course of the study. You are free to contact the following persons at any time; Dr. Robert 
Byamugisha on Telephone 256 772 68 90 28 or Prof James Tumwine on telephone 
256 772 494 120 or Dr Grace Ndeezi on telephone 256 772 453191. You are also free to 
contact the Chairman of the Ethics committee of Makerere University College of Medicine on 
telephone +256 412 530 020. 
Respondent’s consent
I have understood the information given to me about this study. I understand that my decision 
to participate in this study is voluntary and my decision not to participate will not alter the 
care I receive from this hospital. I also understand that my identity will remain anonymous in 
the use of the information generated from this study. I am aware that I may withdraw from 
this study any time. 
If I have any questions concerning my rights as a research subject, I may contact Makerere 
University College of Medicine Research and Ethics Committee or the Uganda National 
Council of Science and Technology (Tel: +256 412 250 499 or +256 412 250 431). 
I understand that by signing this consent form, I do not waive my legal rights nor does it 
relieve investigators of liability but merely indicates that I have been informed about the 
research study in which I am voluntarily agreeing to participate. 
_____________________________  ____________________ _____________ 
Respondent’s Names    Signature/ thumb print  Date 
_____________________________  ____________________ _____________ 
Person administering consent  Signature   Date 
_____________________________      _____________ 
Principal Investigator’s Signature      Date 
Questionnaire for Paper IV: Initial visit at ANC 
Title: Facility-based intervention to increase male involvement in antenatal care and the 
prevention programme of mother-to-child transmission of HIV in Eastern Uganda 
Interview of females 
Hello, I come from Makerere University, Uganda and the Centre for International Health,
University of Bergen, Norway. The title of study is:  Facility-based intervention to increase 
male involvement in antenatal care and the prevention programme of mother-to-child 
transmission of HIV in Eastern Uganda 
The purpose of the study is to collect information on women's views on the current service 
delivery at the antenatal clinic at Mbale Regional Referral Hospital and to study how to 
increase the male partners’ involvement in the ANC clinic work. The results of the study will 
be used to improve the delivery of health services. You will be given a letter to take to your 
spouse and we are using letters with slightly different content.
The information you give shall be confidential and you will not be personally identified in any 
publication or presentation about this study. 
I.  IDENTIFICATION       
1. Date of interview                 <dd/mm/yyyy> .…/.…/……… 
2. Name of Interviewer ………………………………………………… 
3. Participant’s ID Number         ………………. 
4. Participant’s names …………………………………………………… 
5. What are your husband’s names? ---------------------------------------------------------------
6.  Would he be willing to attend ANC with you?   --------- 1=yes, 2=no 
If no, give reasons----------------------------------------------------------------------------------
7.  Do you mind taking this written document to him? ------ 1=yes, 2=no 
If no, give reasons----------------------------------------------------------------------------------
If she accepts to take the document, remind her about her next ANC visit and the 
importance of adhering to the visits. Complete the interview and thank her cooperation 
and for participating. 
Signature of the interviewer---------------------------                               Date-------------- 
Questionnaire for Paper IV: Return visit at ANC
Title: Facility-based intervention to increase male involvement in antenatal care and the 
prevention programme of mother-to-child transmission of HIV in Eastern Uganda 
Interview of females 
Hello, I come from Makerere University, Uganda and the Centre for International Health,
University of Bergen, Norway. The title of study is:  Facility-based intervention to increase 
male involvement in antenatal care and the prevention programme of mother-to-child 
transmission of HIV in Eastern Uganda 
The purpose of the study is to obtain information on women's views on the current service 
delivery at the antenatal clinic at Mbale Regional Referral Hospital. It is also to explore 
whether a letter of invitation for the male partners will increase couple ANC attendance; and 
whether the increase in couple ANC attendance will lead to an increase in couple counselling 
and testing for HIV. The results of the study will be used to improve the delivery of health 
services. The information you give shall be confidential and you will not be personally 
identified in any publication or presentation about this study. 
I.  IDENTIFICATION       
1. Date of interview                 <dd/mm/yyyy> .…/.…/……… 
2.   Name of Interviewer ………………………………………………… 
3.  Participant’s ID Number         ………………. 
4. Participant’s names …………………………………………………… 
5. What are your husband’s names? --------------------------------------------------------------
II SOCIO-DEMOGRAPHIC CHARACTERISTICS 
6.  Where do you live?      --------- 1=rural, 2=urban 
(a) How old were you on your last birthday?  --------- (completed years), 99= do not 
know ……. 
(b) When were you born? ................ (Year) 
7.  What is your current   marital status?       ………. 1=single, 2=divorced/separated,
               3=widower, 4=cohabiting, 5=married   
8.  Is this your first pregnancy?     1=Yes, 2= No ……… 
9. If no, how many pregnancies have you had before the current one?  …………. 
10.  What is your religion?  ------ 1=Protestant/Lutheran, 2=Catholic,
                                                      3=Muslim, 4=other, specify: --------- 
11.  What is your tribe (ethnic background)? ------ 1=Mugisu, 2=Mugwere, 3=Atesot,
4=Musoga, 5=Muganda, 6=other, specify: ---------- 
12. Did you attend school? …….. 1=Yes, 2=No 
13. If yes, what level of schooling did you achieve? ................ 
14. How many completed years of schooling have you had? /do you have? (Exclude 
repeated years and pre-school) ……… 
15. What do you do for a living? ---- 1=housewife, 2=farmer, 3=service,
4=business, 5=professional, 6=student, 7=other, specify: ----------
16.  How old is your husband/ partner? ----- (completed years), 99=do not know 
17.  How many completed years of schooling does your husband/partner have? (Exclude 
repeated years and pre-school)    -------- 99= do not know
18. What does your husband/partner do for a living? ----- 1=farmer, 2=business, 3=skilled
worker, 4=unskilled worker, 5=service, 6=official, 7=professional, 8=unemployed, 
9=student, 0=other, specify: ----------  
19.  Do you own the house you live in? ---- 1=Yes,  
                                                  2=No, rent the house,
                                                  3=No, house of my parents,
                                                  4=No, house of spouse's parents,  
  5=No, other: -------------- 
20.  What type of house is it?  ---- 1=permanent, 2=semi-permanent, 3= other, 
specify……….,.
21.  Does your household own any of the following items (functioning)?      
       Radio                            ----    1=yes, 2=no   
       Bicycle                          ----    1=yes, 2=no  
       Sofa                               ----    1=yes, 2=no  
      Hurricane lamp             ----    1=yes, 2=no  
       Cupboard                      -----   1=yes, 2=no  
       TV                                 ----    1=yes, 2=no  
       Mobile phone                 ----   1=yes, 2=no                                                
       Refrigerator                   ----    1=yes, 2=no  
      Car/truck                        ----    1=yes, 2=no  
       Motorcycle/scooter        ----    1=yes, 2=no
II. CLINICAL ACTIVITIES 
Now I will ask you some questions about the ANC clinic  
22.  How was your visit to the antenatal clinic today? ---- 1=very bad, 2=bad, 3=fair, 
                                                                                             4=good, 5=very good 
23. Did you come to the ANC clinic with your partner (husband)? …… 1=Yes, 2=No 
24. If a score of 10 is very good and 1 is very bad, please give me your score (out of 10) 
for how the following worked out for you: 
Handling/treatment by the midwives (staff) …… 
Waiting                                                         …… 
Facilities                                                        …… 
Health education talk/lection                        …… 
25.  Have you heard about a programme at the clinic regarding prevention of mother-to-
child transmission of HIV?  ------- 1=yes, 2=no
26. Did you get any information about HIV at the antenatal clinic today? ----- 1=yes,  
                                                                                                                   2=no (skip to 28) 
27. If yes, in which form? 
 TV                                ---- - 1=yes, 2=no    
 General information     ------ 1=yes, 2=no    
 Group counselling         ------ 1=yes, 2=no    
 Individual counselling    ------ 1=yes, 2=no  
28.  Were you offered testing for HIV? ---- 1=yes, 2=no (skip to 35) 
29.  Did you ask your husband/partner for permission to be tested before testing? ---- 
1=yes, 2=no 
30.  Did he agree?                    ----- 1=yes, 2=no  
31.  Did you test for HIV?       ----- 1=yes, 2=no (skip to 33) 
32.  Did you receive the results of the test today?  ---- 1=yes (skip to 36), 2=no   
33.   If no, were you told when to come back for the result? ---- 1=yes, 2=no 
34. If you did not test, have you ever tested for HIV? ---- 1=yes, 2=no 
35.  Do you think your husband/partner knows you are being tested for HIV? …… 1=yes, 
2=no
36. Did they suggest your husband/ partner to be tested as well? ....  1=yes, 2=no  
37. Was he tested for HIV ? ………….. 1=Yes, 2=No       
38. What were his HIV tests?  ………….. 1=HIV positive, 2=HIV negative, 3=don’t know 
39.  How was your pre-test counselling at the antenatal clinic? ----- 1=very bad, 2=bad, 
3=fair,   good, 5=very good 
40.  How was your post-test counselling at the antenatal clinic? …. 1=very bad, 2=bad, 
3=fair,   4=good, 5=very good 
41. What were HIV test results? ………… 1=HIV positive, 2=HIV negative  
42.  Nowadays in this clinic all mothers are supposed to be tested for HIV unless they say 
no. What do you think about this system? Is it: ----- 1=very bad, 2=bad, 3=fair, 
4=good, 5=very good 
43.  Why do you think it is good or bad? ……………………………………………..   
….…………………………………………………………………………………..
VI.  HIV AND INFANTS  
  Now I will ask you some questions about HIV and infants 
44.  Is it possible that the mother or the father is HIV positive, and their newborn child is 
HIV negative?                                        …… 1=Yes, 2=No  
45.  When can HIV be passed from a mother to her child? 
 During pregnancy                  ----- 1=yes, 2=no  
 Labour                                   ------ 1=yes, 2=no    
 Through breastfeeding           ------ 1=yes, 2=no  
 Sexual intercourse                  ------ 1=yes, 2=no  
 Other                                       ------ 1=yes, 2=no, (specify :----------) 
46.  If there are 10 HIV infected pregnant women, how many do you think would have 
babies born with HIV virus?        ------- (number between 0 and 10) 
47.  If the baby gets breast milk from the mother and the mother is HIV positive, can the 
baby get HIV?          -------- 1=yes, 2=no (skip to 52) 
48. How many babies could get HIV infected through breastfeeding out of 10 HIV 
infected mothers?      -------- (number between 0 and 10)  
49.  Can a mother who HIV positive do anything to reduce the risk of transmission of HIV 
to her child during pregnancy? -------- 1=Yes, 2=No, 3=Do not know
50.  If yes, what can a mother do to reduce the risk of transmission of   HIV to her child 
during pregnancy? 
 Take medicine            -------- 1=yes, 2=no      
 Use condoms              --------- 1=yes, 2=no  
 Other                          --------- 1=yes, 2=no (specify :----------) 
51.  Can a HIV infected mother do anything to reduce the risk of transmission of HIV to 
her child during the breastfeeding period?  -------- 1=Yes, 2=No, 3=Do not know  
52.  If yes, what would an HIV positive mother do to reduce the risk of her baby becoming          
infected with HIV during the breastfeeding period? 
Give breast milk only and no other feeds up to 6 months (exclusive breastfeeding) ----- 
1=yes, 2=no 
Use condom                                                  ------- 1=yes, 2=no
Stop breastfeeding; give infant formula       ------ 1=yes, 2=no
Stop breastfeeding; give diluted cow’s milk ------ 1=yes, 2=no    
Breast care                   ------- 1=yes, 2=no (specify :----------) 
Other                     -------- 1=yes, 2=no (specify :----------) 
53.  If you hypothetically were HIV positive, what infant feeding option would be 
feasible? -----------    1=Infant feeding formula, 2=Cow milk, 3=Give breast milk only 
and no other feeds, other (specify) ----------
V.  SERVICE IMPROVEMENT 
54.  What would you wish done differently?--------------------------------------------------------
--------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------
Remind her about her next ANC visit and the importance of adhering to the visits. 
Complete the interview and thank her cooperation and for participating. 
Signature of the interviewer---------------------------                               Date-------------- 
Letter to the spouse 
Non-intervention letter 
Dr. Robert Byamugisha 
Department of Obstetrics and Gynaecology 
Mbale Regional Referral Hospital 
Tel: +256 772 68 90 28 
        Mbale _____/______/ 2009 
To
Mr _________________________________________________ 
RE: INFORMATION ABOUT ANTENATAL CARE OF YOUR SPOUSE 
Your spouse has attended her first antenatal visit at Mbale Regional Referral Hospital today. 
The appointment date for her next antenatal visit has been scheduled. We would like to 
inform you about the services we provide at our clinic.
At the antenatal clinic, we carry out the following investigations: blood pressure as some 
women develop high blood pressure during pregnancy; urine test to check for protein and 
exclude infection; blood test to check if haemoglobin is low (if she has enough blood); blood 
test to check for syphilis (kabotongo) which can easily be treated. We also check the baby in 
the womb. In addition to the antenatal services, the hospital offers prevention of mother-to-
child transmission of HIV (PMTCT) services free of charge. As a hospital, we have noticed 
that utilization of these services by the women is high and these services have many benefits 
to your spouse and the unborn baby. 
I hope this brief information can be useful for you and your spouse.  
Yours sincerely, 
Dr Robert Byamugisha 
Intervention letter 
Dr. Robert Byamugisha 
Department of Obstetrics and Gynaecology 
Mbale Regional Referral Hospital 
Tel: +256 772 68 90 28 
        Mbale _____/______/ 2009 
To
Mr _________________________________________________ 
RE: INVITATION TO ATTEND ANTENATAL CARE WITH YOUR SPOUSE 
Your spouse has attended her first antenatal visit at Mbale Regional Referral Hospital today. 
The appointment date for her next antenatal visit will be on day…………../………/……….  
at ………….am. 
In addition to the antenatal services, the hospital offers prevention of mother-to-child 
transmission of HIV (PMTCT) services free of charge. As a hospital, we have noticed that 
utilization of these services by the men is low and yet these services have many benefits to 
you and your spouse and the unborn baby. Therefore I have the pleasure to invite you to come 
with your spouse on next antenatal visit as per appointment date. There are important issues 
we want to discuss with you and your spouse concerning her antenatal care. We shall be 
happy to answer any questions that you might have concerning her care in this hospital. 
Your presence is highly appreciated and you will be given first priority to minimize the time 
spent on the hospital on that day. 
I look forward to seeing you on that day. 
Yours sincerely, 
Dr Robert Byamugisha
